"Name","Gene.s.","Protein.change","Condition.s.","Clinical.significance..Last.reviewed.","Review.status","Accession","GRCh37Chromosome","GRCh37Location","GRCh38Chromosome","GRCh38Location","VariationID","AlleleID.s.","dbSNP.ID","Canonical.SPDI"
"0","0","0","0","0","0","0","0","0","0","0",0,"0","0","0"
"NM_002506.2(NGF):c.661C>T (p.Arg221Trp)","NGF|NGF-AS1","R211W, R221W","Congenital sensory neuropathy with selective loss of small myelinated fibers","Pathogenic(Last reviewed: Feb 1, 2011)","no assertion criteria provided","VCV000014045","1","115828756","1","115286135",14045,"29084","rs11466112","NC_000001.11:115286134:G:A"
"NM_170707.4(LMNA):c.254T>G (p.Leu85Arg)","LMNA","L85R","not provided|Dilated cardiomyopathy 1A","Pathogenic(Last reviewed: Dec 2, 1999)","no assertion criteria provided","VCV000014480","1","156084963","1","156115172",14480,"29519","rs28933090","NC_000001.11:156115171:T:G"
"NM_170707.4(LMNA):c.585C>G (p.Asn195Lys)","LMNA","N195K, N114K, N83K","Charcot-Marie-Tooth disease, type 2|Primary dilated cardiomyopathy|not provided|Dilated cardiomyopathy 1A","Pathogenic(Last reviewed: Jul 9, 2019)","criteria provided, multiple submitters, no conflicts","VCV000014483","1","156104265","1","156134474",14483,"29522","rs28933091","NC_000001.11:156134473:C:G"
"NM_170707.4(LMNA):c.608A>G (p.Glu203Gly)","LMNA","E203G, E122G, E91G","Dilated cardiomyopathy 1A|Primary dilated cardiomyopathy|not provided","Pathogenic(Last reviewed: Aug 21, 2015)","criteria provided, single submitter","VCV000014484","1","156104288","1","156134497",14484,"29523","rs28933092","NC_000001.11:156134496:A:G"
"NM_170707.4(LMNA):c.169G>C (p.Ala57Pro)","LMNA","A57P","not provided|Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome","Pathogenic(Last reviewed: Feb 15, 2009)","no assertion criteria provided","VCV000014506","1","156084878","1","156115087",14506,"29545","rs28928903","NC_000001.11:156115086:G:C"
"NM_000198.4(HSD3B2):c.29C>A (p.Ala10Glu)","HSD3B2","A10E","3 beta-Hydroxysteroid dehydrogenase deficiency","Pathogenic(Last reviewed: May 1, 2000)","no assertion criteria provided","VCV000012188","1","119958071","1","119415448",12188,"27227","rs28934880","NC_000001.11:119415447:C:A"
"NM_001007792.1(NTRK1):c.1730G>T (p.Gly577Val)","NTRK1","G607V, G577V, G613V","not specified|not provided|Hereditary insensitivity to pain with anhidrosis|Familial medullary thyroid carcinoma","Benign/Likely benign(Last reviewed: Jun 10, 2021)","criteria provided, multiple submitters, no conflicts","VCV000012308","1","156848946","1","156879154",12308,"27347","rs6339","NC_000001.11:156879153:G:T"
"NM_000702.4(ATP1A2):c.2659T>C (p.Trp887Arg)","ATP1A2","W887R","Familial hemiplegic migraine|Familial hemiplegic migraine type 2","Pathogenic(Last reviewed: Apr 22, 2021)","no assertion criteria provided","VCV000012918","1","160106455","1","160136665",12918,"27957","rs28933399","NC_000001.11:160136664:T:C"
"NM_000702.4(ATP1A2):c.2192T>C (p.Met731Thr)","ATP1A2","M731T","Familial hemiplegic migraine type 2","Pathogenic(Last reviewed: Jan 13, 2012)","no assertion criteria provided","VCV000012919","1","160105300","1","160135510",12919,"27958","rs28933400","NC_000001.11:160135509:T:C"
"NM_002036.3(ACKR1):c.-67T>C","ACKR1","","White blood cell count quantitative trait locus 1|Plasmodium vivax, resistance to|DUFFY BLOOD GROUP SYSTEM, FY(a-b-) PHENOTYPE","Pathogenic, association, protective(Last reviewed: Dec 11, 2017)","no assertion criteria provided","VCV000018395","1","159174683","1","159204893",18395,"33434","rs2814778","NC_000001.11:159204892:T:C"
"NM_001007792.1(NTRK1):c.1702C>T (p.His568Tyr)","NTRK1","H598Y, H568Y, H604Y","not specified|not provided|Hereditary insensitivity to pain with anhidrosis|Familial medullary thyroid carcinoma","Benign/Likely benign(Last reviewed: Jul 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000037077","1","156848918","1","156879126",37077,"38397","rs6336","NC_000001.11:156879125:C:T"
"NM_001002294.3(FMO3):c.923A>G (p.Glu308Gly)","FMO3","E308G, E245G, E288G","Trimethylaminuria|not specified","Benign/Likely benign(Last reviewed: May 28, 2019)","criteria provided, multiple submitters, no conflicts","VCV000038395","1","171083242","1","171114102",38395,"31357","rs2266780","NC_000001.11:171114101:A:G"
"NM_000186.3(CFH):c.1204= (p.His402=)","CFH","","Basal laminar drusen|Age-related macular degeneration 4","Pathogenic, risk factor(Last reviewed: Jun 11, 2019)","no assertion criteria provided","VCV000016549","1","196659237","1","196690107",16549,"31588","rs1061170","NC_000001.11:196690106:C:C"
"NM_000069.3(CACNA1S):c.3716G>A (p.Arg1239His)","CACNA1S","R1239H","Malignant hyperthermia, susceptibility to, 5|Hypokalemic periodic paralysis 1|not provided|Hypokalemic periodic paralysis 1","Pathogenic(Last reviewed: Sep 24, 2020)","criteria provided, multiple submitters, no conflicts","VCV000017623","1","201022666","1","201053538",17623,"32662","rs28930068","NC_000001.11:201053537:C:T"
"NM_000069.3(CACNA1S):c.3715C>G (p.Arg1239Gly)","CACNA1S","R1239G","Malignant hyperthermia, susceptibility to, 5|Hypokalemic periodic paralysis 1|not provided|Hypokalemic periodic paralysis 1","Pathogenic(Last reviewed: May 25, 2020)","criteria provided, multiple submitters, no conflicts","VCV000017624","1","201022667","1","201053539",17624,"32663","rs28930069","NC_000001.11:201053538:G:C"
"NM_007375.3(TARDBP):c.892G>A (p.Gly298Ser)","TARDBP","","not provided|Amyotrophic lateral sclerosis type 10","Pathogenic(Last reviewed: Jun 22, 2018)","criteria provided, single submitter","VCV000005232","1","11082358","1","11022301",5232,"20271","rs4884357","NC_000001.11:11022300:G:A"
"NM_000157.4(GBA):c.680A>G (p.Asn227Ser)","GBA|LOC106627981","N227S, N140S, N178S","Gaucher disease type 3C|Gaucher disease type III|Gaucher disease type I|Gaucher disease type II|not provided|Gaucher disease|Gaucher disease type I|Gaucher disease type III","Pathogenic/Likely pathogenic(Last reviewed: Jul 26, 2020)","criteria provided, multiple submitters, no conflicts","VCV000004314","1","155208006","1","155238215",4314,"19353","rs364897","NC_000001.11:155238214:T:C"
"NM_000157.3(GBA):c.1448T>C","GBA|LOC106627981","L483P, L396P, L434P","not provided|Gaucher disease type 3C|Gaucher disease type III|Gaucher disease type I|Gaucher disease type II|Parkinson disease, late-onset|Gaucher disease|Dementia, Lewy body, susceptibility to|Hereditary late onset Parkinson disease|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Thoracolumbar scoliosis|Resting tremor|Parkinsonism|Hypomimic face|Movement disorder","Pathogenic, risk factor(Last reviewed: Jun 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000004288","1","155205043","1","155235252",4288,"19327","rs421016","NC_000001.11:155235251:A:G"
"NM_000157.4(GBA):c.1342G>C (p.Asp448His)","GBA|LOC106627981","D448H, D361H, D399H","Gaucher disease type 3C|Gaucher disease type III|Gaucher disease type I|Gaucher disease type II|Gaucher disease, perinatal lethal|Gaucher disease type 3C|Gaucher disease type III|Gaucher disease type I|Parkinson disease, late-onset|Gaucher disease type II|Lewy body dementia|not provided|Gaucher disease|Hereditary late onset Parkinson disease|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type II|Gaucher disease type 3C|Gaucher disease type III","Pathogenic/Likely pathogenic(Last reviewed: May 3, 2021)","criteria provided, multiple submitters, no conflicts","VCV000004293","1","155205518","1","155235727",4293,"19332","rs1064651","NC_000001.11:155235726:C:G"
"NM_000157.4(GBA):c.754T>A (p.Phe252Ile)","GBA|LOC106627981","F252I, F165I, F203I","not provided|Gaucher disease|Gaucher disease type I|Gaucher disease type III|Gaucher disease type II","Pathogenic(Last reviewed: Oct 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000004301","1","155207932","1","155238141",4301,"19340","rs381737","NC_000001.11:155238140:A:T"
"NM_004700.4(KCNQ4):c.853G>A (p.Gly285Ser)","KCNQ4","G285S","Autosomal dominant nonsyndromic deafness 2A|Rare genetic deafness|Nonsyndromic hearing loss and deafness","Pathogenic(Last reviewed: Sep 11, 2018)","reviewed by expert panel","VCV000006241","1","41285565","1","40819893",6241,"21280","rs28937588","NC_000001.11:40819892:G:A"
"NM_004700.4(KCNQ4):c.853G>T (p.Gly285Cys)","KCNQ4","G285C","Autosomal dominant nonsyndromic deafness 2A","Pathogenic(Last reviewed: Feb 17, 2011)","no assertion criteria provided","VCV000006244","1","41285565","1","40819893",6244,"21283","rs28937588","NC_000001.11:40819892:G:T"
"NM_024009.3(GJB3):c.101T>C (p.Leu34Pro)","GJB3","L34P","Erythrokeratodermia variabilis et progressiva 1","Pathogenic(Last reviewed: May 15, 2002)","no assertion criteria provided","VCV000006491","1","35250464","1","34784863",6491,"21530","rs28937583","NC_000001.11:34784862:T:C"
"NM_174936.3(PCSK9):c.2037C>A (p.Cys679Ter)","PCSK9","C679*","Familial hypercholesterolemia|not provided|Low density lipoprotein cholesterol level quantitative trait locus 1|Familial hypercholesterolemia 3|Hypocholesterolemia","Conflicting interpretations of pathogenicity(Last reviewed: Mar 31, 2021)","criteria provided, conflicting interpretations","VCV000002877","1","55529215","1","55063542",2877,"17916","rs28362286","NC_000001.11:55063541:C:A"
"NM_001008216.2(GALE):c.937C>A (p.Leu313Met)","GALE","L313M","UDPglucose-4-epimerase deficiency","Pathogenic(Last reviewed: Jan 1, 1998)","no assertion criteria provided","VCV000003680","1","24122692","1","23796202",3680,"18719","rs3180383","NC_000001.11:23796201:G:T"
"NM_001122764.3(PPOX):c.35T>C (p.Ile12Thr)","PPOX","I12T","Variegate porphyria, homozygous","Pathogenic(Last reviewed: Apr 1, 2001)","no assertion criteria provided","VCV000008703","1","161136672","1","161166882",8703,"23742","rs28936677","NC_000001.11:161166881:T:C"
"NM_001122764.3(PPOX):c.767C>G (p.Pro256Arg)","PPOX","P256R, P120R, P223R, P94R","not provided|Variegate porphyria|Variegate porphyria, homozygous","Conflicting interpretations of pathogenicity(Last reviewed: Dec 5, 2020)","criteria provided, conflicting interpretations","VCV000008704","1","161138933","1","161169143",8704,"23743","rs12735723","NC_000001.11:161169142:C:G"
"NM_005263.5(GFI1):c.1145A>G (p.Asn382Ser)","GFI1","N382S","not provided|Severe congenital neutropenia 2, autosomal dominant","Pathogenic(Last reviewed: Mar 1, 2018)","criteria provided, single submitter","VCV000008739","1","92941710","1","92476153",8739,"23778","rs28936381","NC_000001.11:92476152:T:C"
"NM_000350.3(ABCA4):c.2828G>A (p.Arg943Gln)","ABCA4","R943Q","not provided|not specified|MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO|none provided|Stargardt disease|Macular degeneration|Stargardt disease 1|ABCA4-Related Disorders|Stargardt Disease, Recessive|Cone-Rod Dystrophy, Recessive|Retinitis Pigmentosa, Recessive","Benign/Likely benign(Last reviewed: Dec 2, 2020)","criteria provided, multiple submitters, no conflicts","VCV000007913","1","94512565","1","94047009",7913,"22952","rs1801581","NC_000001.11:94047008:C:T"
"NM_000261.2(MYOC):c.1196G>T (p.Gly399Val)","MYOC","G399V","Glaucoma 1, open angle, a, digenic","Pathogenic(Last reviewed: Feb 1, 2002)","no assertion criteria provided","VCV000007957","1","171605384","1","171636244",7957,"22996","rs28936694","NC_000001.11:171636243:C:A"
"NM_000447.3(PSEN2):c.715A>G (p.Met239Val)","PSEN2","M239V","not provided|Alzheimer disease, type 4","Pathogenic(Last reviewed: Aug 31, 1995)","no assertion criteria provided","VCV000008846","1","227076678","1","226888977",8846,"23885","rs28936379","NC_000001.11:226888976:A:G"
"NM_000098.3(CPT2):c.149C>A (p.Pro50His)","CPT2","P50H","Carnitine palmitoyltransferase II deficiency|not provided|Carnitine palmitoyltransferase II deficiency, infantile|Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced|Gastrointestinal dysmotility|Inappropriate sinus tachycardia|Chronic pain|Dysautonomia|Sinus tachycardia|Arthritis|Pancytopenia|Polyarticular arthritis|Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced|Carnitine palmitoyltransferase II deficiency, infantile|Carnitine palmitoyltransferase II deficiency, lethal neonatal|Encephalopathy, acute, infection-induced, 4, susceptibility to","Pathogenic(Last reviewed: Sep 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000008954","1","53662764","1","53197092",8954,"23993","rs28936375","NC_000001.11:53197091:C:A"
"NM_000098.3(CPT2):c.1883A>C (p.Tyr628Ser)","CPT2","Y628S, Y605S","Carnitine palmitoyltransferase II deficiency|Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced|Carnitine palmitoyltransferase II deficiency, infantile","Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)","criteria provided, multiple submitters, no conflicts","VCV000008956","1","53679173","1","53213501",8956,"23995","rs28936673","NC_000001.11:53213500:A:C"
"NM_001205293.3(CACNA1E):c.2104G>A (p.Ala702Thr)","CACNA1E","A702T","not provided|Developmental and epileptic encephalopathy, 69|Inborn genetic diseases","Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000521483","1","181693635","1","181724499",521483,"511197","rs12131800","NC_000001.11:181724498:G:A"
"NM_001244753.2(FCGR3B):c.316A>G (p.Ile106Val)","FCGR3B","I106V, I105V, I89V","not specified","Benign(Last reviewed: Mar 28, 2016)","criteria provided, single submitter","VCV000402858","1","161599571","1","161629781",402858,"389362","rs2290834","NC_000001.11:161629780:T:C"
"NC_000001.11:g.198807802C>A","","","Acute myeloid leukemia with maturation","Pathogenic","no assertion criteria provided","VCV000427752","1","198776931","1","198807802",427752,"417641","rs9660525","NC_000001.11:198807801:C:A"
"NM_001205293.3(CACNA1E):c.2104G>C (p.Ala702Pro)","CACNA1E","A702P","not provided","Likely pathogenic(Last reviewed: Apr 20, 2016)","criteria provided, single submitter","VCV000427007","1","181693635","1","181724499",427007,"414747","rs12131800","NC_000001.11:181724498:G:C"
"NR_040073.1(MIR181A1HG):n.363+1456C>T","MIR181A1HG","","Acute myeloid leukemia with maturation","Pathogenic","no assertion criteria provided","VCV000427755","1","198868084","1","198898955",427755,"417644","rs10800597","NC_000001.11:198898954:G:A"
"NM_003126.4(SPTA1):c.2353C>T (p.Arg785Ter)","SPTA1","R785*","Hemolytic anemia","Likely pathogenic","no assertion criteria provided","VCV000812891","1","158632603","1","158662813",812891,"800979","rs2022057","NC_000001.11:158662812:G:A"
"NM_007375.3(TARDBP):c.892G>T (p.Gly298Cys)","TARDBP","G298C","not provided","Uncertain significance(Last reviewed: Aug 3, 2018)","criteria provided, single submitter","VCV000586812","1","11082358","1","11022301",586812,"576388","rs4884357","NC_000001.11:11022300:G:T"
"NM_000069.3(CACNA1S):c.2748C>G (p.His916Gln)","CACNA1S","H916Q","Hypokalemic periodic paralysis 1","Pathogenic(Last reviewed: Jul 31, 2014)","no assertion criteria provided","VCV000143198","1","201035071","1","201065943",143198,"152916","rs2297902","NC_000001.11:201065942:G:C"
"NM_000701.8(ATP1A1):c.311T>G (p.Leu104Arg)","ATP1A1","L104R, L73R","Aldosterone-producing adrenal cortex adenoma","Pathogenic(Last reviewed: Feb 17, 2013)","no assertion criteria provided","VCV000162466","1","116930037","1","116387415",162466,"172140","rs11540945","NC_000001.11:116387414:T:G"
"NM_170707.4(LMNA):c.585C>A (p.Asn195Lys)","LMNA","N195K, N114K, N83K","not provided","not provided","no assertion provided","VCV000066913","1","156104265","1","156134474",66913,"77810","rs28933091","NC_000001.11:156134473:C:A"
"NM_170707.4(LMNA):c.608A>T (p.Glu203Val)","LMNA","E203V, E91V, E122V","not provided","not provided","no assertion provided","VCV000066915","1","156104288","1","156134497",66915,"77812","rs28933092","NC_000001.11:156134496:A:T"
"NM_000350.3(ABCA4):c.3386G>T (p.Arg1129Leu)","ABCA4","R1129L","Retinal dystrophy|not provided|Stargardt disease 1|Stargardt disease 1|Cone-rod dystrophy 3|Age-related macular degeneration 2|Retinitis pigmentosa 19|Age-related macular degeneration 2","Pathogenic/Likely pathogenic(Last reviewed: Aug 7, 2020)","criteria provided, multiple submitters, no conflicts","VCV000099224","1","94506901","1","94041345",99224,"105113","rs1801269","NC_000001.11:94041344:C:A"
"NM_000350.3(ABCA4):c.4685T>C (p.Ile1562Thr)","ABCA4","I1562T","Stargardt disease|Cone-rod dystrophy 3|Retinal dystrophy|not provided|Cone-Rod Dystrophy, Recessive|Retinitis Pigmentosa, Recessive|Cone-rod dystrophy|ABCA4-Related Disorders|Stargardt disease 1","Conflicting interpretations of pathogenicity(Last reviewed: Oct 8, 2020)","criteria provided, conflicting interpretations","VCV000099311","1","94487490","1","94021934",99311,"105200","rs1762111","NC_000001.11:94021933:A:G"
"NM_000350.3(ABCA4):c.5693G>A (p.Arg1898His)","ABCA4","R1898H","Age-related macular degeneration 2|Inborn genetic diseases|Retinal dystrophy|ABCA4-Related Disorders|not provided|Stargardt disease|Stargardt disease 1|Retinitis pigmentosa","Conflicting interpretations of pathogenicity(Last reviewed: Jan 23, 2021)","criteria provided, conflicting interpretations","VCV000099398","1","94476377","1","94010821",99398,"105287","rs1800552","NC_000001.11:94010820:C:T"
"NM_000350.3(ABCA4):c.5461-10T>C","ABCA4","","Macular dystrophy|Retinal dystrophy|Stargardt disease 1|Age-related macular degeneration 2|Cone-rod dystrophy 3|Retinitis pigmentosa 19|Cone-rod dystrophy 3|Retinitis pigmentosa 19|Stargardt disease|not specified|Benign concentric annular macular dystrophy|Retinitis pigmentosa|Age-related macular degeneration 2|not provided|Stargardt disease 1","Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2021)","criteria provided, multiple submitters, no conflicts","VCV000092870","1","94476951","1","94011395",92870,"98777","rs1800728","NC_000001.11:94011394:A:G"
"NM_000157.4(GBA):c.1448T>G (p.Leu483Arg)","GBA|LOC106627981","L483R, L434R, L396R","not provided|Gaucher disease type II|Gaucher disease type III|Gaucher disease type I|Gaucher disease type II|Gaucher disease type 3C|Gaucher disease type I|Gaucher disease","Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2020)","criteria provided, multiple submitters, no conflicts","VCV000093449","1","155205043","1","155235252",93449,"99356","rs421016","NC_000001.11:155235251:A:C"
"NM_000157.4(GBA):c.681T>G (p.Asn227Lys)","GBA|LOC106627981","N227K, N140K, N178K","Gaucher disease type II|Gaucher disease type I|Gaucher disease type 3C|Gaucher disease type III|not provided|Gaucher disease","Pathogenic(Last reviewed: May 26, 2017)","criteria provided, multiple submitters, no conflicts","VCV000093458","1","155208005","1","155238214",93458,"99363","rs381418","NC_000001.11:155238213:A:C"
"NM_000157.4(GBA):c.721G>A (p.Gly241Arg)","GBA|LOC106627981","G241R, G154R, G192R","Gaucher disease|not provided|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|Gaucher disease type I","Pathogenic(Last reviewed: Oct 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000093459","1","155207965","1","155238174",93459,"99364","rs409652","NC_000001.11:155238173:C:T"
"NM_000069.3(CACNA1S):c.2748C>T (p.His916=)","CACNA1S","","Hypokalemic periodic paralysis 1|Malignant hyperthermia, susceptibility to, 5|not specified|Hypokalemic periodic paralysis 1|not provided","Benign(Last reviewed: Dec 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000254822","1","201035071","1","201065943",254822,"249618","rs2297902","NC_000001.11:201065942:G:A"
"NM_003126.4(SPTA1):c.6531-12C>T","SPTA1","","Hemolytic anemia|Elliptocytosis 2|Hereditary pyropoikilocytosis|not specified|Spherocytosis type 3","Conflicting interpretations of pathogenicity(Last reviewed: Jan 11, 2019)","criteria provided, conflicting interpretations","VCV000258954","1","158587858","1","158618068",258954,"249428","rs28525570","NC_000001.11:158618067:G:A"
"NM_003126.4(SPTA1):c.6549-12G>A","SPTA1","","Hemolytic anemia|Elliptocytosis 2|Hereditary pyropoikilocytosis|not specified|Spherocytosis type 3","Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2019)","criteria provided, conflicting interpretations","VCV000258955","1","158587390","1","158617600",258955,"249427","rs857716","NC_000001.11:158617599:C:T"
"NM_000350.3(ABCA4):c.3377T>C (p.Leu1126Pro)","ABCA4","L1126P","Stargardt disease 1","Likely pathogenic(Last reviewed: Jan 1, 2016)","criteria provided, single submitter","VCV000236101","1","94506910","1","94041354",236101,"237679","rs1047376","NC_000001.11:94041353:A:G"
"NM_170707.4(LMNA):c.254T>A (p.Leu85His)","LMNA","L85H","Charcot-Marie-Tooth disease, type 2","Uncertain significance(Last reviewed: Dec 16, 2015)","criteria provided, single submitter","VCV000242004","1","156084963","1","156115172",242004,"238146","rs28933090","NC_000001.11:156115171:T:A"
"NM_000570.4(FCGR3B):c.316A= (p.Ile106=)","FCGR3B","","","no interpretation for the single variant","no interpretation for the single variant","VCV000242687","1","161599571","1","161629781",242687,"45585","rs2290834","NC_000001.11:161629780:T:T"
"NM_003126.4(SPTA1):c.2353C>A (p.Arg785=)","SPTA1","","not provided|Elliptocytosis 2|Spherocytosis type 3|Hereditary pyropoikilocytosis|none provided","Benign/Likely benign(Last reviewed: Aug 31, 2020)","criteria provided, multiple submitters, no conflicts","VCV000293017","1","158632603","1","158662813",293017,"277717","rs2022057","NC_000001.11:158662812:G:T"
"NM_000186.3(CFH):c.1204C>T (p.His402Tyr)","CFH","H402Y","Atypical hemolytic-uremic syndrome 1|Basal laminar drusen|Age-related macular degeneration 4|not provided|CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II","Benign(Last reviewed: Dec 5, 2020)","criteria provided, multiple submitters, no conflicts","VCV000294490","1","196659237","1","196690107",294490,"278205","rs1061170","NC_000001.11:196690106:C:T"
"NM_000157.4(GBA):c.1093G>A (p.Glu365Lys)","GBA|LOC106627981","E365K, E278K, E316K","Parkinsonism|Cogwheel rigidity|Parkinsonism|Rigidity|Tremor|Neurological speech impairment|Parkinsonism|Lower limb muscle weakness|Dementia|Hyperlipidemia|Hypertensive disorder|not specified|Hereditary late onset Parkinson disease|Gaucher disease|not provided|Gaucher disease, perinatal lethal","Conflicting interpretations of pathogenicity, risk factor(Last reviewed: May 18, 2021)","criteria provided, conflicting interpretations","VCV000199044","1","155206167","1","155236376",199044,"38432","rs2230288","NC_000001.11:155236375:C:T"
"NM_014625.3(NPHS2):c.-51G>T","NPHS2","","Idiopathic nephrotic syndrome|not provided|not specified","Benign(Last reviewed: May 18, 2021)","criteria provided, multiple submitters, no conflicts","VCV000225144","1","179545050","1","179575915",225144,"227036","rs12406197","NC_000001.11:179575914:C:A"
"NM_001083116.3(PRF1):c.1034C>T (p.Pro345Leu)","PRF1","P345L","Familial hemophagocytic lymphohistiocytosis 2","Pathogenic(Last reviewed: Dec 3, 1999)","no assertion criteria provided","VCV000013713","10","72358443","10","70598687",13713,"28752","rs28933374","NC_000010.11:70598686:G:A"
"NC_000010.10:g.6122009T>A","IL2RA","","Diabetes mellitus, insulin-dependent, 10","Pathogenic(Last reviewed: Sep 1, 2007)","no assertion criteria provided","VCV000014670","10","6122009","10","6080046",14670,"29709","rs11594656","NC_000010.11:6080045:T:A"
"NM_001354.5(AKR1C2):c.666T>G (p.His222Gln)","AKR1C2","H222Q, H196Q","46,XY sex reversal 8","Pathogenic(Last reviewed: Aug 12, 2011)","no assertion criteria provided","VCV000030067","10","5037962","10","4995770",30067,"39022","rs13222","NC_000010.11:4995769:A:C"
"CYP2C19*4A","CYP2C19","M1V","Mephenytoin, poor metabolism of|CYP2C19: no function|clopidogrel response - Efficacy|not provided","drug response","practice guideline","VCV000016900","10","96522463","10","94762706",16900,"31939","rs28399504","NC_000010.11:94762705:A:G"
"NM_021830.5(TWNK):c.1001G>A (p.Arg334Gln)","TWNK","R334Q","Progressive external ophthalmoplegia with mitochondrial DNA deletions, digenic|Infantile onset spinocerebellar ataxia|Mitochondrial diseases|not provided","Pathogenic(Last reviewed: Aug 1, 2016)","criteria provided, multiple submitters, no conflicts","VCV000004623","10","102748968","10","100989211",4623,"19662","rs28937887","NC_000010.11:100989210:G:A"
"NM_001008212.2(OPTN):c.293T>A (p.Met98Lys)","OPTN|LOC108903148","M98K","Primary open angle glaucoma|Glaucoma, normal tension, susceptibility to|not specified|Glaucoma 1, open angle, e|Amyotrophic lateral sclerosis type 12|none provided|Amyotrophic lateral sclerosis type 12|Primary open angle glaucoma|Glaucoma 1, open angle, e","Benign/Likely benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000007099","10","13152400","10","13110400",7099,"22138","rs11258194","NC_000010.11:13110399:T:A"
"CYP2C19*4A/*30","CYP2C19","R73C","Voriconazole response|Sertraline response|Citalopram response|Escitalopram response","drug response","practice guideline","VCV000634307","10","96534863","10","94775106",634307,"622283","rs145328984","NC_000010.11:94775105:C:T"
"CYP2C19*4A/*15","CYP2C19","I19L","Citalopram response|Voriconazole response|Escitalopram response|Sertraline response","drug response","practice guideline","VCV000634363","10","96522517","10","94762760",634363,"622281","rs17882687","NC_000010.11:94762759:A:C"
"NM_001354.5(AKR1C2):c.666T>C (p.His222=)","AKR1C2","","CIC-DUX Sarcoma","Pathogenic","no assertion criteria provided","VCV000805966","10","5037962","10","4995770",805966,"794307","rs13222","NC_000010.11:4995769:A:G"
"CYP2C19*4A/*23","CYP2C19","G91R","Citalopram response|Escitalopram response|Voriconazole response|Sertraline response","drug response","practice guideline","VCV000634160","10","96534917","10","94775160",634160,"622285","rs118203756","NC_000010.11:94775159:G:C"
"CYP2C19*4A/*31","CYP2C19","H78Y","Escitalopram response|Sertraline response|Voriconazole response|Citalopram response","drug response","practice guideline","VCV000634161","10","96534878","10","94775121",634161,"622284","rs1564660997","NC_000010.11:94775120:C:T"
"CYP2C19*4A/*10","CYP2C19","P227L","Voriconazole response|Sertraline response|Escitalopram response|Citalopram response","drug response","practice guideline","VCV000633981","10","96541615","10","94781858",633981,"47951","rs6413438","NC_000010.11:94781857:C:T"
"CYP2C19*4A/*16","CYP2C19","R442C","Voriconazole response|Escitalopram response|Citalopram response|Sertraline response","drug response","practice guideline","VCV000633982","10","96612522","10","94852765",633982,"622295","rs192154563","NC_000010.11:94852764:C:T"
"NM_000392.5(ABCC2):c.2901C>A (p.Tyr967Ter)","ABCC2","Y967*","not provided","Pathogenic(Last reviewed: May 19, 2015)","criteria provided, single submitter","VCV000195649","10","101591385","10","99831628",195649,"192810","rs17222547","NC_000010.11:99831627:C:A"
"NM_000315.4(PTH):c.247C>T (p.Arg83Ter)","PTH","R83*, R115*","Primary hyperparathyroidism","Pathogenic(Last reviewed: Sep 11, 2008)","no assertion criteria provided","VCV000013759","11","13514053","11","13492506",13759,"28798","rs6256","NC_000011.10:13492505:G:A"
"NM_000518.4(HBB):c.20A>C (p.Glu7Ala)","LOC106099062|LOC107133510|HBB","E7A","HEMOGLOBIN G (MAKASSAR)","other(Last reviewed: Dec 12, 2017)","no assertion criteria provided","VCV000015175","11","5248232","11","5227002",15175,"30214","rs334","NC_000011.10:5227001:T:G"
"NM_000518.5(HBB):c.20A>T (p.Glu7Val)","HBB|LOC106099062|LOC107133510","E7V","HEMOGLOBIN S|Hemoglobin E|Fetal hemoglobin quantitative trait locus 1|not provided|none provided|Anemia|Hb SS disease|Sickle cell disease and related diseases|Malaria, resistance to|Fetal hemoglobin quantitative trait locus 1|Hb SS disease|Erythrocytosis 6, familial|Methemoglobinemia, beta-globin type|Susceptibility to malaria|alpha Thalassemia|Heinz body anemia|Beta-thalassemia, dominant inclusion body type|beta Thalassemia|beta Thalassemia|Inborn genetic diseases|Fetal hemoglobin quantitative trait locus 1|Hb SS disease|Susceptibility to malaria|Heinz body anemia|Beta-thalassemia, dominant inclusion body type|beta Thalassemia","Conflicting interpretations of pathogenicity(Last reviewed: Jun 30, 2021)","criteria provided, conflicting interpretations","VCV000015333","11","5248232","11","5227002",15333,"30372","rs334","NC_000011.10:5227001:T:A"
"NM_000518.5(HBB):c.93G>T (p.Arg31Ser)","LOC106099062|LOC107133510|HBB","R31S","Heinz body anemia|not specified|not provided","Uncertain significance(Last reviewed: Nov 11, 2019)","criteria provided, multiple submitters, no conflicts","VCV000015368","11","5248029","11","5226799",15368,"30407","rs1135071","NC_000011.10:5226798:C:A"
"NM_001382.4(DPAGT1):c.509A>G (p.Tyr170Cys)","DPAGT1","Y170C","DPAGT1-CDG|Congenital myasthenic syndrome 13|DPAGT1-CDG|Congenital disorder of glycosylation","Uncertain significance(Last reviewed: Nov 21, 2018)","criteria provided, single submitter","VCV000012296","11","118971106","11","119100396",12296,"27335","rs28934876","NC_000011.10:119100395:T:C"
"NM_000360.4(TH):c.733A>C (p.Thr245Pro)","TH","T276P, T245P, T272P","Autosomal recessive DOPA responsive dystonia","Pathogenic(Last reviewed: Jan 1, 2000)","no assertion criteria provided","VCV000012329","11","2188225","11","2166995",12329,"27368","rs28934581","NC_000011.10:2166994:T:G"
"NM_000260.4(MYO7A):c.635G>A (p.Arg212His)","MYO7A","R212H, R201H","Deafness, autosomal recessive 2|Usher syndrome type 1|Rare genetic deafness|not provided|Usher syndrome, type 1B|Retinal dystrophy","Pathogenic/Likely pathogenic(Last reviewed: Jun 16, 2019)","criteria provided, multiple submitters, no conflicts","VCV000011850","11","76867950","11","77156904",11850,"26889","rs28934610","NC_000011.10:77156903:G:A"
"NM_000448.2(RAG1):c.2164G>A (p.Glu722Lys)","RAG1","E722K","Severe combined immunodeficiency, B cell-negative","Pathogenic(Last reviewed: Oct 4, 1996)","no assertion criteria provided","VCV000013139","11","36597018","11","36575468",13139,"28178","rs28933392","NC_000011.10:36575467:G:A"
"NM_021961.6(TEAD1):c.1261T>C (p.Tyr421His)","TEAD1","Y421H","Sveinsson chorioretinal atrophy","Pathogenic(Last reviewed: Oct 5, 2007)","no assertion criteria provided","VCV000012630","11","12958749","11","12937202",12630,"27669","rs11567847","NC_000011.10:12937201:T:C"
"NM_005343.4(HRAS):c.181C>A (p.Gln61Lys)","HRAS|LRRC56","Q61K","not provided|Noonan syndrome 3|Lip and oral cavity carcinoma|Spermatocytic seminoma|Breast neoplasm|Thyroid cancer, nonmedullary, 2","Pathogenic/Likely pathogenic(Last reviewed: Aug 16, 2018)","criteria provided, multiple submitters, no conflicts","VCV000012601","11","533875","11","533875",12601,"27640","rs28933406","NC_000011.10:533874:G:T"
"NM_001360.3(DHCR7):c.452G>A (p.Trp151Ter)","DHCR7","W151*","not provided|2-3 toe syndactyly|Congenital microcephaly|Small for gestational age|Elevated 7-dehydrocholesterol|Smith-Lemli-Opitz syndrome","Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000021273","11","71152447","11","71441401",21273,"34125","rs11555217","NC_000011.10:71441400:C:T"
"NM_000256.3(MYBPC3):c.2992C>G (p.Gln998Glu)","MYBPC3","Q998E","Primary familial hypertrophic cardiomyopathy|Primary dilated cardiomyopathy|Cardiovascular phenotype|not provided|Cardiomyopathy|Left ventricular noncompaction 10|Primary dilated cardiomyopathy|Cardiomyopathy|Hypertrophic cardiomyopathy|none provided|Familial hypertrophic cardiomyopathy 4|not specified","Benign/Likely benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000036610","11","47355475","11","47333924",36610,"45272","rs11570112","NC_000011.10:47333923:G:C"
"NM_000480.3(AMPD3):c.1744C>T (p.Arg582Cys)","AMPD3","R573C, R582C, R580C, R414C","Erythrocyte AMP deaminase deficiency","Pathogenic(Last reviewed: Apr 27, 2017)","criteria provided, single submitter","VCV000018270","11","10521792","11","10500245",18270,"33309","rs3741040","NC_000011.10:10500244:C:T"
"NM_199161.5(SAA1):c.209C>T (p.Ala70Val)","SAA1","A70V","Serum amyloid a variant|not provided","Likely benign(Last reviewed: Sep 30, 2018)","criteria provided, single submitter","VCV000018108","11","18290859","11","18269312",18108,"33147","rs1136743","NC_000011.10:18269311:C:T"
"NM_000260.4(MYO7A):c.47T>C (p.Leu16Ser)","MYO7A","L16S, L5S","Usher syndrome type 1|Usher syndrome, type 1B|Deafness, autosomal dominant 11|Deafness, autosomal recessive 2|not provided|none provided|not specified","Benign(Last reviewed: Jul 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000043258","11","76853783","11","77142737",43258,"52428","rs1052030","NC_000011.10:77142736:T:C"
"NM_001567.4(INPPL1):c.2415+1G>A","INPPL1","","Opsismodysplasia","Pathogenic(Last reviewed: Jan 10, 2013)","no assertion criteria provided","VCV000039476","11","71945660","11","72234616",39476,"48075","rs655423","NC_000011.10:72234615:G:A"
"NM_000244.3(MEN1):c.76G>A (p.Glu26Lys)","MEN1","E26K","not provided|Multiple endocrine neoplasia, type 1|Parathyroid adenoma, somatic","Conflicting interpretations of pathogenicity(Last reviewed: Mar 29, 2019)","criteria provided, conflicting interpretations","VCV000016689","11","64577506","11","64810034",16689,"31728","rs28931612","NC_000011.10:64810033:C:T"
"NM_000039.2(APOA1):c.589C>T (p.Arg197Cys)","APOA1","R197C, R88C","APOLIPOPROTEIN A-I (MILANO)","Pathogenic(Last reviewed: Nov 5, 2003)","no assertion criteria provided","VCV000017909","11","116706739","11","116836023",17909,"32948","rs28931573","NC_000011.10:116836022:G:A"
"NM_018389.4(SLC35C1):c.923C>G (p.Thr308Arg)","SLC35C1","T308R, T295R","Leukocyte adhesion deficiency type II","Pathogenic(Last reviewed: Jun 15, 2002)","no assertion criteria provided","VCV000004740","11","45832714","11","45811163",4740,"19779","rs28937886","NC_000011.10:45811162:C:G"
"NM_003356.4(UCP3):c.304G>A (p.Val102Ile)","UCP3","V102I","UCP3 POLYMORPHISM G/A|Obesity, severe, and type II diabetes","Conflicting interpretations of pathogenicity(Last reviewed: Oct 1, 1998)","no assertion criteria provided","VCV000007576","11","73717247","11","74006202",7576,"22615","rs2229707","NC_000011.10:74006201:C:T"
"NM_003356.4(UCP3):c.208C>T (p.Arg70Trp)","UCP3","R70W","Obesity, severe, and type II diabetes","Pathogenic(Last reviewed: Sep 2, 2008)","no assertion criteria provided","VCV000007579","11","73717343","11","74006298",7579,"22618","rs17848368","NC_000011.10:74006297:G:A"
"NM_004183.4(BEST1):c.355G>C (p.Glu119Gln)","BEST1","E119Q, E13Q, E59Q","not provided|Vitelliform macular dystrophy type 2","Uncertain significance(Last reviewed: Sep 12, 2020)","criteria provided, single submitter","VCV000002735","11","61723297","11","61955825",2735,"17774","rs1805142","NC_000011.10:61955824:G:C"
"NM_000051.3(ATM):c.7271T>G (p.Val2424Gly)","ATM|C11orf65","V2424G","not provided|Breast cancer, susceptibility to|Familial cancer of breast|Ataxia-telangiectasia syndrome|Familial cancer of breast|Breast neoplasm|Hereditary cancer-predisposing syndrome|Ataxia-telangiectasia variant|T-cell prolymphocytic leukemia|Ataxia-telangiectasia syndrome","Pathogenic/Likely pathogenic(Last reviewed: Jun 17, 2021)","criteria provided, multiple submitters, no conflicts","VCV000003023","11","108199929","11","108329202",3023,"18062","rs28904921","NC_000011.10:108329201:T:G"
"NM_000051.3(ATM):c.3118A>G (p.Met1040Val)","ATM","M1040V","not specified|none provided|B-cell non-Hodgkin lymphoma|Ataxia-telangiectasia syndrome|Hereditary cancer-predisposing syndrome|not provided","Benign/Likely benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000003027","11","108143299","11","108272572",3027,"18066","rs3092857","NC_000011.10:108272571:A:G"
"NM_000051.3(ATM):c.2250G>A (p.Lys750=)","ATM","","Malignant tumor of breast|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Ataxia-telangiectasia syndrome|not provided|Familial cancer of breast|Ataxia-telangiectasia syndrome","Pathogenic/Likely pathogenic(Last reviewed: May 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000003044","11","108127067","11","108256340",3044,"18083","rs1137887","NC_000011.10:108256339:G:A"
"NM_181798.1(KCNQ1):c.651G>A (p.Ala217=)","KCNQ1","","Cardiovascular phenotype|Long QT syndrome 1|not provided|Long QT syndrome|Long QT syndrome 2","Pathogenic(Last reviewed: Oct 23, 2020)","criteria provided, multiple submitters, no conflicts","VCV000003135","11","2604775","11","2583545",3135,"18174","rs1800171","NC_000011.10:2583544:G:A"
"NM_181798.1(KCNQ1):c.1366C>T (p.Arg456Cys)","KCNQ1","R583C, R456C","not provided|Congenital long QT syndrome|Short QT syndrome 2|Jervell and Lange-Nielsen syndrome 1|Long QT syndrome 1|Atrial fibrillation, familial, 3|Beckwith-Wiedemann syndrome|Acquired susceptibility to long QT syndrome 1|Long QT syndrome 1","Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)","criteria provided, multiple submitters, no conflicts","VCV000003142","11","2799220","11","2777990",3142,"18181","rs17221854","NC_000011.10:2777989:C:T"
"NM_000372.5(TYR):c.1205G>A (p.Arg402Gln)","TYR","R402Q","not provided|Oculocutaneous albinism type 1B|Skin/hair/eye pigmentation, variation in, 3|Cutaneous malignant melanoma 8|Skin/hair/eye pigmentation 3, blue/green eyes|Tyrosinase-negative oculocutaneous albinism|Autosomal recessive ocular albinism|Albinism|Foveal hypoplasia|Abnormality of metabolism/homeostasis|Choroidal neovascularization|Slow decrease in visual acuity|Elevated hepatic transaminases|Oculocutaneous albinism type 1, temperature sensitive|not specified|Malignant tumor of breast|Oculocutaneous albinism","Conflicting interpretations of pathogenicity, other(Last reviewed: Nov 26, 2020)","criteria provided, conflicting interpretations","VCV000003779","11","89017961","11","89284793",3779,"18818","rs1126809","NC_000011.10:89284792:G:A"
"NM_000525.3(KCNJ11):c.440T>C (p.Leu147Pro)","KCNJ11","L147P, L60P","Hyperinsulinemic hypoglycemia, familial, 2","Pathogenic(Last reviewed: Mar 16, 2015)","criteria provided, single submitter","VCV000008665","11","17409199","11","17387652",8665,"23704","rs28936678","NC_000011.10:17387651:A:G"
"NM_001876.4(CPT1A):c.2126G>A (p.Gly709Glu)","CPT1A","G709E","Carnitine palmitoyltransferase 1A deficiency","Pathogenic(Last reviewed: Mar 7, 2013)","no assertion criteria provided","VCV000009069","11","68527709","11","68760241",9069,"24108","rs28936374","NC_000011.10:68760240:C:T"
"NM_000352.6(ABCC8):c.4477C>T (p.Arg1493Trp)","ABCC8","R1494W, R1493W, R1515W, R1492W","Hyperinsulinemic hypoglycemia, familial, 1|not provided","Pathogenic/Likely pathogenic(Last reviewed: Oct 13, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009096","11","17415881","11","17394334",9096,"24135","rs28936371","NC_000011.10:17394333:G:A"
"NM_000051.3(ATM):c.2193C>A (p.Tyr731Ter)","ATM","Y731*","Ataxia-telangiectasia syndrome","Pathogenic(Last reviewed: Aug 21, 2020)","criteria provided, single submitter","VCV000453407","11","108127010","11","108256283",453407,"461330","rs2229019","NC_000011.10:108256282:C:A"
"NM_005343.4(HRAS):c.181C>G (p.Gln61Glu)","HRAS|LRRC56","Q61E","Neoplasm of the large intestine|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Chronic lymphocytic leukemia|Hepatocellular carcinoma|Squamous cell lung carcinoma|Malignant neoplasm of body of uterus|Neoplasm of the thyroid gland|Malignant melanoma of skin|Adenocarcinoma of stomach|Acute myeloid leukemia|Pancreatic adenocarcinoma|Multiple myeloma","Likely pathogenic(Last reviewed: May 31, 2016)","no assertion criteria provided","VCV000376444","11","533875","11","533875",376444,"363323","rs28933406","NC_000011.10:533874:G:C"
"NM_000518.5(HBB):c.93G>C (p.Arg31Ser)","HBB|LOC106099062|LOC107133510","R31S","beta Thalassemia","Pathogenic(Last reviewed: Nov 25, 2019)","no assertion criteria provided","VCV000869321","11","5248029","11","5226799",869321,"857494","","NC_000011.10:5226798:C:G"
"NM_181798.1(KCNQ1):c.651G>T (p.Ala217=)","KCNQ1","","Long QT syndrome","Likely pathogenic(Last reviewed: Nov 11, 2015)","no assertion criteria provided","VCV000560649","11","2604775","11","2583545",560649,"551716","rs1800171","NC_000011.10:2583544:G:T"
"NM_000260.4(MYO7A):c.47T>A (p.Leu16Ter)","MYO7A","L16*, L5*","not provided|Usher syndrome type 1|Deafness, autosomal recessive 2","Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2019)","criteria provided, multiple submitters, no conflicts","VCV000549974","11","76853783","11","77142737",549974,"546385","rs1052030","NC_000011.10:77142736:T:A"
"NM_000051.3(ATM):c.2193C>T (p.Tyr731=)","ATM","","not provided|not specified|Ataxia-telangiectasia syndrome|Malignant tumor of breast|none provided|Hereditary cancer-predisposing syndrome","Benign(Last reviewed: Dec 2, 2020)","criteria provided, multiple submitters, no conflicts","VCV000140761","11","108127010","11","108256283",140761,"150475","rs2229019","NC_000011.10:108256282:C:T"
"NM_000256.3(MYBPC3):c.2992C>T (p.Gln998Ter)","MYBPC3","Q998*","not provided|Hypertrophic cardiomyopathy","Pathogenic(Last reviewed: Feb 19, 2020)","criteria provided, multiple submitters, no conflicts","VCV000180993","11","47355475","11","47333924",180993,"179222","rs11570112","NC_000011.10:47333923:G:A"
"NM_000256.3(MYBPC3):c.1147C>G (p.Leu383Val)","MYBPC3","L383V","Familial hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Nov 8, 2019)","criteria provided, conflicting interpretations","VCV000181062","11","47365119","11","47343568",181062,"179338","rs11570077","NC_000011.10:47343567:G:C"
"NM_004588.5(SCN2B):c.82C>T (p.Arg28Trp)","SCN2B","R28W","not provided|Atrial fibrillation, familial, 14","Uncertain significance(Last reviewed: Feb 6, 2017)","criteria provided, single submitter","VCV000060769","11","118039455","11","118168740",60769,"75311","rs17121819","NC_000011.10:118168739:G:A"
"NM_181798.1(KCNQ1):c.121G>A (p.Gly41Arg)","KCNQ1","G168R, G41R","Long QT syndrome|Long QT syndrome 1|Arrhythmia|Cardiovascular phenotype|not provided|Congenital long QT syndrome","Pathogenic(Last reviewed: Oct 28, 2020)","criteria provided, multiple submitters, no conflicts","VCV000053052","11","2591882","11","2570652",53052,"67720","rs179489","NC_000011.10:2570651:G:A"
"NM_181798.1(KCNQ1):c.651G>C (p.Ala217=)","KCNQ1","","not provided","Pathogenic(Last reviewed: Jul 26, 2013)","criteria provided, single submitter","VCV000052939","11","2604775","11","2583545",52939,"67607","rs1800171","NC_000011.10:2583544:G:C"
"NM_181798.1(KCNQ1):c.121G>C (p.Gly41Arg)","KCNQ1","G168R, G41R","Cardiovascular phenotype|not provided|Congenital long QT syndrome|Long QT syndrome","Pathogenic(Last reviewed: Aug 20, 2019)","criteria provided, multiple submitters, no conflicts","VCV000053053","11","2591882","11","2570652",53053,"67721","rs179489","NC_000011.10:2570651:G:C"
"NM_004183.4(BEST1):c.889C>G (p.Pro297Ala)","BEST1","P297A, P191A, P237A","not provided","not provided","no assertion provided","VCV000099765","11","61726991","11","61959519",99765,"105654","rs1805143","NC_000011.10:61959518:C:G"
"NM_004183.4(BEST1):c.889C>T (p.Pro297Ser)","BEST1","P297S, P237S, P191S","Vitelliform macular dystrophy type 2|not provided","Pathogenic(Last reviewed: Sep 1, 2019)","criteria provided, single submitter","VCV000099766","11","61726991","11","61959519",99766,"105655","rs1805143","NC_000011.10:61959518:C:T"
"NM_000518.5(HBB):c.*132+101G>C","HBB|LOC107133510|LOC110006319","","not provided|not specified|beta Thalassemia","Benign(Last reviewed: Nov 25, 2020)","criteria provided, multiple submitters, no conflicts","VCV000256341","11","5246595","11","5225365",256341,"254202","rs12788013","NC_000011.10:5225364:C:G"
"NM_000315.4(PTH):c.247C>A (p.Arg83=)","PTH","","not specified|Familial isolated hypoparathyroidism","Benign(Last reviewed: Mar 6, 2018)","criteria provided, multiple submitters, no conflicts","VCV000255817","11","13514053","11","13492506",255817,"254060","rs6256","NC_000011.10:13492505:G:T"
"NM_001065.4(TNFRSF1A):c.362G>C (p.Arg121Pro)","TNFRSF1A","R92P, R121P, R13P","TNF receptor-associated periodic fever syndrome (TRAPS)","Pathogenic(Last reviewed: Jan 1, 2001)","no assertion criteria provided","VCV000012341","12","6442643","12","6333477",12341,"27380","rs4149584","NC_000012.12:6333476:C:G"
"NM_006446.5(SLCO1B1):c.521T>C (p.Val174Ala)","SLCO1B1","V174A","Gilbert syndrome|not provided|Rotor syndrome|cerivastatin response - Toxicity/ADR|rosuvastatin response - Other|hmg coa reductase inhibitors response - Toxicity/ADR, Metabolism/PK|simvastatin acid response - Metabolism/PK|simvastatin response - Toxicity/ADR|pravastatin response - Metabolism/PK","drug response(Last reviewed: May 21, 2018)","reviewed by expert panel","VCV000037346","12","21331549","12","21178615",37346,"40587","rs4149056","NC_000012.12:21178614:T:C"
"NM_000486.5(AQP2):c.170A>C (p.Gln57Pro)","AQP2","Q57P","not provided|Nephrogenic diabetes insipidus, autosomal","Pathogenic(Last reviewed: Feb 5, 2019)","criteria provided, single submitter","VCV000017842","12","50344783","12","49951000",17842,"32881","rs28931580","NC_000012.12:49950999:A:C"
"NM_000017.4(ACADS):c.511C>T (p.Arg171Trp)","ACADS","R171W","not provided|Deficiency of butyryl-CoA dehydrogenase","Conflicting interpretations of pathogenicity(Last reviewed: Aug 24, 2020)","criteria provided, conflicting interpretations","VCV000003830","12","121175678","12","120737875",3830,"18869","rs1800556","NC_000012.12:120737874:C:T"
"NM_000277.3(PAH):c.782G>A (p.Arg261Gln)","PAH","R261Q","not provided|Phenylketonuria","Pathogenic(Last reviewed: Aug 13, 2018)","reviewed by expert panel","VCV000000582","12","103246653","12","102852875",582,"15621","rs5030849","NC_000012.12:102852874:C:T"
"NM_000277.3(PAH):c.754C>T (p.Arg252Trp)","PAH","R252W","not provided|Phenylketonuria","Pathogenic(Last reviewed: Aug 13, 2018)","reviewed by expert panel","VCV000000584","12","103246681","12","102852903",584,"15623","rs5030847","NC_000012.12:102852902:G:A"
"NM_000277.3(PAH):c.727C>T (p.Arg243Ter)","PAH","R243*","not provided|Phenylketonuria","Pathogenic(Last reviewed: Aug 7, 2018)","reviewed by expert panel","VCV000000588","12","103246708","12","102852930",588,"15627","rs5030846","NC_000012.12:102852929:G:A"
"NM_000277.3(PAH):c.842C>T (p.Pro281Leu)","PAH","P281L","not provided|Inborn genetic diseases|Phenylketonuria","Likely pathogenic(Last reviewed: Aug 27, 2018)","reviewed by expert panel","VCV000000589","12","103246593","12","102852815",589,"15628","rs5030851","NC_000012.12:102852814:G:A"
"NM_000277.3(PAH):c.842+1G>A","PAH","","not provided|Phenylketonuria","Pathogenic(Last reviewed: Aug 13, 2018)","reviewed by expert panel","VCV000000599","12","103246592","12","102852814",599,"15638","rs5030852","NC_000012.12:102852813:C:T"
"NM_000277.3(PAH):c.781C>T (p.Arg261Ter)","PAH","R261*","not provided|Phenylketonuria","Pathogenic(Last reviewed: Aug 5, 2018)","reviewed by expert panel","VCV000000610","12","103246654","12","102852876",610,"15649","rs5030850","NC_000012.12:102852875:G:A"
"NM_000277.3(PAH):c.1223G>A (p.Arg408Gln)","PAH","R408Q","Phenylketonuria|not provided","Pathogenic(Last reviewed: Aug 5, 2018)","reviewed by expert panel","VCV000000612","12","103234270","12","102840492",612,"15651","rs5030859","NC_000012.12:102840491:C:T"
"NM_000277.3(PAH):c.1222C>T (p.Arg408Trp)","PAH","R408W","not provided|Phenylketonuria","Pathogenic(Last reviewed: Aug 6, 2018)","reviewed by expert panel","VCV000000577","12","103234271","12","102840493",577,"15616","rs5030858","NC_000012.12:102840492:G:A"
"NM_000552.5(VWF):c.4196G>A","VWF","R1399H","Abnormality of coagulation|not provided|VON WILLEBRAND FACTOR POLYMORPHISM|von Willebrand disease type 1|none provided","Conflicting interpretations of pathogenicity(Last reviewed: Oct 27, 2019)","criteria provided, conflicting interpretations","VCV000000293","12","6128388","12","6019222",293,"15332","rs1800382","NC_000012.12:6019221:C:T"
"NM_000552.4(VWF):c.4751A>G (p.Tyr1584Cys)","VWF","Y1584C","not provided|not specified|von Willebrand disorder|von Willebrand disease, type 1, susceptibility to|Inborn genetic diseases|none provided|von Willebrand disease type 2","Conflicting interpretations of pathogenicity(Last reviewed: Jan 7, 2021)","criteria provided, conflicting interpretations","VCV000000310","12","6127833","12","6018667",310,"15349","rs1800386","NC_000012.12:6018666:T:C"
"NM_002150.3(HPD):c.97= (p.Thr33=)","HPD","","Tyrosinemia type 3|Hawkinsinuria|Hawkinsinuria","Benign(Last reviewed: Dec 4, 2020)","criteria provided, single submitter","VCV000001577","12","122295335","12","121857429",1577,"16616","rs1154510","NC_000012.12:121857428:T:T"
"NM_000785.4(CYP27B1):c.320G>A (p.Arg107His)","CYP27B1","R107H","Vitamin D-dependent rickets type 1A|Vitamin D-dependent rickets, type 1","Likely pathogenic(Last reviewed: Apr 27, 2017)","criteria provided, single submitter","VCV000001658","12","58159856","12","57766073",1658,"16697","rs28934604","NC_000012.12:57766072:C:T"
"NM_000785.4(CYP27B1):c.1004G>C (p.Arg335Pro)","CYP27B1","R335P","Vitamin D-dependent rickets type 1A","Pathogenic(Last reviewed: Mar 5, 1998)","no assertion criteria provided","VCV000001660","12","58158293","12","57764510",1660,"16699","rs28934606","NC_000012.12:57764509:C:G"
"NM_000020.2(ACVRL1):c.1127T>G (p.Met376Arg)","ACVRL1","M376R","Telangiectasia, hereditary hemorrhagic, type 2","Pathogenic(Last reviewed: Jun 1, 1996)","no assertion criteria provided","VCV000008244","12","52309898","12","51916114",8244,"23283","rs28936399","NC_000012.12:51916113:T:G"
"NM_000020.2(ACVRL1):c.1120C>T (p.Arg374Trp)","ACVRL1","R374W","not provided|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|Telangiectasia, hereditary hemorrhagic, type 2","Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2020)","criteria provided, multiple submitters, no conflicts","VCV000008249","12","52309891","12","51916107",8249,"23288","rs28936401","NC_000012.12:51916106:C:T"
"NM_020297.3(ABCC9):c.3650G>A (p.Arg1217Lys)","ABCC9","R1217K","Hypertrichotic osteochondrodysplasia Cantu type","Likely pathogenic(Last reviewed: Dec 8, 2016)","criteria provided, single submitter","VCV000545440","12","21981911","12","21828977",545440,"535704","rs12298510","NC_000012.12:21828976:C:T"
"NM_002905.4(RDH5):c.208C>T (p.Arg70Trp)","RDH5|BLOC1S1-RDH5","R70W","not provided|Retinitis pigmentosa|Pigmentary retinal dystrophy","Conflicting interpretations of pathogenicity(Last reviewed: May 9, 2020)","criteria provided, conflicting interpretations","VCV000636196","12","56115176","12","55721392",636196,"623998","rs1058635","NC_000012.12:55721391:C:T"
"NM_002429.6(MMP19):c.13C>T (p.Gln5Ter)","MMP19","Q5*","not provided","Benign(Last reviewed: Dec 31, 2019)","criteria provided, single submitter","VCV000776900","12","56236602","12","55842818",776900,"702418","rs17844787","NC_000012.12:55842817:G:A"
"NM_002150.3(HPD):c.97A>G (p.Thr33Ala)","HPD","T33A","Hawkinsinuria|Tyrosinemia type 3|Hawkinsinuria","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000802899","12","122295335","12","121857429",802899,"791201","rs1154510","NC_000012.12:121857428:T:C"
"NM_000020.3(ACVRL1):c.1120C>A (p.Arg374=)","ACVRL1","","not provided","Uncertain significance(Last reviewed: Sep 1, 2018)","criteria provided, single submitter","VCV000806892","12","52309891","12","51916107",806892,"796796","rs28936401","NC_000012.12:51916106:C:A"
"NM_000277.3(PAH):c.782G>T (p.Arg261Leu)","PAH","R261L","Phenylketonuria","Uncertain significance(Last reviewed: Nov 8, 2019)","reviewed by expert panel","VCV000585208","12","103246653","12","102852875",585208,"576255","rs5030849","NC_000012.12:102852874:C:A"
"NM_005002.5(NDUFA9):c.1078C>T (p.Arg360Cys)","NDUFA9","R360C","Mitochondrial complex 1 deficiency, nuclear type 26","Pathogenic(Last reviewed: Dec 13, 2018)","no assertion criteria provided","VCV000587683","12","4796218","12","4687052",587683,"578641","rs3210083","NC_000012.12:4687051:C:T"
"NM_000552.4(VWF):c.1548T>A (p.Tyr516Ter)","VWF","Y516*","not provided","Pathogenic(Last reviewed: Mar 16, 2018)","criteria provided, single submitter","VCV000619930","12","6167196","12","6058030",619930,"611150","rs1800379","NC_000012.12:6058029:A:T"
"NM_000277.3(PAH):c.781C>G (p.Arg261Gly)","PAH","R261G","Phenylketonuria","Uncertain significance(Last reviewed: May 4, 2019)","reviewed by expert panel","VCV000133314","12","103246654","12","102852876",133314,"137051","rs5030850","NC_000012.12:102852875:G:C"
"NM_031157.4(HNRNPA1):c.995A>G (p.Asn332Ser)","HNRNPA1","N332S, N280S","Relapsing remitting multiple sclerosis","Likely pathogenic","no assertion criteria provided","VCV000135599","12","54677683","12","54283899",135599,"139325","rs3207617","NC_000012.12:54283898:A:G"
"NM_000277.3(PAH):c.1089del (p.Lys363fs)","PAH","K363fs","not provided|Phenylketonuria","Pathogenic(Last reviewed: Aug 10, 2018)","reviewed by expert panel","VCV000102518","12","103237534","12","102843756",102518,"108254","rs5030654","NC_000012.12:102843755:C:"
"NM_000277.3(PAH):c.754C>G (p.Arg252Gly)","PAH","R252G","not provided|Phenylketonuria","Pathogenic(Last reviewed: Dec 8, 2018)","reviewed by expert panel","VCV000102823","12","103246681","12","102852903",102823,"108559","rs5030847","NC_000012.12:102852902:G:C"
"NM_000277.3(PAH):c.782G>C (p.Arg261Pro)","PAH","R261P","not provided|Phenylketonuria","Pathogenic(Last reviewed: Aug 11, 2019)","reviewed by expert panel","VCV000102832","12","103246653","12","102852875",102832,"108568","rs5030849","NC_000012.12:102852874:C:G"
"NM_000277.3(PAH):c.842+1G>T","PAH","","Phenylketonuria|not provided","Pathogenic(Last reviewed: Apr 9, 2019)","reviewed by expert panel","VCV000102869","12","103246592","12","102852814",102869,"108605","rs5030852","NC_000012.12:102852813:C:A"
"NM_000552.4(VWF):c.3379+1G>A","VWF","","von Willebrand disorder|not provided|Von Willebrand disease, recessive form","Pathogenic(Last reviewed: Feb 1, 2019)","criteria provided, single submitter","VCV000100257","12","6132796","12","6023630",100257,"106134","rs2363337","NC_000012.12:6023629:C:T"
"NM_000277.3(PAH):c.735G>A (p.Val245=)","PAH","","not specified|not provided|Phenylketonuria","Benign(Last reviewed: Apr 24, 2018)","reviewed by expert panel","VCV000092748","12","103246700","12","102852922",92748,"98655","rs1042503","NC_000012.12:102852921:C:T"
"NM_000552.4(VWF):c.1548T>C (p.Tyr516=)","VWF","","not provided|not specified|none provided|von Willebrand disorder","Benign/Likely benign(Last reviewed: Aug 6, 2020)","criteria provided, multiple submitters, no conflicts","VCV000256655","12","6167196","12","6058030",256655,"254693","rs1800379","NC_000012.12:6058029:A:G"
"NM_001065.4(TNFRSF1A):c.362G>A (p.Arg121Gln)","TNFRSF1A","R121Q, R13Q","TNF receptor-associated periodic fever syndrome (TRAPS)|Multiple sclerosis, susceptibility to, 5|not specified|none provided|TNF receptor-associated periodic fever syndrome (TRAPS)|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)","criteria provided, conflicting interpretations","VCV000217017","12","6442643","12","6333477",217017,"213624","rs4149584","NC_000012.12:6333476:C:T"
"NM_004004.6(GJB2):c.35G>T (p.Gly12Val)","GJB2","G12V","Nonsyndromic hearing loss and deafness|not provided|none provided|Hearing impairment|Deafness, autosomal dominant 3a|Deafness, autosomal recessive 1A|Rare genetic deafness","Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2020)","criteria provided, multiple submitters, no conflicts","VCV000021387","13","20763686","13","20189547",21387,"34239","rs1801002","NC_000013.11:20189546:C:A"
"NM_000059.4(BRCA2):c.8851G>A (p.Ala2951Thr)","BRCA2","A2951T","Hereditary breast and ovarian cancer syndrome|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Malignant tumor of breast|none provided|not provided|Breast-ovarian cancer, familial 2|Fanconi anemia, complementation group D1|not specified","Benign(Last reviewed: Sep 28, 2016)","reviewed by expert panel","VCV000041570","13","32953550","13","32379413",41570,"50009","rs11571769","NC_000013.11:32379412:G:A"
"NM_000059.3(BRCA2):c.9302T>G (p.Leu3101Arg)","BRCA2","L3101R","Hereditary breast and ovarian cancer syndrome|none provided|Breast-ovarian cancer, familial 2|not provided|Hereditary cancer-predisposing syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Sep 9, 2020)","criteria provided, conflicting interpretations","VCV000038230","13","32968871","13","32394734",38230,"46786","rs28897758","NC_000013.11:32394733:T:G"
"NM_004004.6(GJB2):c.148G>A (p.Asp50Asn)","GJB2","D50N","Keratitis-ichthyosis-deafness syndrome, autosomal dominant|Sensorineural hearing loss|Hearing loss|not provided|Hystrix-like ichthyosis with deafness","Pathogenic(Last reviewed: Jun 14, 2017)","criteria provided, multiple submitters, no conflicts","VCV000017020","13","20763573","13","20189434",17020,"32059","rs28931594","NC_000013.11:20189433:C:T"
"NM_004004.6(GJB2):c.224G>A (p.Arg75Gln)","GJB2","R75Q","not provided|Autosomal recessive nonsyndromic deafness|Deafness, autosomal dominant 3a|Rare genetic deafness|Deafness, autosomal recessive 1A|Nonsyndromic hearing loss and deafness|Hereditary palmoplantar keratoderma|Palmoplantar keratoderma-deafness syndrome","Pathogenic(Last reviewed: Aug 21, 2020)","criteria provided, multiple submitters, no conflicts","VCV000017027","13","20763497","13","20189358",17027,"32066","rs28931593","NC_000013.11:20189357:C:T"
"NM_004004.6(GJB2):c.148G>T (p.Asp50Tyr)","GJB2","D50Y","Keratitis-ichthyosis-deafness syndrome, autosomal dominant","Pathogenic(Last reviewed: Jan 1, 2004)","no assertion criteria provided","VCV000017028","13","20763573","13","20189434",17028,"32067","rs28931594","NC_000013.11:20189433:C:A"
"NM_001110219.3(GJB6):c.263C>T (p.Ala88Val)","GJB6","A88V","Deafness, autosomal dominant 3b|Deafness, autosomal recessive 1b|Deafness, autosomal recessive 1A|Hidrotic ectodermal dysplasia syndrome|Hidrotic ectodermal dysplasia syndrome","Pathogenic(Last reviewed: Aug 10, 2018)","criteria provided, single submitter","VCV000005545","13","20797357","13","20223218",5545,"20584","rs28937872","NC_000013.11:20223217:G:A"
"NM_000059.3(BRCA2):c.8375T>G (p.Leu2792Arg)","BRCA2","L2792R","Hereditary cancer-predisposing syndrome|Hereditary breast and ovarian cancer syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Jan 24, 2020)","criteria provided, conflicting interpretations","VCV000481525","13","32944582","13","32370445",481525,"477236","rs28897751","NC_000013.11:32370444:T:G"
"NM_000059.3(BRCA2):c.8851G>T (p.Ala2951Ser)","BRCA2","A2951S","Hereditary cancer-predisposing syndrome|Familial cancer of breast","Uncertain significance(Last reviewed: Apr 13, 2016)","criteria provided, single submitter","VCV000441405","13","32953550","13","32379413",441405,"435087","rs11571769","NC_000013.11:32379412:G:T"
"NM_004004.6(GJB2):c.35G>A (p.Gly12Asp)","GJB2","G12D","Deafness, autosomal recessive 1A","Uncertain significance(Last reviewed: Apr 4, 2017)","criteria provided, single submitter","VCV000551229","13","20763686","13","20189547",551229,"547105","rs1801002","NC_000013.11:20189546:C:T"
"NM_000059.3(BRCA2):c.9302T>A (p.Leu3101Gln)","BRCA2","L3101Q","Hereditary breast and ovarian cancer syndrome","Uncertain significance(Last reviewed: Oct 30, 2019)","criteria provided, single submitter","VCV000573951","13","32968871","13","32394734",573951,"566097","rs28897758","NC_000013.11:32394733:T:A"
"NM_000059.3(BRCA2):c.2786T>C (p.Leu929Ser)","BRCA2","","not provided|Hereditary breast and ovarian cancer syndrome|Fanconi anemia, complementation group D1|not specified|Breast-ovarian cancer, familial 2|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|none provided","Benign(Last reviewed: Aug 10, 2015)","reviewed by expert panel","VCV000051343","13","32911278","13","32337141",51343,"66011","rs2227943","NC_000013.11:32337140:T:C"
"NM_000059.3(BRCA2):c.8375T>C (p.Leu2792Pro)","BRCA2","L2792P","Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Apr 20, 2020)","criteria provided, conflicting interpretations","VCV000052568","13","32944582","13","32370445",52568,"67236","rs28897751","NC_000013.11:32370444:T:C"
"NM_000059.3(BRCA2):c.9302T>C (p.Leu3101Pro)","BRCA2","L3101P","not specified|Hereditary breast and ovarian cancer syndrome","Uncertain significance(Last reviewed: Aug 16, 2019)","criteria provided, multiple submitters, no conflicts","VCV000216263","13","32968871","13","32394734",216263,"213090","rs28897758","NC_000013.11:32394733:T:C"
"NM_020529.2(NFKBIA):c.95G>T (p.Ser32Ile)","NFKBIA","S32I","Ectodermal dysplasia and immunodeficiency 2","Pathogenic(Last reviewed: Sep 6, 2004)","no assertion criteria provided","VCV000014003","14","35873756","14","35404550",14003,"29042","rs28933100","NC_000014.9:35404549:C:A"
"NM_000257.4(MYH7):c.1207C>T (p.Arg403Trp)","MYH7","R403W","not provided|Cardiomyopathy|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 1|Cardiovascular phenotype|MYH7-related late-onset scapuloperoneal muscular dystrophy|Congenital myopathy with fiber type disproportion|Myopathy, myosin storage, autosomal recessive|Familial hypertrophic cardiomyopathy 1|Myopathy, distal, 1|Dilated cardiomyopathy 1S|Myosin storage myopathy","Pathogenic(Last reviewed: Dec 15, 2016)","reviewed by expert panel","VCV000014102","14","23898488","14","23429279",14102,"29141","rs3218714","NC_000014.9:23429278:G:A"
"NM_006194.3(PAX9):c.83G>C (p.Arg28Pro)","PAX9","R28P","Tooth agenesis, selective, 3","Pathogenic(Last reviewed: Feb 1, 2004)","no assertion criteria provided","VCV000013773","14","37132180","14","36662975",13773,"28812","rs28933971","NC_000014.9:36662974:G:C"
"NM_006194.3(PAX9):c.76C>T (p.Arg26Trp)","PAX9","R26W","Tooth agenesis, selective, 3","Pathogenic(Last reviewed: Aug 1, 2009)","no assertion criteria provided","VCV000013774","14","37132173","14","36662968",13774,"28813","rs28933972","NC_000014.9:36662967:C:T"
"NM_001127701.1(SERPINA1):c.194T>C (p.Leu65Pro)","SERPINA1","L65P","Alpha-1-antitrypsin deficiency|Chronic obstructive pulmonary disease|PI M(PROCIDA)|not provided|Alpha-1-antitrypsin deficiency","Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000017971","14","94849381","14","94383044",17971,"33010","rs28931569","NC_000014.9:94383043:A:G"
"NM_001127701.1(SERPINA1):c.187C>T (p.Arg63Cys)","SERPINA1","R63C","Alpha-1-antitrypsin deficiency|PI I|not provided","Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)","criteria provided, multiple submitters, no conflicts","VCV000017974","14","94849388","14","94383051",17974,"33013","rs28931570","NC_000014.9:94383050:G:A"
"NM_001127701.1(SERPINA1):c.415G>A (p.Gly139Ser)","SERPINA1","G139S","Alpha-1-antitrypsin deficiency|PI NULL(NEWPORT)|PI Q0(NEWPORT)|PI NULL(DEVON)|PI Q0(DEVON)","Pathogenic, other(Last reviewed: Jul 15, 2016)","no assertion criteria provided","VCV000017986","14","94849160","14","94382823",17986,"33025","rs11558261","NC_000014.9:94382822:C:T"
"NM_001127701.1(SERPINA1):c.863A>T (p.Glu288Val)","SERPINA1","E288V","not specified|not provided|Cystic fibrosis|Alpha-1-antitrypsin deficiency|Chronic obstructive pulmonary disease|PI S|Alpha-1-antitrypsin deficiency","Conflicting interpretations of pathogenicity, other(Last reviewed: Oct 25, 2020)","criteria provided, conflicting interpretations","VCV000017969","14","94847262","14","94380925",17969,"33008","rs17580","NC_000014.9:94380924:T:A"
"NM_001127701.1(SERPINA1):c.272G>A (p.Gly91Glu)","SERPINA1","G91E","Alpha-1-antitrypsin deficiency|PI M(MINERAL SPRINGS)","Pathogenic, other(Last reviewed: Jul 15, 2016)","no assertion criteria provided","VCV000017966","14","94849303","14","94382966",17966,"33005","rs28931568","NC_000014.9:94382965:C:T"
"NM_001127701.1(SERPINA1):c.1096G>A (p.Glu366Lys)","SERPINA1","E366K","Alpha-1-antitrypsin deficiency|Chronic obstructive pulmonary disease|FRAXE|Alpha-1-antitrypsin deficiency|Chronic obstructive pulmonary disease|PI Z|PI Z(AUGSBURG)|PI Z(TUN)|Inborn genetic diseases|not provided","Pathogenic, risk factor(Last reviewed: May 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000017967","14","94844947","14","94378610",17967,"33006","rs28929474","NC_000014.9:94378609:C:T"
"NM_001040108.1(MLH3):c.2221G>T (p.Val741Phe)","AREL1|MLH3","V741F","Endometrial carcinoma|not provided|Hereditary nonpolyposis colorectal cancer type 7","Benign/Likely benign(Last reviewed: Dec 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000005561","14","75514138","14","75047435",5561,"20600","rs28756990","NC_000014.9:75047434:C:A"
"NM_001079668.3(NKX2-1):c.727C>A (p.Arg243Ser)","NKX2-1|SFTA3","R243S, R213S","Benign hereditary chorea","Pathogenic(Last reviewed: Apr 15, 2002)","no assertion criteria provided","VCV000008973","14","36986962","14","36517757",8973,"24012","rs28936671","NC_000014.9:36517756:G:T"
"NM_000257.4(MYH7):c.1207C>G (p.Arg403Gly)","MYH7","R403G","Hypertrophic cardiomyopathy","Likely pathogenic(Last reviewed: Jan 9, 2017)","criteria provided, single submitter","VCV000505562","14","23898488","14","23429279",505562,"497452","rs3218714","NC_000014.9:23429278:G:C"
"NM_020529.2(NFKBIA):c.95G>A (p.Ser32Asn)","NFKBIA","S32N","Ectodermal dysplasia and immunodeficiency 2","Pathogenic(Last reviewed: Nov 15, 2018)","no assertion criteria provided","VCV000590311","14","35873756","14","35404550",590311,"581252","rs28933100","NC_000014.9:35404549:C:T"
"NM_001126106.2(SLC7A7):c.475C>T (p.Arg159Cys)","SLC7A7","R159C","not provided|Lysinuric protein intolerance","Conflicting interpretations of pathogenicity(Last reviewed: Nov 23, 2020)","criteria provided, conflicting interpretations","VCV000203944","14","23282133","14","22812924",203944,"200280","rs11568437","NC_000014.9:22812923:G:A"
"NM_002435.3(MPI):c.884G>A (p.Arg295His)","MPI","R295H, R245H, R234H, R275H","MPI-CDG","Pathogenic(Last reviewed: Nov 1, 2002)","no assertion criteria provided","VCV000014349","15","75189391","15","74897050",14349,"29388","rs28928906","NC_000015.10:74897049:G:A"
"NM_000137.3(FAH):c.1021C>T (p.Arg341Trp)","FAH","R341W","not provided|Fumarylacetoacetase pseudodeficiency|Tyrosinemia type I","Benign/Likely benign, other(Last reviewed: May 18, 2021)","criteria provided, multiple submitters, no conflicts","VCV000011868","15","80472526","15","80180184",11868,"26907","rs11555096","NC_000015.10:80180183:C:T"
"NM_000326.5(RLBP1):c.700C>T (p.Arg234Trp)","RLBP1","R234W","Bothnia retinal dystrophy|RLBP1-Related Disorders|none provided|not provided|Retinitis pigmentosa|Retinitis punctata albescens","Pathogenic/Likely pathogenic(Last reviewed: Aug 25, 2020)","criteria provided, multiple submitters, no conflicts","VCV000013100","15","89754025","15","89210794",13100,"28139","rs28933990","NC_000015.10:89210793:G:A"
"NM_000138.5(FBN1):c.247+1G>A","FBN1","","not provided|Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection","Pathogenic(Last reviewed: Jul 24, 2020)","criteria provided, multiple submitters, no conflicts","VCV000042307","15","48905206","15","48613009",42307,"51477","rs25404","NC_000015.10:48613008:C:T"
"NM_000138.5(FBN1):c.529T>C (p.Cys177Arg)","FBN1","C177R","Marfan syndrome","Likely pathogenic(Last reviewed: Oct 4, 2012)","criteria provided, single submitter","VCV000042380","15","48888489","15","48596292",42380,"51550","rs363853","NC_000015.10:48596291:A:G"
"NM_000138.4(FBN1):c.3037G>C (p.Gly1013Arg)","FBN1","G1013R","Marfan syndrome","Pathogenic(Last reviewed: Jan 1, 2001)","no assertion criteria provided","VCV000016455","15","48782093","15","48489896",16455,"31494","rs140593","NC_000015.10:48489895:C:G"
"NM_014249.4(NR2E3):c.932G>A (p.Arg311Gln)","NR2E3","R311Q","Retinal dystrophy|not provided|Retinitis pigmentosa|Autosomal recessive retinitis pigmentosa|Retinitis pigmentosa 37|Goldmann-Favre syndrome|NR2E3-Related Disorders|Enhanced S-cone syndrome|NR2E3-Related Disorders|Enhanced S-cone syndrome|Retinitis pigmentosa 37|Enhanced S-cone syndrome","Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2021)","criteria provided, multiple submitters, no conflicts","VCV000005532","15","72105913","15","71813573",5532,"20571","rs28937873","NC_000015.10:71813572:G:A"
"NM_207581.4(DUOXA2):c.738C>G (p.Tyr246Ter)","DUOXA2","Y246*","Thyroglobulin synthesis defect","Pathogenic(Last reviewed: Feb 1, 2008)","no assertion criteria provided","VCV000000444","15","45409472","15","45117274",444,"15483","rs4774518","NC_000015.10:45117273:C:G"
"NM_000138.4(FBN1):c.3458G>A (p.Cys1153Tyr)","FBN1","C1153Y","Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection|Marfan syndrome","Pathogenic(Last reviewed: Jan 27, 2017)","criteria provided, single submitter","VCV000457194","15","48779514","15","48487317",457194,"465123","rs140599","NC_000015.10:48487316:C:T"
"NM_014249.4(NR2E3):c.951del (p.Thr318fs)","NR2E3","T318fs","not provided|Autosomal recessive retinitis pigmentosa","Likely benign(Last reviewed: May 4, 2017)","criteria provided, single submitter","VCV000445726","15","72105929","15","71813589",445726,"438998","rs11351249","NC_000015.10:71813588:CCCC:CCC"
"NM_000138.4(FBN1):c.7498T>C (p.Cys2500Arg)","FBN1","C2500R","Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection|Marfan syndrome","Pathogenic/Likely pathogenic(Last reviewed: Mar 19, 2020)","criteria provided, multiple submitters, no conflicts","VCV000547346","15","48714221","15","48422024",547346,"538034","rs363810","NC_000015.10:48422023:A:G"
"NM_000138.4(FBN1):c.247+1G>T","FBN1","","Marfan syndrome","Pathogenic(Last reviewed: Nov 7, 2017)","no assertion criteria provided","VCV000549086","15","48905206","15","48613009",549086,"539942","rs25404","NC_000015.10:48613008:C:A"
"NM_000138.4(FBN1):c.5015G>C (p.Cys1672Ser)","FBN1","C1672S","Marfan syndrome","Pathogenic(Last reviewed: Nov 7, 2017)","no assertion criteria provided","VCV000549257","15","48756146","15","48463949",549257,"539675","rs140627","NC_000015.10:48463948:C:G"
"NM_000138.4(FBN1):c.6331T>C (p.Cys2111Arg)","FBN1","C2111R","Familial thoracic aortic aneurysm and aortic dissection|Marfan syndrome|Isolated thoracic aortic aneurysm","Likely pathogenic(Last reviewed: Sep 1, 2018)","criteria provided, multiple submitters, no conflicts","VCV000549340","15","48729567","15","48437370",549340,"539601","rs363815","NC_000015.10:48437369:A:G"
"NM_000138.4(FBN1):c.4022A>G (p.Asn1341Ser)","FBN1","N1341S","Marfan syndrome|Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Dec 27, 2019)","criteria provided, conflicting interpretations","VCV000495603","15","48766790","15","48474593",495603,"487575","rs140638","NC_000015.10:48474592:T:C"
"NM_000138.5(FBN1):c.7498T>A (p.Cys2500Ser)","FBN1","C2500S","Marfan syndrome","Likely pathogenic(Last reviewed: Jun 22, 2016)","criteria provided, single submitter","VCV000504529","15","48714221","15","48422024",504529,"497066","rs363810","NC_000015.10:48422023:A:T"
"NM_000138.4(FBN1):c.5015G>T (p.Cys1672Phe)","FBN1","C1672F","Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection","Pathogenic(Last reviewed: Jan 27, 2019)","criteria provided, single submitter","VCV000640108","15","48756146","15","48463949",640108,"643359","rs140627","NC_000015.10:48463948:C:A"
"NM_002693.2(POLG):c.2481-7C>T","POLG","","Toe walking|none provided|POLG-Related Spectrum Disorders|Progressive sclerosing poliodystrophy|not provided|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2021)","criteria provided, conflicting interpretations","VCV000138747","15","89865091","15","89321860",138747,"142450","rs2307448","NC_000015.10:89321859:G:A"
"NM_000138.5(FBN1):c.3037G>A (p.Gly1013Arg)","FBN1","G1013R","Marfan syndrome|not provided|Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection","Pathogenic(Last reviewed: Feb 15, 2020)","criteria provided, multiple submitters, no conflicts","VCV000177648","15","48782093","15","48489896",177648,"175987","rs140593","NC_000015.10:48489895:C:T"
"NM_000138.5(FBN1):c.7540G>A (p.Gly2514Arg)","FBN1","G2514R","Marfan syndrome|Isolated thoracic aortic aneurysm|not provided|not specified|Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection|Cardiovascular phenotype","Conflicting interpretations of pathogenicity(Last reviewed: Nov 25, 2020)","criteria provided, conflicting interpretations","VCV000178034","15","48714179","15","48421982",178034,"176123","rs363811","NC_000015.10:48421981:C:T"
"NM_000138.4(FBN1):c.5015G>A (p.Cys1672Tyr)","FBN1","C1672Y","not provided","Pathogenic/Likely pathogenic(Last reviewed: Dec 7, 2018)","criteria provided, multiple submitters, no conflicts","VCV000200187","15","48756146","15","48463949",200187,"197683","rs140627","NC_000015.10:48463948:C:T"
"NM_014249.4(NR2E3):c.119-2A>C","NR2E3","","Cone-rod dystrophy|Enhanced S-cone syndrome|Retinitis pigmentosa 37|Goldmann-Favre syndrome|Retinitis pigmentosa 37|Enhanced S-cone syndrome|Retinitis pigmentosa|NR2E3-Related Disorders|Retinal dystrophy|not provided|not specified|Horizontal nystagmus|Visual impairment|Retinal dystrophy|Abnormality of color vision","Pathogenic/Likely pathogenic(Last reviewed: Jun 17, 2021)","criteria provided, multiple submitters, no conflicts","VCV000191059","15","72103821","15","71811481",191059,"188865","rs2723341","NC_000015.10:71811480:A:C"
"NM_002386.3(MC1R):c.478C>T (p.Arg160Trp)","MC1R","R160W","not specified|Cutaneous malignant melanoma 5|Increased analgesia from kappa-opioid receptor agonist, female-specific|OCULOCUTANEOUS ALBINISM, TYPE II, MODIFIER OF|Skin/hair/eye pigmentation 2, red hair/fair skin|Malignant tumor of breast|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)","criteria provided, conflicting interpretations","VCV000014310","16","89986144","16","89919736",14310,"29349","rs1805008","NC_000016.10:89919735:C:T"
"NM_003361.3(UMOD):c.649T>C (p.Cys217Arg)","UMOD","C217R, C250R","Familial juvenile hyperuricemic nephropathy type 1","Pathogenic(Last reviewed: Dec 17, 2004)","no assertion criteria provided","VCV000012256","16","20359974","16","20348652",12256,"27295","rs28934583","NC_000016.10:20348651:A:G"
"NM_003361.3(UMOD):c.307G>T (p.Gly103Cys)","UMOD","G103C, G136C","Familial juvenile hyperuricemic nephropathy type 1","Pathogenic(Last reviewed: Dec 1, 2002)","no assertion criteria provided","VCV000012257","16","20360316","16","20348994",12257,"27296","rs28934584","NC_000016.10:20348993:C:A"
"NM_000548.5(TSC2):c.1832G>A (p.Arg611Gln)","TSC2","R611Q, R411Q, R622Q, R574Q, R562Q","Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Lymphangiomyomatosis|Tuberous sclerosis 2|Focal cortical dysplasia type II|Lymphangiomyomatosis","Pathogenic(Last reviewed: Sep 29, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012397","16","2120572","16","2070571",12397,"27436","rs28934872","NC_000016.10:2070570:G:A"
"NM_003361.3(UMOD):c.649T>G (p.Cys217Gly)","UMOD","C217G, C250G","Familial juvenile hyperuricemic nephropathy type 1","Pathogenic(Last reviewed: Jan 6, 2012)","no assertion criteria provided","VCV000039418","16","20359974","16","20348652",39418,"48017","rs28934583","NC_000016.10:20348651:A:C"
"NM_000558.3(HBA1):c.179G>T (p.Gly60Val)","HBA1|LOC106804613","G60V","HEMOGLOBIN TOTTORI","other(Last reviewed: Jul 20, 2016)","no assertion criteria provided","VCV000015827","16","227011","16","177012",15827,"30866","rs28928878","NC_000016.10:177011:G:T"
"NM_000558.3(HBA1):c.179G>A (p.Gly60Asp)","HBA1|LOC106804613","G60D","Hemoglobin H disease, nondeletional|HEMOGLOBIN ADANA|not provided","Pathogenic(Last reviewed: Mar 19, 2019)","criteria provided, multiple submitters, no conflicts","VCV000015849","16","227011","16","177012",15849,"30888","rs28928878","NC_000016.10:177011:G:A"
"NM_021615.5(CHST6):c.599T>G (p.Leu200Arg)","CHST6","L200R","not provided|Macular corneal dystrophy|Macular corneal dystrophy, type II","Pathogenic(Last reviewed: Sep 1, 2019)","criteria provided, multiple submitters, no conflicts","VCV000005075","16","75513128","16","75479230",5075,"20114","rs28937879","NC_000016.10:75479229:A:C"
"NM_001040667.3(HSF4):c.355C>T (p.Arg119Cys)","HSF4","R119C","Cataract 5 multiple types","Pathogenic(Last reviewed: Jul 1, 2002)","no assertion criteria provided","VCV000007093","16","67199744","16","67165841",7093,"22132","rs28937573","NC_000016.10:67165840:C:T"
"NM_000243.3(MEFV):c.442G>C","MEFV","","Familial Mediterranean fever|Familial mediterranean fever, autosomal dominant|none provided|not provided|Familial Mediterranean fever|Familial mediterranean fever, autosomal dominant|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2021)","criteria provided, conflicting interpretations","VCV000002542","16","3304626","16","3254626",2542,"17581","rs3743930","NC_000016.10:3254625:C:G"
"NM_001126108.2(SLC12A3):c.625C>T (p.Arg209Trp)","SLC12A3","R209W, R208W","not provided|Familial hypokalemia-hypomagnesemia","Pathogenic(Last reviewed: Jun 6, 2020)","criteria provided, single submitter","VCV000008586","16","56904031","16","56870119",8586,"23625","rs28936388","NC_000016.10:56870118:C:T"
"NM_001039.4(SCNN1G):c.547G>A (p.Gly183Ser)","SCNN1G","G183S","Liddle syndrome 2|not provided|not specified|Autosomal recessive pseudohypoaldosteronism type 1|Bronchiectasis with or without elevated sweat chloride 3","Benign/Likely benign(Last reviewed: Dec 31, 2019)","criteria provided, multiple submitters, no conflicts","VCV000008828","16","23200921","16","23189600",8828,"23867","rs5736","NC_000016.10:23189599:G:A"
"NM_004380.3(CREBBP):c.3524A>G (p.Tyr1175Cys)","CREBBP","Y1175C, Y1137C","Rubinstein-Taybi syndrome 1","Likely pathogenic(Last reviewed: Nov 5, 2019)","criteria provided, single submitter","VCV000009432","16","3807895","16","3757894",9432,"24471","rs28937315","NC_000016.10:3757893:T:C"
"NM_001009944.3(PKD1):c.1396G>A (p.Val466Met)","PKD1","V466M","not provided|Autosomal dominant polycystic kidney disease|Polycystic kidney disease","Conflicting interpretations of pathogenicity(Last reviewed: Jan 1, 2019)","criteria provided, conflicting interpretations","VCV000447971","16","2167044","16","2117043",447971,"441874","rs2855341","NC_000016.10:2117042:C:T"
"NM_201400.4(EEF2KMT):c.*804G>A","ALG1|EEF2KMT","R337*","not provided|ALG1-CDG","Conflicting interpretations of pathogenicity(Last reviewed: Dec 26, 2018)","criteria provided, conflicting interpretations","VCV000382581","16","5134829","16","5084828",382581,"377609","rs1047747","NC_000016.10:5084827:C:T"
"NM_000558.5(HBA1):c.207C>A (p.Asn69Lys)","HBA1|LOC106804613","N69K","alpha Thalassemia","Pathogenic(Last reviewed: Dec 29, 2016)","no assertion criteria provided","VCV000375748","16","227039","16","177040",375748,"362634","rs1060339","NC_000016.10:177039:C:A"
"NM_000558.5(HBA1):c.207C>G (p.Asn69Lys)","HBA1|LOC106804613","N69K","none provided|not provided","Likely benign(Last reviewed: Jul 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000439095","16","227039","16","177040",439095,"432867","rs1060339","NC_000016.10:177039:C:G"
"NM_019109.5(ALG1):c.1312C>T (p.Arg438Trp)","ALG1|EEF2KMT","R327W, R438W","Congenital disorder of glycosylation","Likely pathogenic(Last reviewed: May 25, 2017)","no assertion criteria provided","VCV000690315","16","5134799","16","5084798",690315,"678020","rs16835020","NC_000016.10:5084797:C:T"
"NM_001009944.3(PKD1):c.2180T>A (p.Leu727Gln)","PKD1","L727Q","not provided","Uncertain significance(Last reviewed: Feb 1, 2018)","criteria provided, single submitter","VCV000586255","16","2164844","16","2114843",586255,"577527","rs1616940","NC_000016.10:2114842:A:T"
"NM_001009944.3(PKD1):c.2180T>C (p.Leu727Pro)","PKD1","L727P","Polycystic kidney disease, adult type|Autosomal dominant polycystic kidney disease|not provided|Polycystic kidney disease|Polycystic kidney disease 3","Conflicting interpretations of pathogenicity(Last reviewed: Jun 30, 2021)","criteria provided, conflicting interpretations","VCV000562302","16","2164844","16","2114843",562302,"553486","rs1616940","NC_000016.10:2114842:A:G"
"NM_002474.3(MYH11):c.4401C>T (p.Tyr1467=)","MYH11|NDE1","","not specified|Familial thoracic aortic aneurysm and aortic dissection|Cardiovascular phenotype|Lissencephaly, Recessive|Aortic aneurysm, familial thoracic 4|none provided","Benign/Likely benign(Last reviewed: Dec 2, 2020)","criteria provided, multiple submitters, no conflicts","VCV000138343","16","15815456","16","15721599",138343,"142046","rs8046180","NC_000016.10:15721598:G:A"
"NM_004608.3(TBX6):c.1227G>A (p.Pro409=)","TBX6","","not specified|not provided","Benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000259448","16","30097630","16","30086309",259448,"255673","rs2289292","NC_000016.10:30086308:C:T"
"NM_002474.3(MYH11):c.4401C>G (p.Tyr1467Ter)","MYH11|NDE1","Y1467*, Y1474*","Aortic aneurysm, familial thoracic 4","Pathogenic(Last reviewed: Nov 16, 2019)","criteria provided, single submitter","VCV000201075","16","15815456","16","15721599",201075,"197866","rs8046180","NC_000016.10:15721598:G:C"
"NM_004448.3(ERBB2):c.2326G>A (p.Gly776Ser)","ERBB2","G776S, G746S, G761S","Adenocarcinoma of stomach|Neoplasm of stomach|Neoplasm","Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)","no assertion criteria provided","VCV000013879","17","37880997","17","39724744",13879,"28918","rs28933369","NC_000017.11:39724743:G:A"
"NM_000422.3(KRT17):c.296T>C (p.Leu99Pro)","KRT17","L99P","not provided|Pachyonychia congenita 2","Pathogenic(Last reviewed: Jun 9, 2015)","criteria provided, single submitter","VCV000014598","17","39780466","17","41624214",14598,"29637","rs28933089","NC_000017.11:41624213:A:G"
"NM_005557.4(KRT16):c.362T>C (p.Met121Thr)","KRT16","M121T","not provided|Pachyonychia congenita 1","Pathogenic(Last reviewed: Mar 23, 2016)","criteria provided, single submitter","VCV000014608","17","39768579","17","41612327",14608,"29647","rs28928894","NC_000017.11:41612326:A:G"
"NM_005557.4(KRT16):c.383T>A (p.Leu128Gln)","KRT16","L128Q","not provided|Pachyonychia congenita 1","Pathogenic(Last reviewed: Dec 1, 2001)","no assertion criteria provided","VCV000014609","17","39768558","17","41612306",14609,"29648","rs28928895","NC_000017.11:41612305:A:T"
"NM_000526.5(KRT14):c.356T>C (p.Met119Thr)","KRT14","M119T","not provided|Epidermolysis bullosa simplex Dowling-Meara type","Pathogenic(Last reviewed: Dec 8, 2020)","criteria provided, single submitter","VCV000014619","17","39742731","17","41586479",14619,"29658","rs28928893","NC_000017.11:41586478:A:G"
"NM_000422.3(KRT17):c.284T>C (p.Leu95Pro)","KRT17","L95P","not provided|Pachyonychia congenita 2","Pathogenic(Last reviewed: May 14, 2015)","criteria provided, single submitter","VCV000014596","17","39780478","17","41624226",14596,"29635","rs28928899","NC_000017.11:41624225:A:G"
"NM_000422.3(KRT17):c.274A>G (p.Asn92Asp)","KRT17","N92D","not provided|Pachyonychia congenita 2","Pathogenic(Last reviewed: Nov 3, 2016)","criteria provided, single submitter","VCV000014586","17","39780488","17","41624236",14586,"29625","rs28928896","NC_000017.11:41624235:T:C"
"NM_000422.3(KRT17):c.292T>G (p.Tyr98Asp)","KRT17","Y98D","not provided|Pachyonychia congenita 2","Pathogenic(Last reviewed: Feb 1, 1997)","no assertion criteria provided","VCV000014588","17","39780470","17","41624218",14588,"29627","rs28933088","NC_000017.11:41624217:A:C"
"NM_000422.3(KRT17):c.274A>C (p.Asn92His)","KRT17","N92H","not provided|Steatocystoma multiplex","Pathogenic(Last reviewed: Feb 1, 1997)","no assertion criteria provided","VCV000014589","17","39780488","17","41624236",14589,"29628","rs28928896","NC_000017.11:41624235:T:G"
"NM_000422.3(KRT17):c.281G>A (p.Arg94His)","KRT17","R94H","not provided|Pachyonychia congenita 2|Steatocystoma multiplex","Pathogenic(Last reviewed: Dec 1, 2019)","criteria provided, single submitter","VCV000014590","17","39780481","17","41624229",14590,"29629","rs28928897","NC_000017.11:41624228:C:T"
"NM_000422.3(KRT17):c.263T>C (p.Met88Thr)","KRT17","M88T","Pachyonychia congenita 2|not provided","Pathogenic(Last reviewed: Nov 1, 1999)","no assertion criteria provided","VCV000014592","17","39780499","17","41624247",14592,"29631","rs28928898","NC_000017.11:41624246:A:G"
"NM_000422.3(KRT17):c.281G>C (p.Arg94Pro)","KRT17","R94P","not provided|Pachyonychia congenita 2","Pathogenic(Last reviewed: May 1, 2001)","no assertion criteria provided","VCV000014594","17","39780481","17","41624229",14594,"29633","rs28928897","NC_000017.11:41624228:C:G"
"NM_000422.3(KRT17):c.284T>A (p.Leu95Gln)","KRT17","L95Q","not provided|Pachyonychia congenita 2","Pathogenic(Last reviewed: May 1, 2001)","no assertion criteria provided","VCV000014595","17","39780478","17","41624226",14595,"29634","rs28928899","NC_000017.11:41624225:A:T"
"NM_000546.6(TP53):c.215C>G (p.Pro72Arg)","TP53","P72R, P33R","not specified|not provided|Li-Fraumeni syndrome|fluorouracil response - Efficacy, Toxicity/ADR|paclitaxel response - Efficacy, Toxicity/ADR|antineoplastic agents response - Efficacy, Toxicity/ADR|cisplatin response - Efficacy, Toxicity/ADR|cyclophosphamide response - Efficacy, Toxicity/ADR|Li-Fraumeni syndrome 1|CODON 72 POLYMORPHISM|none provided|Lip and oral cavity carcinoma|Hereditary cancer-predisposing syndrome","drug response(Last reviewed: Oct 17, 2016)","reviewed by expert panel","VCV000012351","17","7579472","17","7676154",12351,"27390","rs1042522","NC_000017.11:7676153:G:C"
"NM_000546.6(TP53):c.747G>T","TP53","R249S, R117S, R210S, R90S","Hereditary cancer-predisposing syndrome|Neoplasm of ovary|Squamous cell carcinoma of the head and neck|Hepatocellular carcinoma|Cancer of cervix|Li-Fraumeni syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Sep 9, 2018)","criteria provided, conflicting interpretations","VCV000012352","17","7577534","17","7674216",12352,"27391","rs28934571","NC_000017.11:7674215:C:A"
"NM_000546.6(TP53):c.743G>A (p.Arg248Gln)","TP53","R248Q, R116Q, R209Q, R89Q","Breast neoplasm|Neoplasm|Nasopharyngeal carcinoma|Carcinoma of colon|Li-Fraumeni syndrome 1|Carcinoma of pancreas|Choroid plexus papilloma|Osteosarcoma|Glioma susceptibility 1|Familial cancer of breast|Adrenocortical carcinoma, hereditary|Hepatocellular carcinoma|Basal cell carcinoma, susceptibility to, 7|Pancreatic adenocarcinoma|Multiple myeloma|Li-Fraumeni syndrome|Medulloblastoma|Chronic lymphocytic leukemia|Squamous cell carcinoma of the skin|Brainstem glioma|Transitional cell carcinoma of the bladder|Small cell lung carcinoma|Lung adenocarcinoma|Malignant melanoma of skin|Hepatocellular carcinoma|not provided|Neoplasm of ovary|Acute myeloid leukemia|Li-Fraumeni syndrome 1|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Myelodysplastic syndrome|Familial cancer of breast|Malignant Colorectal Neoplasm|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Lip and oral cavity carcinoma|Lymphoma|Neoplasm of the large intestine|Hereditary cancer-predisposing syndrome|Neoplasm of brain|Ductal carcinoma in situ|Sarcoma|Rhabdomyosarcoma (disease)|Carcinoma of esophagus|Uterine Carcinosarcoma|Glioblastoma","Pathogenic(Last reviewed: Aug 28, 2019)","reviewed by expert panel","VCV000012356","17","7577538","17","7674220",12356,"27395","rs11540652","NC_000017.11:7674219:C:T"
"NM_000546.5(TP53):c.451C>A (p.Pro151Thr)","TP53","P151T, P112T, P19T","Uterine Carcinosarcoma|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Breast adenocarcinoma|Rhabdomyosarcoma (disease)|Multiple myeloma|Adenoid cystic carcinoma|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Li-Fraumeni syndrome|Neoplasm of brain|Hepatocellular carcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Pancreatic adenocarcinoma|Malignant melanoma of skin|Hereditary cancer-predisposing syndrome|Breast neoplasm|Transitional cell carcinoma of the bladder|not provided|Lung adenocarcinoma","Likely pathogenic(Last reviewed: Oct 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012369","17","7578479","17","7675161",12369,"27408","rs28934874","NC_000017.11:7675160:G:T"
"NM_000546.6(TP53):c.451C>T (p.Pro151Ser)","TP53","P151S, P112S, P19S","Breast neoplasm|Pancreatic adenocarcinoma|Li-Fraumeni syndrome|Multiple myeloma|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Hepatocellular carcinoma|Neoplasm of ovary|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Breast adenocarcinoma|Uterine Carcinosarcoma|Adenoid cystic carcinoma|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Neoplasm of the large intestine|Hereditary cancer-predisposing syndrome|Neoplasm of brain|Rhabdomyosarcoma (disease)|Carcinoma of esophagus|not provided","Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012370","17","7578479","17","7675161",12370,"27409","rs28934874","NC_000017.11:7675160:G:A"
"NM_001276697.2(TP53):c.-66G>C","TP53","A138P, A6P, A99P","Li-Fraumeni syndrome|Li-Fraumeni syndrome 1","Likely pathogenic(Last reviewed: Jan 1, 2020)","criteria provided, single submitter","VCV000012376","17","7578518","17","7675200",12376,"27415","rs28934875","NC_000017.11:7675199:C:G"
"NM_000346.4(SOX9):c.507C>T (p.His169=)","SOX9","","not specified|Camptomelic dysplasia|none provided","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000021164","17","70118935","17","72122794",21164,"34016","rs2229989","NC_000017.11:72122793:C:T"
"NM_000018.4(ACADVL):c.194C>T (p.Pro65Leu)","ACADVL","P65L, P88L","not provided|Very long chain acyl-CoA dehydrogenase deficiency|not specified","Benign/Likely benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000038798","17","7123838","17","7220519",38798,"16670","rs28934585","NC_000017.11:7220518:C:T"
"NM_002055.5(GFAP):c.1055T>C (p.Leu352Pro)","GFAP","L352P","not provided|Alexander Disease","Pathogenic(Last reviewed: Jan 8, 2015)","no assertion criteria provided","VCV000016178","17","42988676","17","44911308",16178,"31217","rs28932769","NC_000017.11:44911307:A:G"
"NM_000342.3(SLC4A1):c.268G>A (p.Glu90Lys)","SLC4A1","E90K","Spherocytosis type 4","Pathogenic(Last reviewed: Jun 1, 2001)","no assertion criteria provided","VCV000017775","17","42338084","17","44260716",17775,"32814","rs28929480","NC_000017.11:44260715:C:T"
"NM_000342.3(SLC4A1):c.2608C>T (p.Arg870Trp)","SLC4A1","R870W","Spherocytosis type 4|not provided","Likely pathogenic(Last reviewed: Jan 15, 2021)","criteria provided, multiple submitters, no conflicts","VCV000017776","17","42328574","17","44251206",17776,"32815","rs28931585","NC_000017.11:44251205:G:A"
"NM_007294.4(BRCA1):c.3748G>T (p.Glu1250Ter)","BRCA1","E1250*, E1203*","not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Hereditary breast and ovarian cancer syndrome|not specified|Breast-ovarian cancer, familial 1","Pathogenic(Last reviewed: Sep 8, 2016)","reviewed by expert panel","VCV000017672","17","41243800","17","43091783",17672,"32711","rs28897686","NC_000017.11:43091782:C:A"
"NM_000342.4(SLC4A1):c.166A>G (p.Lys56Glu)","SLC4A1","K56E","not provided|not specified|Hemolytic anemia|none provided|Spherocytosis type 4|Band 3 memphis|Autosomal dominant distal renal tubular acidosis","Benign/Likely benign(Last reviewed: Dec 5, 2020)","criteria provided, multiple submitters, no conflicts","VCV000017752","17","42338945","17","44261577",17752,"32791","rs5036","NC_000017.11:44261576:T:C"
"NM_000342.4(SLC4A1):c.2561C>T (p.Pro854Leu)","SLC4A1","P854L","Spherocytosis type 4|not provided|not specified|Autosomal dominant distal renal tubular acidosis|DIEGO BLOOD GROUP ANTIGEN|Hemolytic anemia","Benign(Last reviewed: Dec 31, 2019)","criteria provided, multiple submitters, no conflicts","VCV000017768","17","42328621","17","44251253",17768,"32807","rs2285644","NC_000017.11:44251252:G:A"
"NM_018127.7(ELAC2):c.650C>T (p.Ser217Leu)","ELAC2","S217L","not specified|Combined oxidative phosphorylation deficiency 17|Prostate cancer, hereditary, 2|not provided","Benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000005055","17","12915009","17","13011692",5055,"20094","rs4792311","NC_000017.11:13011691:G:A"
"NM_018127.7(ELAC2):c.1621G>A (p.Ala541Thr)","ELAC2","A541T, A501T, A540T","Prostate cancer, hereditary, 2|not specified|not provided|Combined oxidative phosphorylation deficiency 17","Benign(Last reviewed: Dec 6, 2020)","criteria provided, multiple submitters, no conflicts","VCV000005056","17","12899902","17","12996585",5056,"20095","rs5030739","NC_000017.11:12996584:C:T"
"NM_000152.3(GAA):c.2065G>A (p.Glu689Lys)","GAA","E689K","not specified|not provided|Glycogen storage disease, type II|Acid alpha-glucosidase, allele 4","Benign, other(Last reviewed: Jun 10, 2021)","criteria provided, multiple submitters, no conflicts","VCV000004030","17","78087041","17","80113242",4030,"19069","rs1800309","NC_000017.11:80113241:G:A"
"NM_005450.5(NOG):c.103C>G (p.Pro35Ala)","NOG","P35A","Brachydactyly type B2","Pathogenic(Last reviewed: Aug 1, 2007)","no assertion criteria provided","VCV000006708","17","54671687","17","56594326",6708,"21747","rs28937580","NC_000017.11:56594325:C:G"
"NM_005450.5(NOG):c.103C>T (p.Pro35Ser)","NOG","P35S","Symphalangism, proximal, 1A|Brachydactyly type B2|Stapes ankylosis with broad thumb and toes","Pathogenic(Last reviewed: Jul 1, 2008)","no assertion criteria provided","VCV000006703","17","54671687","17","56594326",6703,"21742","rs28937580","NC_000017.11:56594325:C:T"
"NM_000049.4(ASPA):c.693C>A (p.Tyr231Ter)","ASPA|SPATA22","Y231*","Canavan Disease, Familial Form|not provided|Spongy degeneration of central nervous system","Pathogenic(Last reviewed: Dec 4, 2019)","criteria provided, multiple submitters, no conflicts","VCV000002609","17","3397702","17","3494408",2609,"17648","rs12948217","NC_000017.11:3494407:C:A"
"NM_000286.3(PEX12):c.959C>T (p.Ser320Phe)","PEX12","S320F","not provided|Peroxisomal biogenesis disorder 3b|Peroxisome biogenesis disorder 3A","Conflicting interpretations of pathogenicity(Last reviewed: Oct 23, 2020)","criteria provided, conflicting interpretations","VCV000007775","17","33902922","17","35575903",7775,"22814","rs28936697","NC_000017.11:35575902:G:A"
"NM_001614.5(ACTG1):c.611C>G (p.Ala204Gly)","ACTG1","A204G","Baraitser-Winter Syndrome 2|not provided","Likely pathogenic(Last reviewed: Jul 14, 2020)","criteria provided, multiple submitters, no conflicts","VCV000452404","17","79478405","17","81511379",452404,"445921","rs11549225","NC_000017.11:81511378:G:C"
"NM_000546.5(TP53):c.993+1G>A","TP53","","not provided|Li-Fraumeni syndrome|Neoplasm of ovary","Pathogenic(Last reviewed: Sep 24, 2020)","criteria provided, single submitter","VCV000528261","17","7576852","17","7673534",528261,"532188","rs11575997","NC_000017.11:7673533:C:T"
"NM_000080.4(CHRNE):c.293T>C (p.Leu98Pro)","CHRNE|C17orf107","L98P","Myasthenic syndrome, congenital, 4a, slow-channel","Likely pathogenic(Last reviewed: Sep 22, 2019)","criteria provided, single submitter","VCV000534249","17","4805563","17","4902268",534249,"531399","rs28929768","NC_000017.11:4902267:A:G"
"NM_000546.5(TP53):c.329G>T (p.Arg110Leu)","TP53","R110L, R71L","Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Neoplasm of ovary","Pathogenic/Likely pathogenic(Last reviewed: Jan 14, 2021)","criteria provided, multiple submitters, no conflicts","VCV000406597","17","7579358","17","7676040",406597,"402569","rs11540654","NC_000017.11:7676039:C:A"
"NM_000546.5(TP53):c.747G>C (p.Arg249Ser)","TP53","R210S, R249S, R117S, R90S","Li-Fraumeni syndrome","Uncertain significance(Last reviewed: Nov 9, 2019)","criteria provided, single submitter","VCV000406598","17","7577534","17","7674216",406598,"403018","rs28934571","NC_000017.11:7674215:C:G"
"NM_005557.4(KRT16):c.362T>G (p.Met121Arg)","KRT16","M121R","not provided","Pathogenic(Last reviewed: Dec 31, 2015)","criteria provided, single submitter","VCV000419351","17","39768579","17","41612327",419351,"409923","rs28928894","NC_000017.11:41612326:A:C"
"NM_001276697.2(TP53):c.-27C>G","TP53","P112A, P151A, P19A","Adenocarcinoma of stomach|Neoplasm of the large intestine|Carcinoma of esophagus|Uterine Carcinosarcoma|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenoid cystic carcinoma|Pancreatic adenocarcinoma|Breast neoplasm|Neoplasm of brain|Multiple myeloma|Hepatocellular carcinoma|Malignant melanoma of skin|Squamous cell lung carcinoma|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck|Transitional cell carcinoma of the bladder","Pathogenic(Last reviewed: Jun 16, 2020)","criteria provided, single submitter","VCV000376641","17","7578479","17","7675161",376641,"363520","rs28934874","NC_000017.11:7675160:G:C"
"NM_000546.5(TP53):c.832C>T (p.Pro278Ser)","TP53","P146S, P239S, P278S, P119S","Ovarian Serous Cystadenocarcinoma|Carcinoma of esophagus|Malignant neoplasm of body of uterus|Neoplasm of the large intestine|Breast neoplasm|Neoplasm of brain|Pancreatic adenocarcinoma|Hereditary cancer-predisposing syndrome|not provided|Neoplasm of ovary|Multiple myeloma|Malignant melanoma of skin|Lung adenocarcinoma|Squamous cell lung carcinoma|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck|Squamous cell carcinoma of the skin","Conflicting interpretations of pathogenicity(Last reviewed: Dec 29, 2019)","criteria provided, conflicting interpretations","VCV000376642","17","7577106","17","7673788",376642,"363521","rs17849781","NC_000017.11:7673787:G:A"
"NM_000546.5(TP53):c.832C>A (p.Pro278Thr)","TP53","P146T, P239T, P278T, P119T","Squamous cell lung carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the head and neck|Breast neoplasm|Multiple myeloma|Poly (ADP-Ribose) polymerase inhibitor response|Neoplasm of ovary|Lung adenocarcinoma|Malignant neoplasm of body of uterus|Neoplasm of brain|Squamous cell carcinoma of the skin|Ovarian Serous Cystadenocarcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Malignant melanoma of skin","Likely pathogenic, drug response(Last reviewed: Dec 1, 2018)","no assertion criteria provided","VCV000376643","17","7577106","17","7673788",376643,"363522","rs17849781","NC_000017.11:7673787:G:T"
"NM_000546.5(TP53):c.832C>G (p.Pro278Ala)","TP53","P146A, P239A, P278A, P119A","Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Neoplasm of the large intestine|Carcinoma of esophagus|Pancreatic adenocarcinoma|Breast neoplasm|Hereditary cancer-predisposing syndrome|Neoplasm of brain|Multiple myeloma|Neoplasm of ovary|Malignant melanoma of skin|Lung adenocarcinoma|Squamous cell lung carcinoma|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck|Squamous cell carcinoma of the skin","Conflicting interpretations of pathogenicity(Last reviewed: Nov 11, 2019)","criteria provided, conflicting interpretations","VCV000376645","17","7577106","17","7673788",376645,"363524","rs17849781","NC_000017.11:7673787:G:C"
"NM_000546.6(TP53):c.993+1G>C","TP53","","not provided|Li-Fraumeni syndrome","Pathogenic(Last reviewed: Feb 21, 2020)","criteria provided, multiple submitters, no conflicts","VCV000379801","17","7576852","17","7673534",379801,"375717","rs11575997","NC_000017.11:7673533:C:G"
"NM_000546.5(TP53):c.993G>A (p.Gln331=)","TP53","","Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided","Likely pathogenic(Last reviewed: Jul 7, 2020)","criteria provided, multiple submitters, no conflicts","VCV000428868","17","7576853","17","7673535",428868,"420639","rs11575996","NC_000017.11:7673534:C:T"
"NM_001614.5(ACTG1):c.430G>A (p.Ala144Thr)","ACTG1","A144T","Baraitser-Winter Syndrome 2","Likely pathogenic(Last reviewed: May 3, 2016)","criteria provided, single submitter","VCV000434079","17","79478586","17","81511560",434079,"430029","rs11549196","NC_000017.11:81511559:C:T"
"NM_001614.5(ACTG1):c.773C>T (p.Pro258Leu)","ACTG1","P258L","not provided|Deafness, autosomal dominant 20|Baraitser-Winter Syndrome 2","Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2021)","criteria provided, conflicting interpretations","VCV000639093","17","79478243","17","81511217",639093,"646969","rs11549191","NC_000017.11:81511216:G:A"
"NM_000088.3(COL1A1):c.4171C>T (p.Gln1391Ter)","COL1A1","Q1391*","Osteogenesis imperfecta","Pathogenic(Last reviewed: Jul 11, 2019)","criteria provided, single submitter","VCV000691323","17","48263216","17","50185855",691323,"679011","rs2586486","NC_000017.11:50185854:G:A"
"NM_000546.5(TP53):c.993+1G>T","TP53","","Neoplasm of ovary|Li-Fraumeni syndrome|not provided","Pathogenic(Last reviewed: Dec 23, 2019)","criteria provided, single submitter","VCV000634766","17","7576852","17","7673534",634766,"622662","rs11575997","NC_000017.11:7673533:C:A"
"NM_000546.6(TP53):c.329G>A (p.Arg110His)","TP53","R110H, R71H","Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|not provided|not specified","Likely benign(Last reviewed: Aug 11, 2020)","reviewed by expert panel","VCV000127808","17","7579358","17","7676040",127808,"133265","rs11540654","NC_000017.11:7676039:C:T"
"NM_000546.5(TP53):c.215= (p.Pro72=)","TP53","","not specified","Benign(Last reviewed: Aug 15, 2013)","criteria provided, single submitter","VCV000165560","17","7579472","17","7676154",165560,"176504","rs1042522","NC_000017.11:7676153:G:G"
"NM_000422.3(KRT17):c.263T>A (p.Met88Lys)","KRT17","M88K","not provided","not provided","no assertion provided","VCV000066182","17","39780499","17","41624247",66182,"77079","rs28928898","NC_000017.11:41624246:A:T"
"NM_005557.4(KRT16):c.362T>A (p.Met121Lys)","KRT16","M121K","not provided","not provided","no assertion provided","VCV000066604","17","39768579","17","41612327",66604,"77501","rs28928894","NC_000017.11:41612326:A:T"
"NM_007294.4(BRCA1):c.3748G>A (p.Glu1250Lys)","BRCA1","E1250K, E1203K","Malignant tumor of breast|Hereditary cancer-predisposing syndrome|none provided|Breast-ovarian cancer, familial 1|Breast neoplasm|not specified|Breast and/or ovarian cancer|Hereditary breast and ovarian cancer syndrome","Benign(Last reviewed: Aug 10, 2015)","reviewed by expert panel","VCV000054987","17","41243800","17","43091783",54987,"69654","rs28897686","NC_000017.11:43091782:C:T"
"NM_000180.4(GUCY2D):c.2511G>C (p.Glu837Asp)","GUCY2D","E837D","not provided","not provided","no assertion provided","VCV000098567","17","7918017","17","8014699",98567,"24393","rs28933695","NC_000017.11:8014698:G:C"
"NM_000546.5(TP53):c.743G>C (p.Arg248Pro)","TP53","R116P, R209P, R248P, R89P","Small cell lung carcinoma|Multiple myeloma|Medulloblastoma|Hepatocellular carcinoma|Neoplasm of the large intestine|Pancreatic adenocarcinoma|Myelodysplastic syndrome|Breast neoplasm|Chronic lymphocytic leukemia|Glioblastoma|Squamous cell lung carcinoma|Carcinoma of esophagus|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of brain|Li-Fraumeni syndrome|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Brainstem glioma|Uterine Carcinosarcoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Malignant melanoma of skin|Acute myeloid leukemia","Pathogenic(Last reviewed: Jan 10, 2019)","criteria provided, single submitter","VCV000237954","17","7577538","17","7674220",237954,"242980","rs11540652","NC_000017.11:7674219:C:G"
"NM_000152.5(GAA):c.2238G>A (p.Trp746Ter)","GAA","W746*","not provided|Glycogen storage disease, type II","Pathogenic(Last reviewed: May 5, 2020)","reviewed by expert panel","VCV000370904","17","78090815","17","80117016",370904,"358515","rs1800312","NC_000017.11:80117015:G:A"
"NM_000152.5(GAA):c.2238G>C (p.Trp746Cys)","GAA","W746C","Glycogen storage disease, type II|not provided|Glycogen storage disease","Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000265160","17","78090815","17","80117016",265160,"260196","rs1800312","NC_000017.11:80117015:G:C"
"NM_005557.4(KRT16):c.383T>C (p.Leu128Pro)","KRT16","L128P","not provided","Pathogenic(Last reviewed: Aug 1, 2016)","criteria provided, single submitter","VCV000265486","17","39768558","17","41612306",265486,"260164","rs28928895","NC_000017.11:41612305:A:G"
"NM_000346.4(SOX9):c.507C>G (p.His169Gln)","SOX9","H169Q","not provided|Camptomelic dysplasia|Inborn genetic diseases","Conflicting interpretations of pathogenicity(Last reviewed: Feb 1, 2021)","criteria provided, conflicting interpretations","VCV000235914","17","70118935","17","72122794",235914,"237540","rs2229989","NC_000017.11:72122793:C:G"
"NM_000180.4(GUCY2D):c.3139-1G>C","GUCY2D","","not provided","Pathogenic(Last reviewed: Sep 29, 2016)","criteria provided, single submitter","VCV000280359","17","7919522","17","8016204",280359,"264708","rs12602083","NC_000017.11:8016203:G:C"
"NM_000049.3(ASPA):c.693C>T (p.Tyr231=)","ASPA|SPATA22","","Spongy degeneration of central nervous system|not specified","Benign/Likely benign(Last reviewed: Jul 8, 2021)","criteria provided, multiple submitters, no conflicts","VCV000197621","17","3397702","17","3494408",197621,"194782","rs12948217","NC_000017.11:3494407:C:T"
"NM_000546.5(TP53):c.215C>A (p.Pro72His)","TP53","P33H, P72H","Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1","Likely benign(Last reviewed: Apr 19, 2021)","reviewed by expert panel","VCV000185120","17","7579472","17","7676154",185120,"185405","rs1042522","NC_000017.11:7676153:G:T"
"NM_000546.5(TP53):c.743G>T (p.Arg248Leu)","TP53","R116L, R209L, R248L, R89L","Small cell lung carcinoma|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Medulloblastoma|Transitional cell carcinoma of the bladder|Hepatocellular carcinoma|Multiple myeloma|Neoplasm of the large intestine|Pancreatic adenocarcinoma|Myelodysplastic syndrome|Breast neoplasm|Chronic lymphocytic leukemia|Acute myeloid leukemia|Squamous cell carcinoma of the head and neck|Glioblastoma|Squamous cell lung carcinoma|Carcinoma of esophagus|Lung adenocarcinoma|Neoplasm of brain|Brainstem glioma|Squamous cell carcinoma of the skin|Adenocarcinoma of prostate|Uterine Carcinosarcoma|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Malignant melanoma of skin","Pathogenic(Last reviewed: Aug 28, 2019)","reviewed by expert panel","VCV000230253","17","7577538","17","7674220",230253,"236469","rs11540652","NC_000017.11:7674219:C:A"
"NM_000546.5(TP53):c.329G>C (p.Arg110Pro)","TP53","R110P, R71P","Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome","Pathogenic(Last reviewed: Sep 30, 2020)","criteria provided, multiple submitters, no conflicts","VCV000233627","17","7579358","17","7676040",233627,"236497","rs11540654","NC_000017.11:7676039:C:G"
"NM_000894.2(LHB):c.221A>G (p.Gln74Arg)","LHB","Q74R","Isolated lutropin deficiency","Pathogenic(Last reviewed: Jan 16, 1992)","no assertion criteria provided","VCV000014413","19","49519530","19","49016273",14413,"29452","rs5030773","NC_000019.10:49016272:T:C"
"NM_001329877.1(FUT1):c.725T>G (p.Leu242Arg)","FUT1","L242R","BOMBAY PHENOTYPE, DIGENIC|Bombay phenotype","Pathogenic, Affects(Last reviewed: Sep 8, 1997)","no assertion criteria provided","VCV000012142","19","49253814","19","48750557",12142,"27181","rs28934588","NC_000019.10:48750556:A:C"
"NM_000540.3(RYR1):c.742G>A (p.Gly248Arg)","RYR1","G248R","not provided|Malignant hyperthermia, susceptibility to, 1|enflurane response - Toxicity/ADR|succinylcholine response - Toxicity/ADR|sevoflurane response - Toxicity/ADR|methoxyflurane response - Toxicity/ADR|isoflurane response - Toxicity/ADR|halothane response - Toxicity/ADR|desflurane response - Toxicity/ADR","drug response","reviewed by expert panel","VCV000012965","19","38937350","19","38446710",12965,"28004","rs1801086","NC_000019.10:38446709:G:A"
"NM_020956.2(PRX):c.*2156G>A","PRX","D651N","Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, demyelinating, type 4F","Uncertain significance(Last reviewed: Aug 20, 2019)","criteria provided, single submitter","VCV000038452","19","40902308","19","40396401",38452,"47011","rs3814290","NC_000019.10:40396400:C:T"
"NM_001972.4(ELANE):c.211T>C (p.Cys71Arg)","ELANE","C71R","Neutropenia, severe congenital 1, autosomal dominant","Pathogenic(Last reviewed: Nov 1, 2001)","no assertion criteria provided","VCV000016746","19","853019","19","853019",16746,"31785","rs28931611","NC_000019.10:853018:T:C"
"NM_000041.2(APOE):c.526C>T (p.Arg176Cys)","APOE","R176C, R202C","not specified|not provided|atorvastatin response - Efficacy|Warfarin response|Hypercholesterolemia|Familial type 3 hyperlipoproteinemia","drug response(Last reviewed: Feb 26, 2016)","reviewed by expert panel","VCV000017848","19","45412079","19","44908822",17848,"32887","rs7412","NC_000019.10:44908821:C:T"
"NM_000041.4(APOE):c.487C>T (p.Arg163Cys)","APOE","R163C, R189C","not provided|Familial type 3 hyperlipoproteinemia","Benign(Last reviewed: Dec 31, 2019)","criteria provided, single submitter","VCV000017851","19","45412040","19","44908783",17851,"32890","rs769455","NC_000019.10:44908782:C:T"
"NM_000041.4(APOE):c.388T>C (p.Cys130Arg)","APOE","C130R, C156R","Warfarin response|not provided|Alzheimer disease|Alzheimer disease, type 4|Alzheimer disease 2|Lipoprotein glomerulopathy|Primary degenerative dementia of the Alzheimer type, presenile onset","Conflicting interpretations of pathogenicity, other, risk factor(Last reviewed: Mar 24, 2020)","criteria provided, conflicting interpretations","VCV000017864","19","45411941","19","44908684",17864,"32903","rs429358","NC_000019.10:44908683:T:C"
"NM_001285829.1(CEBPA):c.-107A>T","CEBPA","H84L, H119L, H70L","Acute myeloid leukemia","Pathogenic(Last reviewed: Mar 1, 2001)","no assertion criteria provided","VCV000017568","19","33793070","19","33302164",17568,"32607","rs28931590","NC_000019.10:33302163:T:A"
"NM_000095.3(COMP):c.1358A>G (p.Asn453Ser)","COMP","N453S","Epiphyseal dysplasia, multiple, 1, severe","Pathogenic(Last reviewed: Feb 1, 1998)","no assertion criteria provided","VCV000009190","19","18896906","19","18786096",9190,"24229","rs28936668","NC_000019.10:18786095:T:C"
"NM_000095.3(COMP):c.2152C>T (p.Arg718Trp)","COMP","R718W","not provided|Carpal tunnel syndrome 2|Multiple epiphyseal dysplasia 1","Pathogenic(Last reviewed: Oct 23, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009198","19","18893939","19","18783129",9198,"24237","rs28936368","NC_000019.10:18783128:G:A"
"NM_000435.3(NOTCH3):c.213G>T (p.Trp71Cys)","NOTCH3","W71C","Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy type 1","Pathogenic(Last reviewed: Nov 22, 1997)","no assertion criteria provided","VCV000009218","19","15303315","19","15192504",9218,"24257","rs28937321","NC_000019.10:15192503:C:A"
"NM_000435.3(NOTCH3):c.505C>T (p.Arg169Cys)","NOTCH3","R169C","Stroke|Migraine without aura|none provided|not provided|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy type 1","Pathogenic(Last reviewed: Jun 9, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009219","19","15302945","19","15192134",9219,"24258","rs28933696","NC_000019.10:15192133:G:A"
"NM_000435.3(NOTCH3):c.544C>T (p.Arg182Cys)","NOTCH3","R182C","not specified|not provided|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy type 1","Pathogenic(Last reviewed: Oct 23, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009220","19","15302906","19","15192095",9220,"24259","rs28933697","NC_000019.10:15192094:G:A"
"NM_000435.3(NOTCH3):c.1363T>C (p.Cys455Arg)","NOTCH3","C455R","not provided|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy type 1","Pathogenic(Last reviewed: May 25, 2017)","criteria provided, single submitter","VCV000009223","19","15299815","19","15189004",9223,"24262","rs28933698","NC_000019.10:15189003:A:G"
"NM_000527.4(LDLR):c.1323C>T (p.Ile441=)","LDLR","","Familial hypercholesterolemia 1|Familial hypercholesterolemia|not specified","Benign/Likely benign(Last reviewed: Nov 17, 2020)","criteria provided, multiple submitters, no conflicts","VCV000456650","19","11224090","19","11113414",456650,"468439","rs5933","NC_000019.10:11113413:C:T"
"NM_000041.4(APOE):c.349G>A (p.Ala117Thr)","APOE","A117T, A143T","","no interpretation for the single variant","no interpretation for the single variant","VCV000478851","19","45411902","19","44908645",478851,"32912","rs28931577","NC_000019.10:44908644:G:A"
"NM_000527.4(LDLR):c.1056C>T (p.Cys352=)","LDLR","","not provided|Familial hypercholesterolemia|Familial hypercholesterolemia 1|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2020)","criteria provided, conflicting interpretations","VCV000413780","19","11221443","19","11110767",413780,"403134","rs13306515","NC_000019.10:11110766:C:T"
"NM_000041.4(APOE):c.388= (p.Cys130=)","APOE","","","no interpretation for the single variant","no interpretation for the single variant","VCV000694742","19","45411941","19","44908684",694742,"682795","rs429358","NC_000019.10:44908683:T:T"
"NM_000095.3(COMP):c.2152C>A (p.Arg718=)","COMP","","Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome|not provided|Multiple epiphyseal dysplasia 1","Benign(Last reviewed: Oct 6, 2020)","criteria provided, multiple submitters, no conflicts","VCV000769450","19","18893939","19","18783129",769450,"704863","rs28936368","NC_000019.10:18783128:G:T"
"NM_000540.2(RYR1):c.742G>C (p.Gly248Arg)","RYR1","G248R","not provided|RYR1-Related Disorders","Pathogenic(Last reviewed: Feb 6, 2018)","criteria provided, multiple submitters, no conflicts","VCV000133203","19","38937350","19","38446710",133203,"136950","rs1801086","NC_000019.10:38446709:G:C"
"NM_000215.3(JAK3):c.394C>A (p.Pro132Thr)","JAK3","P132T","Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-negative|not specified|Lymphoblastic leukemia, acute, with lymphomatous features|Acute megakaryoblastic leukemia","Benign/Likely benign(Last reviewed: Nov 23, 2020)","criteria provided, multiple submitters, no conflicts","VCV000134580","19","17954215","19","17843406",134580,"138319","rs3212723","NC_000019.10:17843405:G:T"
"NM_000146.4(FTL):c.163T>C (p.Leu55=)","FTL|GYS1","","sporadic abdominal aortic aneurysm|Hereditary hyperferritinemia with congenital cataracts|Neuroferritinopathy|Neuroferritinopathy|Hereditary hyperferritinemia with congenital cataracts|not specified|Glycogen storage disease 0, muscle|not provided","Benign(Last reviewed: Nov 26, 2020)","criteria provided, multiple submitters, no conflicts","VCV000156440","19","49469087","19","48965830",156440,"166213","rs2230267","NC_000019.10:48965829:T:C"
"NM_001037.5(SCN1B):c.254G>A (p.Arg85His)","SCN1B","R85H, R52H","Atrial fibrillation, familial, 13|not provided|Epileptic encephalopathy, early infantile, 52|Generalized epilepsy with febrile seizures plus, type 1|Atrial fibrillation, familial, 13|Brugada syndrome 5|Brugada syndrome 5","Pathogenic(Last reviewed: Oct 21, 2020)","criteria provided, multiple submitters, no conflicts","VCV000060767","19","35524449","19","35033545",60767,"75309","rs16969925","NC_000019.10:35033544:G:A"
"NM_000527.5(LDLR):c.939C>A (p.Cys313Ter)","LDLR","C313*, C272*, C186*, C145*","Familial hypercholesterolemia|Familial hypercholesterolemia 1","Pathogenic(Last reviewed: Jun 4, 2019)","criteria provided, multiple submitters, no conflicts","VCV000251539","19","11218189","19","11107513",251539,"245872","rs13306512","NC_000019.10:11107512:C:A"
"NM_000527.5(LDLR):c.939C>G (p.Cys313Trp)","LDLR","C313W, C145W, C272W, C186W","Familial hypercholesterolemia|Familial hypercholesterolemia 1","Conflicting interpretations of pathogenicity(Last reviewed: Aug 13, 2018)","criteria provided, conflicting interpretations","VCV000251540","19","11218189","19","11107513",251540,"245873","rs13306512","NC_000019.10:11107512:C:G"
"NM_000527.5(LDLR):c.1056C>A (p.Cys352Ter)","LDLR","C352*, C184*, C225*, C311*","Familial hypercholesterolemia 1","Pathogenic/Likely pathogenic(Last reviewed: Dec 16, 2016)","criteria provided, multiple submitters, no conflicts","VCV000251621","19","11221443","19","11110767",251621,"245944","rs13306515","NC_000019.10:11110766:C:A"
"NM_000527.5(LDLR):c.1056C>G (p.Cys352Trp)","LDLR","C352W, C184W, C225W, C311W","Familial hypercholesterolemia 1|Familial hypercholesterolemia","Pathogenic/Likely pathogenic(Last reviewed: May 24, 2021)","criteria provided, multiple submitters, no conflicts","VCV000251622","19","11221443","19","11110767",251622,"245945","rs13306515","NC_000019.10:11110766:C:G"
"NM_000527.5(LDLR):c.1323C>G (p.Ile441Met)","LDLR","I441M, I400M, I273M, I314M","Familial hypercholesterolemia|Familial hypercholesterolemia 1","Pathogenic/Likely pathogenic(Last reviewed: Mar 22, 2019)","criteria provided, multiple submitters, no conflicts","VCV000251784","19","11224090","19","11113414",251784,"246098","rs5933","NC_000019.10:11113413:C:G"
"NM_000041.4(APOE):c.137T>C (p.Leu46Pro)","APOE","L46P, L72P","Alzheimer disease, type 4|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2021)","criteria provided, conflicting interpretations","VCV000242765","19","45411110","19","44907853",242765,"32909","rs769452","NC_000019.10:44907852:T:C"
"NM_002361.4(MAG):c.399C>G (p.Ser133Arg)","MAG","S133R, S108R","Spastic paraplegia 75, autosomal recessive","Pathogenic(Last reviewed: Sep 1, 2015)","no assertion criteria provided","VCV000218187","19","35786868","19","35295965",218187,"214840","rs2301600","NC_000019.10:35295964:C:G"
"NM_000511.6(FUT2):c.604C>T (p.Arg202Ter)","FUT2|LOC105447645","R202*","Vitamin b12 plasma level quantitative trait locus 1|Familial Otitis Media","Pathogenic(Last reviewed: Mar 18, 2016)","criteria provided, single submitter","VCV000225366","19","49206817","19","48703560",225366,"227407","rs1800028","NC_000019.10:48703559:C:T"
"NM_000523.4(HOXD13):c.964A>C (p.Ile322Leu)","HOXD13","I322L","Brachydactyly type D|Brachydactyly type E1","Pathogenic(Last reviewed: Jan 27, 2006)","no assertion criteria provided","VCV000014869","2","176959390","2","176094662",14869,"29908","rs28928891","NC_000002.12:176094661:A:C"
"NM_000523.4(HOXD13):c.916C>T (p.Arg306Trp)","HOXD13","R306W","Synpolydactyly 1","Pathogenic(Last reviewed: Nov 1, 2002)","no assertion criteria provided","VCV000014872","2","176959342","2","176094614",14872,"29911","rs28933082","NC_000002.12:176094613:C:T"
"NM_006891.4(CRYGD):c.70C>A (p.Pro24Thr)","CRYGD|LOC100507443","P24T","Congenital cataract|Cataract 4|Aculeiform cataract","Pathogenic(Last reviewed: Feb 5, 2019)","criteria provided, single submitter","VCV000016940","2","208989018","2","208124294",16940,"31979","rs28931605","NC_000002.12:208124293:G:T"
"NM_000821.7(GGCX):c.1502G>C (p.Trp501Ser)","GGCX","W501S, W444S","Vitamin K-dependent clotting factors, combined deficiency of, 1","Pathogenic(Last reviewed: Nov 15, 2000)","no assertion criteria provided","VCV000016195","2","85779042","2","85551919",16195,"31234","rs28928872","NC_000002.12:85551918:C:G"
"NM_006891.4(CRYGD):c.70C>T (p.Pro24Ser)","CRYGD|LOC100507443","P24S","Cataract 4","Pathogenic(Last reviewed: Sep 1, 2007)","no assertion criteria provided","VCV000016942","2","208989018","2","208124294",16942,"31981","rs28931605","NC_000002.12:208124293:G:A"
"NM_000145.3(FSHR):c.1699G>A (p.Asp567Asn)","FSHR","D567N, D541N","Ovarian hyperstimulation syndrome","Pathogenic(Last reviewed: Aug 21, 2003)","no assertion criteria provided","VCV000016250","2","49190261","2","48963122",16250,"31289","rs28928871","NC_000002.12:48963121:C:T"
"NM_001372051.1(CASP8):c.742C>T (p.Arg248Trp)","CASP8","R248W, R265W, R307W, R233W, T226M","Autoimmune lymphoproliferative syndrome type 2B","Pathogenic(Last reviewed: Sep 26, 2002)","no assertion criteria provided","VCV000007760","2","202141631","2","201276908",7760,"22799","rs17860424","NC_000002.12:201276907:C:T"
"NM_001142616.3(EHBP1):c.1185+30064G>A","EHBP1","","Prostate cancer, hereditary, 12","Pathogenic(Last reviewed: Mar 1, 2008)","no assertion criteria provided","VCV000001364","2","63131731","2","62904596",1364,"16403","rs721048","NC_000002.12:62904595:G:A"
"NM_004304.5(ALK):c.4587C>G (p.Asp1529Glu)","ALK","D1529E, D461E","Hereditary cancer-predisposing syndrome|not provided|Squamous cell lung carcinoma|not specified|Neuroblastoma 3","Benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000133476","2","29416366","2","29193500",133476,"137215","rs1881421","NC_000002.12:29193499:G:C"
"NM_033109.5(PNPT1):c.1390C>A (p.Arg464=)","PNPT1","","not provided|not specified","Benign(Last reviewed: Dec 5, 2020)","criteria provided, multiple submitters, no conflicts","VCV000138737","2","55883317","2","55656182",138737,"142440","rs2627765","NC_000002.12:55656181:G:T"
"NM_014795.4(ZEB2):c.930C>A (p.Tyr310Ter)","ZEB2","Y310*, Y286*","not provided","Pathogenic(Last reviewed: Feb 25, 2014)","criteria provided, single submitter","VCV000167857","2","145157824","2","144400257",167857,"178162","rs6711223","NC_000002.12:144400256:G:T"
"NM_014795.4(ZEB2):c.930C>T (p.Tyr310=)","ZEB2","","Mowat-Wilson syndrome|History of neurodevelopmental disorder|not provided|not specified","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000095643","2","145157824","2","144400257",95643,"101541","rs6711223","NC_000002.12:144400256:G:A"
"NM_000182.5(HADHA):c.474C>T (p.Tyr158=)","HADHA","","Mitochondrial trifunctional protein deficiency|Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency|Mitochondrial trifunctional protein deficiency|Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency|not specified","Benign(Last reviewed: Jun 10, 2021)","criteria provided, multiple submitters, no conflicts","VCV000092596","2","26455127","2","26232259",92596,"98504","rs11552518","NC_000002.12:26232258:G:A"
"NM_000523.4(HOXD13):c.916C>G (p.Arg306Gly)","HOXD13","R306G","Synpolydactyly 1","Pathogenic(Last reviewed: Aug 12, 2016)","no assertion criteria provided","VCV000225656","2","176959342","2","176094614",225656,"227492","rs28933082","NC_000002.12:176094613:C:G"
"NM_000311.5(PRNP):c.385A>G (p.Met129Val)","PRNP","M129V","Prion disease, susceptibility to|Alzheimer disease, early-onset, susceptibility to|Aphasia, primary progressive, susceptibility to|not specified|Creutzfeldt-Jakob Disease, Familial|Huntington disease-like 1|none provided|Genetic prion disease","Benign/Likely benign(Last reviewed: Nov 26, 2020)","criteria provided, multiple submitters, no conflicts","VCV000013397","20","4680251","20","4699605",13397,"28436","rs1799990","NC_000020.11:4699604:A:G"
"NM_000308.3(CTSA):c.247T>C (p.Trp83Arg)","CTSA","W65R, W83R","Combined deficiency of sialidase AND beta galactosidase","Pathogenic(Last reviewed: Jun 1, 1993)","no assertion criteria provided","VCV000000378","20","44520400","20","45891761",378,"15417","rs28934603","NC_000020.11:45891760:T:C"
"NM_000557.5(GDF5):c.1322T>C (p.Leu441Pro)","GDF5|GDF5-AS1","L441P","Brachydactyly type A2|Fibular hypoplasia and complex brachydactyly","Pathogenic(Last reviewed: Mar 1, 2006)","no assertion criteria provided","VCV000008381","20","34021891","20","35434093",8381,"23420","rs28936683","NC_000020.11:35434092:A:G"
"NM_000178.4(GSS):c.373C>T (p.Arg125Cys)","GSS","R125C","Gluthathione synthetase deficiency","Pathogenic(Last reviewed: Nov 1, 1996)","no assertion criteria provided","VCV000008529","20","33530409","20","34942606",8529,"23568","rs28936396","NC_000020.11:34942605:G:A"
"NM_000361.2(THBD):c.-151G>T","THBD","","Thrombophilia due to thrombomodulin defect|Atypical hemolytic-uremic syndrome 6","Benign(Last reviewed: Apr 28, 2017)","criteria provided, single submitter","VCV000139519","20","23030292","20","23049655",139519,"143163","rs16984852","NC_000020.11:23049654:C:A"
"NM_000214.3(JAG1):c.765C>T (p.Tyr255=)","JAG1","","Cardiovascular phenotype|Isolated Nonsyndromic Congenital Heart Disease|not specified|Alagille syndrome 1|not provided","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000143063","20","10633237","20","10652589",143063,"152781","rs1131695","NC_000020.11:10652588:G:A"
"NM_000214.3(JAG1):c.765= (p.Tyr255=)","JAG1","","not specified","Benign(Last reviewed: Mar 30, 2016)","criteria provided, single submitter","VCV000163705","20","10633237","20","10652589",163705,"176595","rs1131695","NC_000020.11:10652588:G:G"
"NM_000311.5(PRNP):c.679C>T (p.Gln227Ter)","PRNP","Q227*","Gerstmann-Straussler-Scheinker syndrome","Pathogenic(Last reviewed: Feb 1, 2010)","no assertion criteria provided","VCV000088927","20","4680545","20","4699899",88927,"94484","rs17852079","NC_000020.11:4699898:C:T"
"NM_000214.3(JAG1):c.765C>G (p.Tyr255Ter)","JAG1","Y255*","not provided","Pathogenic(Last reviewed: Oct 1, 2015)","criteria provided, single submitter","VCV000234555","20","10633237","20","10652589",234555,"232108","rs1131695","NC_000020.11:10652588:G:C"
"NM_000219.6(KCNE1):c.20C>T (p.Thr7Ile)","KCNE1","T7I","Congenital long QT syndrome|Jervell and Lange-Nielsen syndrome 2","Pathogenic(Last reviewed: Nov 1, 1997)","no assertion criteria provided","VCV000013476","21","35821913","21","34449615",13476,"28515","rs28933384","NC_000021.9:34449614:G:A"
"NM_000219.6(KCNE1):c.253G>A (p.Asp85Asn)","KCNE1","D85N","not provided|none provided|Long QT syndrome|Cardiovascular phenotype|Congenital long QT syndrome|Cardiomyopathy|Long QT syndrome 2/5|Jervell and Lange-Nielsen syndrome 2|Long QT syndrome 5|Long QT syndrome 5, acquired, susceptibility to|not specified","Conflicting interpretations of pathogenicity, other, risk factor(Last reviewed: Dec 7, 2020)","criteria provided, conflicting interpretations","VCV000013479","21","35821680","21","34449382",13479,"28518","rs1805128","NC_000021.9:34449381:C:T"
"NM_000071.2(CBS):c.1265C>T (p.Pro422Leu)","CBS","P422L, P317L","Classic homocystinuria|not provided|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED","Uncertain significance(Last reviewed: Nov 26, 2018)","criteria provided, multiple submitters, no conflicts","VCV000000129","21","44479037","21","43058927",129,"15168","rs28934892","NC_000021.9:43058926:G:A"
"NM_000211.5(ITGB2):c.1756C>T (p.Arg586Trp)","ITGB2","R586W, R517W","Leukocyte adhesion deficiency 1","Benign/Likely benign(Last reviewed: Dec 7, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009463","21","46309312","21","44889397",9463,"24502","rs5030672","NC_000021.9:44889396:G:A"
"NM_000100.4(CSTB):c.43G>T (p.Glu15Ter)","CSTB","E15*","not provided","Likely pathogenic(Last reviewed: Aug 1, 2019)","criteria provided, single submitter","VCV000809294","21","45196108","21","43776227",809294,"798031","rs11553836","NC_000021.9:43776226:C:A"
"NM_000454.4(SOD1):c.420C>A (p.Asn140Lys)","SOD1","N140K","not provided","Pathogenic(Last reviewed: Dec 30, 2017)","criteria provided, single submitter","VCV000586635","21","33040846","21","31668533",586635,"577885","rs1804449","NC_000021.9:31668532:C:A"
"NM_016335.5(PRODH):c.1322T>C (p.Leu441Pro)","PRODH","L441P, L333P","not provided|Schizophrenia 4|Proline dehydrogenase deficiency","Conflicting interpretations of pathogenicity(Last reviewed: Oct 21, 2020)","criteria provided, conflicting interpretations","VCV000004008","22","18905934","22","18918421",4008,"19047","rs2904551","NC_000022.11:18918420:A:G"
"NM_016335.6(PRODH):c.1562= (p.Arg521=)","PRODH","","Proline dehydrogenase deficiency|not provided|Schizophrenia 4","Benign(Last reviewed: Dec 4, 2020)","criteria provided, single submitter","VCV000004010","22","18901004","22","18913491",4010,"19049","rs450046","NC_000022.11:18913490:C:C"
"NM_007194.4(CHEK2):c.254C>T (p.Pro85Leu)","CHEK2","P85L","not specified|not provided|Osteosarcoma|Familial cancer of breast|none provided|Hereditary cancer-predisposing syndrome|Malignant tumor of breast","Benign/Likely benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000005594","22","29130456","22","28734468",5594,"20633","rs17883862","NC_000022.11:28734467:G:A"
"NM_152299.4(NCAPH2):c.*526G>A","SCO2|NCAPH2","R171W","Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency","Pathogenic(Last reviewed: Mar 22, 2000)","no assertion criteria provided","VCV000005680","22","50962330","22","50523901",5680,"20719","rs28937598","NC_000022.11:50523900:G:A"
"NM_007194.4(CHEK2):c.254C>A (p.Pro85His)","CHEK2","P85H","Familial cancer of breast|Hereditary cancer-predisposing syndrome","Uncertain significance(Last reviewed: May 30, 2019)","criteria provided, multiple submitters, no conflicts","VCV000460819","22","29130456","22","28734468",460819,"471874","rs17883862","NC_000022.11:28734467:G:T"
"NM_213720.3(CHCHD10):c.312C>T (p.Tyr104=)","CHCHD10","","Spinal muscular atrophy, jokela type|not specified|Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant","Benign(Last reviewed: Dec 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000379953","22","24108412","22","23766225",379953,"378642","rs9153","NC_000022.11:23766224:G:A"
"NM_001242897.2(DEPDC5):c.1901C>T (p.Ser634Phe)","DEPDC5","S712F, S634F, S684F","Familial focal epilepsy with variable foci|Seizures|Rolandic epilepsy","Benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000414462","22","32229931","22","31833945",414462,"404385","rs16989535","NC_000022.11:31833944:C:T"
"NM_213720.3(CHCHD10):c.312C>G (p.Tyr104Ter)","CHCHD10","Y104*, Y111*","Spinal muscular atrophy, jokela type|Myopathy, isolated mitochondrial, autosomal dominant|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Oct 23, 2020)","criteria provided, conflicting interpretations","VCV000565755","22","24108412","22","23766225",565755,"573956","rs9153","NC_000022.11:23766224:G:C"
"NM_213720.3(CHCHD10):c.312C>A (p.Tyr104Ter)","CHCHD10","Y104*, Y111*","Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant","Uncertain significance(Last reviewed: Nov 28, 2019)","criteria provided, single submitter","VCV000569761","22","24108412","22","23766225",569761,"571718","rs9153","NC_000022.11:23766224:G:T"
"NM_001953.5(TYMP):c.1412C>T (p.Ser471Leu)","TYMP|SCO2","S471L, S476L","Mitochondrial DNA depletion syndrome 1 (MNGIE type)|Fatal Infantile Cardioencephalomyopathy|not provided|not specified|none provided|Spinal muscular atrophy","Benign(Last reviewed: Jul 10, 2021)","criteria provided, multiple submitters, no conflicts","VCV000130693","22","50964236","22","50525807",130693,"136139","rs11479","NC_000022.11:50525806:G:A"
"NM_007194.4(CHEK2):c.1039G>A (p.Asp347Asn)","CHEK2","D347N, D280N, D390N, D126N","Hereditary cancer-predisposing syndrome|not provided|Familial cancer of breast","Conflicting interpretations of pathogenicity(Last reviewed: Oct 8, 2020)","criteria provided, conflicting interpretations","VCV000182432","22","29092945","22","28696957",182432,"181104","rs28909980","NC_000022.11:28696956:C:T"
"NM_007194.4(CHEK2):c.254C>G (p.Pro85Arg)","CHEK2","P85R","not specified|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome","Uncertain significance(Last reviewed: Sep 20, 2020)","criteria provided, multiple submitters, no conflicts","VCV000233261","22","29130456","22","28734468",233261,"236695","rs17883862","NC_000022.11:28734467:G:C"
"NM_001953.5(TYMP):c.1412C>A (p.Ser471Ter)","TYMP|SCO2","S471*, S476*","Mitochondrial DNA depletion syndrome 1 (MNGIE type)","Pathogenic(Last reviewed: Jan 14, 2016)","no assertion criteria provided","VCV000223058","22","50964236","22","50525807",223058,"224783","rs11479","NC_000022.11:50525806:G:T"
"NM_000174.4(GP9):c.167T>C (p.Leu56Pro)","GP9","L40P, L56P","Bernard-Soulier syndrome type C","Pathogenic(Last reviewed: Dec 1, 1998)","no assertion criteria provided","VCV000013532","3","128780749","3","129061906",13532,"28571","rs28933377","NC_000003.12:129061905:T:C"
"NM_000387.6(SLC25A20):c.713A>G (p.Gln238Arg)","SLC25A20","Q238R","Carnitine acylcarnitine translocase deficiency|not provided","Pathogenic(Last reviewed: Dec 17, 2013)","criteria provided, multiple submitters, no conflicts","VCV000012138","3","48896530","3","48859097",12138,"27177","rs28934589","NC_000003.12:48859096:T:C"
"NM_000925.4(PDHB):c.395A>G (p.Tyr132Cys)","PDHB","Y132C, Y114C","Pyruvate dehydrogenase E1-beta deficiency","Pathogenic(Last reviewed: Jul 1, 2004)","no assertion criteria provided","VCV000013188","3","58416578","3","58430851",13188,"28227","rs28935769","NC_000003.12:58430850:T:C"
"NM_000055.2(BCHE):c.1253G>T (p.Gly418Val)","BCHE","G418V","BCHE, fluoride 2|Deficiency of butyrylcholine esterase","Conflicting interpretations of pathogenicity(Last reviewed: Jul 3, 2020)","criteria provided, conflicting interpretations","VCV000013219","3","165547569","3","165829781",13219,"28258","rs28933390","NC_000003.12:165829780:C:A"
"NM_003242.6(TGFBR2):c.923T>C (p.Leu308Pro)","TGFBR2","L308P, L333P","Loeys-Dietz syndrome 2","Pathogenic(Last reviewed: Apr 1, 2010)","no assertion criteria provided","VCV000012505","3","30713598","3","30672106",12505,"27544","rs28934568","NC_000003.12:30672105:T:C"
"NM_001354712.2(THRB):c.1357C>A (p.Pro453Thr)","THRB","P453T, P422T","not provided|Thyroid hormone resistance, generalized, autosomal dominant","Pathogenic(Last reviewed: Sep 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012550","3","24164404","3","24122913",12550,"27589","rs28933408","NC_000003.12:24122912:G:T"
"NM_033337.3(CAV3):c.99C>T (p.Asn33=)","SSUH2|CAV3","","not provided|Caveolinopathy|Limb-Girdle Muscular Dystrophy, Dominant|Congenital long QT syndrome|Cardiovascular phenotype|not specified|Long QT syndrome|none provided","Benign/Likely benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000031709","3","8775661","3","8733975",31709,"40369","rs1008642","NC_000003.12:8733974:C:T"
"NM_000551.4(VHL):c.194C>G (p.Ser65Trp)","VHL","S65W","not provided|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Jul 20, 2019)","criteria provided, multiple submitters, no conflicts","VCV000043597","3","10183725","3","10142041",43597,"52766","rs5030826","NC_000003.12:10142040:C:G"
"NM_000335.5(SCN5A):c.1673A>G (p.His558Arg)","SCN5A","H558R","Arrhythmia|not specified|not provided|Brugada syndrome|Congenital long QT syndrome|Cardiovascular phenotype|Brugada syndrome 1|none provided|Paroxysmal familial ventricular fibrillation 1|Sick sinus syndrome 1, autosomal recessive|Progressive familial heart block, type 1A|Dilated cardiomyopathy 1E|Long QT syndrome 3","Benign/Likely benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000048289","3","38645420","3","38603929",48289,"38447","rs1805124","NC_000003.12:38603928:T:C"
"NM_001904.4(CTNNB1):c.94G>T (p.Asp32Tyr)","CTNNB1","D32Y, D25Y","Transitional cell carcinoma of the bladder|Craniopharyngioma|Medulloblastoma|Malignant melanoma of skin|Hepatoblastoma|Neoplasm of uterine cervix|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Hepatocellular carcinoma|Pilomatrixoma","Pathogenic/Likely pathogenic, other(Last reviewed: May 31, 2016)","no assertion criteria provided","VCV000017581","3","41266097","3","41224606",17581,"32620","rs28931588","NC_000003.12:41224605:G:T"
"NM_023067.4(FOXL2):c.251T>G (p.Ile84Ser)","FOXL2","I84S","Blepharophimosis, ptosis, and epicanthus inversus syndrome type 1","Pathogenic(Last reviewed: Feb 1, 2003)","no assertion criteria provided","VCV000004863","3","138665314","3","138946472",4863,"19902","rs28937884","NC_000003.12:138946471:A:C"
"NM_023067.4(FOXL2):c.772T>A (p.Tyr258Asn)","FOXL2","Y258N","Premature ovarian failure 3|Blepharophimosis, ptosis, and epicanthus inversus","Uncertain significance(Last reviewed: May 28, 2019)","criteria provided, single submitter","VCV000004869","3","138664793","3","138945951",4869,"19908","rs28937885","NC_000003.12:138945950:A:T"
"NM_003907.3(EIF2B5):c.1882T>C (p.Trp628Arg)","EIF2B5","W628R","Leukoencephalopathy with vanishing white matter","Pathogenic(Last reviewed: Dec 1, 2001)","no assertion criteria provided","VCV000005943","3","183861899","3","184144111",5943,"20982","rs28937596","NC_000003.12:184144110:T:C"
"NM_001457.4(FLNB):c.2251G>C (p.Gly751Arg)","FLNB","G751R","not specified|Atelosteogenesis type III","Likely pathogenic(Last reviewed: Jan 30, 2017)","criteria provided, single submitter","VCV000006402","3","58095354","3","58109627",6402,"21441","rs28937587","NC_000003.12:58109626:G:C"
"NM_000404.2(GLB1):c.367G>A","GLB1","G123R, G171R, G93R","Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|Infantile GM1 gangliosidosis|not provided","Pathogenic/Likely pathogenic(Last reviewed: Jul 11, 2019)","criteria provided, multiple submitters, no conflicts","VCV000000928","3","33110341","3","33068849",928,"15967","rs28934274","NC_000003.12:33068848:C:T"
"NM_000404.4(GLB1):c.1370G>A (p.Arg457Gln)","GLB1","R457Q, R427Q, R505Q, R326Q","GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis","Likely pathogenic(Last reviewed: Jan 14, 2020)","criteria provided, single submitter","VCV000000930","3","33058310","3","33016818",930,"15969","rs28934886","NC_000003.12:33016817:C:T"
"NM_001370658.1(BTD):c.1270G>C (p.Asp424His)","BTD","D424H","not provided|Global developmental delay|Seizures|Biotinidase deficiency","Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2021)","criteria provided, conflicting interpretations","VCV000001900","3","15686693","3","15645186",1900,"16939","rs13078881","NC_000003.12:15645185:G:C"
"NM_000551.3(VHL):c.499C>T (p.Arg167Trp)","VHL|LOC107303340","R167W, R126W","Von Hippel-Lindau syndrome|Pheochromocytoma|Renal cell carcinoma, nonpapillary|Erythrocytosis, familial, 2|Pheochromocytoma|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Renal cell carcinoma, papillary, 1|not provided|Hereditary cancer-predisposing syndrome|none provided","Pathogenic(Last reviewed: Sep 16, 2020)","criteria provided, multiple submitters, no conflicts","VCV000002218","3","10191506","3","10149822",2218,"17257","rs5030820","NC_000003.12:10149821:C:T"
"NM_000551.3(VHL):c.499C>G (p.Arg167Gly)","VHL|LOC107303340","R167G, R126G","Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Pathogenic/Likely pathogenic(Last reviewed: Sep 6, 2018)","criteria provided, multiple submitters, no conflicts","VCV000002219","3","10191506","3","10149822",2219,"17258","rs5030820","NC_000003.12:10149821:C:G"
"NM_000551.4(VHL):c.562C>G (p.Leu188Val)","VHL|LOC107303340","L188V, L147V","not provided|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Hereditary cancer-predisposing syndrome|Erythrocytosis, familial, 2|Pheochromocytoma","Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2021)","criteria provided, conflicting interpretations","VCV000002225","3","10191569","3","10149885",2225,"17264","rs5030824","NC_000003.12:10149884:C:G"
"NM_033337.2(CAV3):c.99C>G (p.Asn33Lys)","CAV3|SSUH2","N33K","Long QT syndrome|Distal myopathy, Tateyama type","Uncertain significance(Last reviewed: Sep 20, 2019)","criteria provided, single submitter","VCV000008289","3","8775661","3","8733975",8289,"23328","rs1008642","NC_000003.12:8733974:C:G"
"NM_000388.4(CASR):c.680G>T (p.Arg227Leu)","CASR","R227L","Familial hypocalciuric hypercalcemia|Hypocalcemia, autosomal dominant 1|Neonatal severe hyperparathyroidism","Pathogenic(Last reviewed: Apr 2, 2020)","criteria provided, single submitter","VCV000008317","3","121980562","3","122261715",8317,"23356","rs28936684","NC_000003.12:122261714:G:T"
"NM_000388.4(CASR):c.680G>A (p.Arg227Gln)","CASR","R227Q","Hypocalciuric hypercalcemia, familial, type 1|Familial hypocalciuric hypercalcemia|Hypocalcemia, autosomal dominant 1|not provided","Pathogenic(Last reviewed: Oct 15, 2018)","criteria provided, multiple submitters, no conflicts","VCV000008331","3","121980562","3","122261715",8331,"23370","rs28936684","NC_000003.12:122261714:G:A"
"NM_001330615.1(PPARG):c.735+10750G>A","PPARG","R288H, R77H, R316H","Carcinoma of colon","Pathogenic(Last reviewed: Jun 1, 1999)","no assertion criteria provided","VCV000008135","3","12458330","3","12416831",8135,"23174","rs28936407","NC_000003.12:12416830:G:A"
"NM_000579.3(CCR5):c.-301+246A>G","CCR5|CCR5AS","","Acquired immunodeficiency syndrome, delayed progression to|CCR5 PROMOTER POLYMORPHISM|Human immunodeficiency virus type 1, susceptibility to","Conflicting interpretations of pathogenicity, protective(Last reviewed: Jul 8, 2003)","no assertion criteria provided","VCV000008189","3","46411935","3","46370444",8189,"23228","rs1799987","NC_000003.12:46370443:A:G"
"NM_033337.2(CAV3):c.260T>C (p.Leu87Pro)","CAV3","L87P","not provided|Long QT syndrome|Rippling muscle disease 2","Uncertain significance(Last reviewed: Nov 15, 2017)","criteria provided, single submitter","VCV000008284","3","8787357","3","8745671",8284,"23323","rs28936685","NC_000003.12:8745670:T:C"
"NM_198056.2(SCN5A):c.4931G>A (p.Arg1644His)","SCN5A","R1644H, R1643H, R1590H, R1611H, R1625H, R1626H","Congenital long QT syndrome|Long QT syndrome 3|not provided|Brugada syndrome|Cardiovascular phenotype","Pathogenic(Last reviewed: Mar 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009369","3","38592932","3","38551441",9369,"24408","rs28937316","NC_000003.12:38551440:C:T"
"NM_198056.2(SCN5A):c.1100G>A (p.Arg367His)","SCN5A","R367H","Brugada syndrome|Brugada syndrome 1|Arrhythmia","Pathogenic(Last reviewed: Jul 15, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009390","3","38648200","3","38606709",9390,"24429","rs28937318","NC_000003.12:38606708:C:T"
"NM_000335.5(SCN5A):c.3305C>A (p.Ser1102Tyr)","SCN5A|LOC110121269","S1103Y, S1102Y","Left ventricular noncompaction|none provided|Brugada syndrome|Cardiac arrhythmia|Cardiovascular phenotype|Arrhythmia|Congenital long QT syndrome|not specified|not provided|Paroxysmal familial ventricular fibrillation 1|Progressive familial heart block, type 1A|Long qt syndrome 3, acquired, susceptibility to|SUDDEN INFANT DEATH SYNDROME|Dilated cardiomyopathy 1E|Brugada syndrome 1|Sick sinus syndrome 1, autosomal recessive|Long QT syndrome 3","Benign/Likely benign, risk factor(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009393","3","38620907","3","38579416",9393,"24432","rs7626962","NC_000003.12:38579415:G:T"
"NM_198056.2(SCN5A):c.3893C>T (p.Pro1298Leu)","SCN5A","P1298L, P1297L, P1244L","Sick sinus syndrome|Arrhythmia|Sick sinus syndrome 1, autosomal recessive","Uncertain significance(Last reviewed: Dec 10, 2018)","criteria provided, single submitter","VCV000009394","3","38603976","3","38562485",9394,"24433","rs28937319","NC_000003.12:38562484:G:A"
"NM_033337.2(CAV3):c.99C>A (p.Asn33Lys)","CAV3|SSUH2","N33K","Long QT syndrome","Uncertain significance(Last reviewed: May 25, 2017)","criteria provided, single submitter","VCV000457133","3","8775661","3","8733975",457133,"453192","rs1008642","NC_000003.12:8733974:C:A"
"NM_001354712.2(THRB):c.1357C>G (p.Pro453Ala)","THRB","P453A, P422A","not provided|Thyroid hormone resistance, generalized, autosomal dominant","Pathogenic(Last reviewed: Dec 13, 2019)","criteria provided, single submitter","VCV000492924","3","24164404","3","24122913",492924,"485714","rs28933408","NC_000003.12:24122912:G:C"
"NM_001904.4(CTNNB1):c.94G>C (p.Asp32His)","CTNNB1","D32H, D25H","Melanoma|Neoplasm of uterine cervix|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Malignant melanoma of skin|Hepatocellular carcinoma|Medulloblastoma|Transitional cell carcinoma of the bladder","Likely pathogenic(Last reviewed: May 31, 2016)","no assertion criteria provided","VCV000376054","3","41266097","3","41224606",376054,"362933","rs28931588","NC_000003.12:41224605:G:C"
"NM_001904.4(CTNNB1):c.94G>A (p.Asp32Asn)","CTNNB1","D32N, D25N","Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Malignant melanoma of skin|Adenocarcinoma of stomach|Endometrial neoplasm|Esophageal Squamous Cell Carcinoma|Hepatocellular carcinoma|Neoplasm of uterine cervix|Medulloblastoma|Transitional cell carcinoma of the bladder","Likely pathogenic(Last reviewed: May 31, 2016)","no assertion criteria provided","VCV000376228","3","41266097","3","41224606",376228,"363107","rs28931588","NC_000003.12:41224605:G:A"
"NM_000551.3(VHL):c.533T>C (p.Leu178Pro)","VHL|LOC107303340","L178P, L137P","Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Pathogenic/Likely pathogenic(Last reviewed: Aug 1, 2018)","criteria provided, multiple submitters, no conflicts","VCV000428795","3","10191540","3","10149856",428795,"420453","rs5030822","NC_000003.12:10149855:T:C"
"NM_001354712.2(THRB):c.1357C>T (p.Pro453Ser)","THRB","P453S, P422S","not provided|Thyroid hormone resistance, generalized, autosomal dominant","Pathogenic(Last reviewed: Nov 19, 2016)","criteria provided, single submitter","VCV000439310","3","24164404","3","24122913",439310,"432550","rs28933408","NC_000003.12:24122912:G:A"
"NM_000551.3(VHL):c.344A>G (p.His115Arg)","VHL|LOC107303340","H115R","Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Likely pathogenic(Last reviewed: Sep 13, 2018)","criteria provided, single submitter","VCV000664415","3","10188201","3","10146517",664415,"630722","rs5030812","NC_000003.12:10146516:A:G"
"NM_000551.4(VHL):c.525C>T (p.Tyr175=)","VHL|LOC107303340","","Hereditary cancer-predisposing syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Likely benign(Last reviewed: Aug 6, 2020)","criteria provided, multiple submitters, no conflicts","VCV000761377","3","10191532","3","10149848",761377,"763503","rs5030835","NC_000003.12:10149847:C:T"
"NM_000551.3(VHL):c.490C>G (p.Gln164Glu)","VHL|LOC107303340","Q164E, Q123E","Von Hippel-Lindau syndrome","Uncertain significance(Last reviewed: Aug 1, 2018)","criteria provided, single submitter","VCV000625253","3","10191497","3","10149813",625253,"613585","rs5030819","NC_000003.12:10149812:C:G"
"NM_000551.3(VHL):c.533T>A (p.Leu178Gln)","VHL|LOC107303340","L178Q, L137Q","Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Aug 1, 2018)","criteria provided, single submitter","VCV000625260","3","10191540","3","10149856",625260,"613591","rs5030822","NC_000003.12:10149855:T:A"
"NM_000551.3(VHL):c.533T>G (p.Leu178Arg)","VHL|LOC107303340","L178R, L137R","Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Aug 1, 2018)","criteria provided, single submitter","VCV000625261","3","10191540","3","10149856",625261,"613592","rs5030822","NC_000003.12:10149855:T:G"
"NM_000404.4(GLB1):c.1714C>T (p.Gln572Ter)","GLB1","Q572*, Q441*, Q542*, Q620*","GM1 gangliosidosis type 2|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 3|Mucopolysaccharidosis, MPS-IV-B","Likely pathogenic(Last reviewed: Jan 24, 2018)","criteria provided, single submitter","VCV000556285","3","33055568","3","33014076",556285,"542931","rs1803200","NC_000003.12:33014075:G:A"
"NM_000551.3(VHL):c.344A>C (p.His115Pro)","VHL|LOC107303340","H115P","not provided","Likely pathogenic(Last reviewed: Sep 16, 2015)","criteria provided, single submitter","VCV000560744","3","10188201","3","10146517",560744,"551819","rs5030812","NC_000003.12:10146516:A:C"
"NM_000551.3(VHL):c.525C>G (p.Tyr175Ter)","VHL|LOC107303340","Y175*, Y134*","Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: May 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000182974","3","10191532","3","10149848",182974,"180122","rs5030835","NC_000003.12:10149847:C:G"
"NM_000335.4(SCN5A):c.1100G>T (p.Arg367Leu)","SCN5A","R367L","Brugada syndrome","not provided","no assertion provided","VCV000067634","3","38648200","3","38606709",67634,"78530","rs28937318","NC_000003.12:38606708:C:A"
"NM_000335.5(SCN5A):c.1844G>A (p.Gly615Glu)","SCN5A","G615E","Cardiovascular phenotype|Long QT syndrome, drug-associated|Brugada syndrome|Arrhythmia|Long QT syndrome 3|not provided|Congenital long QT syndrome|not specified|Death in early adulthood|Death in infancy","Conflicting interpretations of pathogenicity(Last reviewed: Feb 17, 2021)","criteria provided, conflicting interpretations","VCV000067691","3","38645249","3","38603758",67691,"78586","rs12720452","NC_000003.12:38603757:C:T"
"NM_000249.3(MLH1):c.265G>T (p.Glu89Ter)","MLH1","E89*","Lynch syndrome","Pathogenic(Last reviewed: Sep 5, 2013)","reviewed by expert panel","VCV000090124","3","37042503","3","37001012",90124,"95598","rs11541859","NC_000003.12:37001011:G:T"
"NM_000551.3(VHL):c.194C>T (p.Ser65Leu)","VHL","S65L","Pancreatic cysts|Cerebellar hemangioblastoma|Retinal capillary hemangioma|Spinal hemangioblastoma|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2","Pathogenic(Last reviewed: Jun 16, 2020)","criteria provided, multiple submitters, no conflicts","VCV000182975","3","10183725","3","10142041",182975,"180112","rs5030826","NC_000003.12:10142040:C:T"
"NM_001337.4(CX3CR1):c.745G>A (p.Val249Ile)","CX3CR1","V249I, V281I","","no interpretation for the single variant","no interpretation for the single variant","VCV000242801","3","39307256","3","39265765",242801,"23191","rs3732379","NC_000003.12:39265764:C:T"
"NM_000313.3(PROS1):c.233C>T (p.Thr78Met)","PROS1","T78M, T110M","Protein S deficiency disease|Deep venous thrombosis|Thrombophilia due to protein S deficiency, autosomal recessive","Conflicting interpretations of pathogenicity(Last reviewed: Mar 22, 2020)","criteria provided, conflicting interpretations","VCV000215991","3","93646095","3","93927251",215991,"212340","rs6122","NC_000003.12:93927250:G:A"
"NM_000551.3(VHL):c.337C>T (p.Arg113Ter)","VHL","R113*","Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Nov 26, 2016)","criteria provided, single submitter","VCV000220414","3","10183868","3","10142184",220414,"221350","rs5030810","NC_000003.12:10142183:C:T"
"NM_000551.3(VHL):c.194C>A (p.Ser65Ter)","VHL","S65*","Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Sep 23, 2019)","criteria provided, single submitter","VCV000223161","3","10183725","3","10142041",223161,"224892","rs5030826","NC_000003.12:10142040:C:A"
"NM_000551.3(VHL):c.362A>G (p.Asp121Gly)","VHL|LOC107303340","D121G","Von Hippel-Lindau syndrome|not provided|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Pathogenic/Likely pathogenic(Last reviewed: Sep 11, 2020)","criteria provided, multiple submitters, no conflicts","VCV000223200","3","10188219","3","10146535",223200,"224931","rs5030832","NC_000003.12:10146534:A:G"
"NM_000551.3(VHL):c.486C>A (p.Cys162Ter)","VHL|LOC107303340","C162*, C121*","Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Nov 25, 2019)","criteria provided, single submitter","VCV000223226","3","10191493","3","10149809",223226,"224956","rs5030622","NC_000003.12:10149808:C:A"
"NM_000551.3(VHL):c.486C>G (p.Cys162Trp)","VHL|LOC107303340","C162W, C121W","Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome|not provided|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Oct 19, 2020)","criteria provided, conflicting interpretations","VCV000223227","3","10191493","3","10149809",223227,"224957","rs5030622","NC_000003.12:10149808:C:G"
"NM_000551.3(VHL):c.490C>T (p.Gln164Ter)","VHL|LOC107303340","Q164*, Q123*","not provided|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Oct 4, 2018)","criteria provided, multiple submitters, no conflicts","VCV000223228","3","10191497","3","10149813",223228,"224958","rs5030819","NC_000003.12:10149812:C:T"
"NM_002448.3(MSX1):c.251A>T (p.Glu84Val)","MSX1","E84V","Orofacial cleft 5","Pathogenic(Last reviewed: Jun 1, 2003)","no assertion criteria provided","VCV000014883","4","4861877","4","4860150",14883,"29922","rs28928890","NC_000004.12:4860149:A:T"
"NM_000128.3(F11):c.1782C>A (p.Ser594Arg)","F11|F11-AS1","S594R","Hereditary factor XI deficiency disease","Pathogenic(Last reviewed: Feb 1, 2019)","criteria provided, single submitter","VCV000011900","4","187209672","4","186288518",11900,"26939","rs28934609","NC_000004.12:186288517:C:A"
"NM_003102.3(SOD3):c.691C>G (p.Arg231Gly)","SOD3","R213G, R231G","Superoxide dismutase, elevated extracellular","Pathogenic(Last reviewed: Jan 6, 2004)","no assertion criteria provided","VCV000012777","4","24801834","4","24800212",12777,"27816","rs1799895","NC_000004.12:24800211:C:G"
"NM_000142.5(FGFR3):c.749C>G (p.Pro250Arg)","FGFR3","P250R","Craniosynostosis syndrome|not specified|not provided|Saethre-Chotzen syndrome|Muenke syndrome|Hypochondroplasia|Camptodactyly-tall stature-scoliosis-hearing loss syndrome|Cancer of cervix|Achondroplasia|Severe achondroplasia with developmental delay and acanthosis nigricans|Malignant tumor of testis|Muenke syndrome|Carcinoma of colon|Hypochondroplasia|Thanatophoric dysplasia type 1|Levy-Hollister syndrome|Crouzon syndrome with acanthosis nigricans|Epidermal nevus|Urinary bladder cancer|Thanatophoric dysplasia, type 2|Inborn genetic diseases|Achondroplasia|Coronal craniosynostosis|Crouzon syndrome|Facial asymmetry|Infantile axial hypotonia|Absence seizures|Unilateral renal agenesis|Seizures","Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000016340","4","1803571","4","1801844",16340,"31379","rs4647924","NC_000004.12:1801843:C:G"
"NM_000142.5(FGFR3):c.1620C>G (p.Asn540Lys)","FGFR3","N540K, N542K, N541K, N428K","Craniosynostosis syndrome|Short stature|Hypochondroplasia|Camptodactyly-tall stature-scoliosis-hearing loss syndrome|Cancer of cervix|Achondroplasia|Severe achondroplasia with developmental delay and acanthosis nigricans|Malignant tumor of testis|Muenke syndrome|Carcinoma of colon|Hypochondroplasia|Thanatophoric dysplasia type 1|Levy-Hollister syndrome|Crouzon syndrome with acanthosis nigricans|Epidermal nevus|Urinary bladder cancer|Thanatophoric dysplasia, type 2|Inborn genetic diseases|Achondroplasia|not provided","Pathogenic(Last reviewed: Feb 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000016338","4","1807371","4","1805644",16338,"31377","rs28933068","NC_000004.12:1805643:C:G"
"NM_000406.3(GNRHR):c.851A>G (p.Tyr284Cys)","GNRHR","Y284C","Hypogonadotropic hypogonadism 7 with or without anosmia","Pathogenic(Last reviewed: Jan 1, 1998)","no assertion criteria provided","VCV000016025","4","68606334","4","67740616",16025,"31064","rs28933074","NC_000004.12:67740615:T:C"
"NM_000142.5(FGFR3):c.1138G>A","FGFR3","G380R, G382R","Inborn genetic diseases|Craniosynostosis syndrome|not provided|none provided|Achondroplasia|Camptodactyly-tall stature-scoliosis-hearing loss syndrome|Cancer of cervix|Achondroplasia|Severe achondroplasia with developmental delay and acanthosis nigricans|Malignant tumor of testis|Muenke syndrome|Carcinoma of colon|Hypochondroplasia|Thanatophoric dysplasia type 1|Levy-Hollister syndrome|Crouzon syndrome with acanthosis nigricans|Epidermal nevus|Urinary bladder cancer|Thanatophoric dysplasia, type 2|Epidermal nevus","Conflicting interpretations of pathogenicity(Last reviewed: Sep 8, 2020)","criteria provided, conflicting interpretations","VCV000016327","4","1806119","4","1804392",16327,"31366","rs28931614","NC_000004.12:1804391:G:A"
"NM_000142.5(FGFR3):c.1138G>C (p.Gly380Arg)","FGFR3","G380R, G382R","not provided|Achondroplasia|Craniosynostosis syndrome|Hypochondroplasia","Pathogenic(Last reviewed: Aug 15, 2019)","criteria provided, multiple submitters, no conflicts","VCV000016328","4","1806119","4","1804392",16328,"31367","rs28931614","NC_000004.12:1804391:G:C"
"NM_000142.5(FGFR3):c.1172C>A (p.Ala391Glu)","FGFR3","A391E, A393E","not provided|Craniosynostosis syndrome|Inborn genetic diseases|Carcinoma|Crouzon syndrome with acanthosis nigricans","Pathogenic(Last reviewed: Oct 31, 2019)","criteria provided, multiple submitters, no conflicts","VCV000016329","4","1806153","4","1804426",16329,"31368","rs28931615","NC_000004.12:1804425:C:A"
"NM_000142.5(FGFR3):c.1620C>A (p.Asn540Lys)","FGFR3","N540K, N542K, N428K, N541K","Craniosynostosis syndrome|not provided|none provided|Hypochondroplasia|Achondroplasia","Pathogenic(Last reviewed: Jan 2, 2020)","criteria provided, multiple submitters, no conflicts","VCV000016337","4","1807371","4","1805644",16337,"31376","rs28933068","NC_000004.12:1805643:C:A"
"NM_002099.8(GYPA):c.232G>A (p.Gly78Arg)","GYPA","G78R, G45R, E78K","BLOOD GROUP ERIK","Pathogenic(Last reviewed: Dec 5, 1993)","no assertion criteria provided","VCV000017714","4","145040839","4","144119686",17714,"32753","rs1800582","NC_000004.12:144119685:C:T"
"NM_000142.5(FGFR3):c.749C>T (p.Pro250Leu)","FGFR3","P250L","Craniosynostosis syndrome","Uncertain significance(Last reviewed: Oct 2, 2017)","criteria provided, single submitter","VCV000533893","4","1803571","4","1801844",533893,"519844","rs4647924","NC_000004.12:1801843:C:T"
"NM_000203.5(IDUA):c.1403-1G>T","IDUA","","Mucopolysaccharidosis type 1","Likely pathogenic(Last reviewed: Dec 21, 2018)","criteria provided, single submitter","VCV000652306","4","996823","4","1003035",652306,"651143","rs4690223","NC_000004.12:1003034:G:T"
"NM_022965.3(FGFR3):c.931-398C>T","FGFR3","A391V, A393V","not provided","Uncertain significance(Last reviewed: Aug 1, 2017)","criteria provided, single submitter","VCV000809609","4","1806153","4","1804426",809609,"795565","rs28931615","NC_000004.12:1804425:C:T"
"NM_000200.3(HTN3):c.122G>A (p.Arg41Gln)","HTN3","R41Q","","no interpretation for the single variant","no interpretation for the single variant","VCV000242714","4","70898903","4","70033186",242714,"38467","rs1136511","NC_000004.12:70033185:G:A"
"NM_001145805.1(IRGM):c.313C>T (p.Leu105=)","IRGM","","Inflammatory bowel disease 19","Pathogenic(Last reviewed: Mar 1, 2011)","no assertion criteria provided","VCV000030716","5","150227998","5","150848436",30716,"39673","rs10065172","NC_000005.10:150848435:C:T"
"NM_000038.6(APC):c.1458T>C (p.Tyr486=)","APC","","Hereditary cancer-predisposing syndrome|APC-Associated Polyposis Disorders|Familial adenomatous polyposis 1|not specified|Carcinoma of colon|Hepatocellular carcinoma|Carcinoma of colon|Neoplasm of stomach|Familial adenomatous polyposis 1|Desmoid disease, hereditary|Familial colorectal cancer","Benign(Last reviewed: Dec 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000042238","5","112162854","5","112827157",42238,"51408","rs2229992","NC_000005.10:112827156:T:C"
"NM_000521.3(HEXB):c.185C>T (p.Ser62Leu)","HEXB","","Sandhoff disease, infantile type|Sandhoff disease","Benign(Last reviewed: Dec 8, 2020)","criteria provided, single submitter","VCV000003882","5","73981270","5","74685445",3882,"18921","rs820878","NC_000005.10:74685444:T:T"
"NM_000038.6(APC):c.1458T>G (p.Tyr486Ter)","APC","Y486*, Y468*, Y458*, Y203*, Y360*, Y385*, Y395*, Y427*, Y326*, Y445*, Y461*, Y496*, Y504*","Familial adenomatous polyposis 1","Pathogenic(Last reviewed: Mar 2, 2019)","criteria provided, single submitter","VCV000000825","5","112162854","5","112827157",825,"15864","rs2229992","NC_000005.10:112827156:T:G"
"NM_004168.4(SDHA):c.1660C>T (p.Arg554Trp)","SDHA","R554W, R506W","Mitochondrial complex II deficiency, nuclear type 1|Paragangliomas 5|Mitochondrial complex II deficiency, nuclear type 1|Hereditary cancer-predisposing syndrome|Leigh syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Oct 27, 2020)","criteria provided, conflicting interpretations","VCV000008742","5","251215","5","251100",8742,"23781","rs9809219","NC_000005.10:251099:C:T"
"NM_004168.4(SDHA):c.1A>C (p.Met1Leu)","SDHA","M1L","Mitochondrial complex II deficiency, nuclear type 1|Paragangliomas 5|Mitochondrial complex II deficiency, nuclear type 1","Pathogenic(Last reviewed: Sep 11, 2020)","criteria provided, single submitter","VCV000008744","5","218471","5","218356",8744,"23783","rs1061517","NC_000005.10:218355:A:C"
"NM_000521.4(HEXB):c.185T>C (p.Leu62Ser)","HEXB","L62S","not specified|Sandhoff disease","Benign(Last reviewed: Jul 10, 2021)","criteria provided, multiple submitters, no conflicts","VCV000167173","5","73981270","5","74685445",167173,"177767","rs820878","NC_000005.10:74685444:T:C"
"NM_004168.4(SDHA):c.1A>G (p.Met1Val)","SDHA","M1V","Hereditary cancer-predisposing syndrome|not provided|Mitochondrial complex II deficiency, nuclear type 1|Paragangliomas 5|Paragangliomas 5","Pathogenic/Likely pathogenic(Last reviewed: Sep 11, 2020)","criteria provided, multiple submitters, no conflicts","VCV000239661","5","218471","5","218356",239661,"239796","rs1061517","NC_000005.10:218355:A:G"
"NM_001127671.2(LIFR):c.3288C>A (p.Asn1096Lys)","LIFR","N1096K, N1085K","not provided|Stve-Wiedemann syndrome|Congenital anomalies of kidney and urinary tract","Conflicting interpretations of pathogenicity(Last reviewed: Dec 5, 2020)","criteria provided, conflicting interpretations","VCV000353605","5","38481703","5","38481601",353605,"299774","rs3729751","NC_000005.10:38481600:G:T"
"NM_004168.4(SDHA):c.1A>T (p.Met1Leu)","SDHA","M1L","Mitochondrial complex II deficiency, nuclear type 1|Paragangliomas 5|Paragangliomas 5","Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2020)","criteria provided, multiple submitters, no conflicts","VCV000371794","5","218471","5","218356",371794,"358789","rs1061517","NC_000005.10:218355:A:T"
"NM_001127671.2(LIFR):c.3288C>T (p.Asn1096=)","LIFR","","not provided|Stve-Wiedemann syndrome|not specified","Benign(Last reviewed: Dec 7, 2020)","criteria provided, multiple submitters, no conflicts","VCV000195484","5","38481703","5","38481601",195484,"192645","rs3729751","NC_000005.10:38481600:G:A"
"NM_000500.9(CYP21A2):c.713T>A (p.Val238Glu)","CYP21A2|LOC106780800","V238E, V103E, V208E","not provided","Pathogenic(Last reviewed: May 23, 2017)","criteria provided, single submitter","VCV000012173","6","32007587","6","32039810",12173,"27212","rs12530380","NC_000006.12:32039809:T:A"
"NM_000500.9(CYP21A2):c.1069C>T (p.Arg357Trp)","CYP21A2|TNXB|LOC106780800","R357W, R327W, R222W","not provided|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","Pathogenic(Last reviewed: Aug 20, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012152","6","32008312","6","32040535",12152,"27191","rs7769409","NC_000006.12:32040534:C:T"
"NM_000500.9(CYP21A2):c.1360C>T (p.Pro454Ser)","CYP21A2|LOC106780800","P454S, P424S, P319S","not provided|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","Pathogenic(Last reviewed: Oct 31, 2018)","criteria provided, multiple submitters, no conflicts","VCV000012159","6","32008783","6","32041006",12159,"27198","rs6445","NC_000006.12:32041005:C:T"
"NM_000500.7(CYP21A2):c.955C>T (p.Gln319Ter)","CYP21A2|TNXB|LOC106780800","Q319*, Q289*, Q184*","not provided|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","Pathogenic(Last reviewed: May 27, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012169","6","32008198","6","32040421",12169,"27208","rs7755898|rs6445","NC_000006.12:32040420:C:T"
"NM_000129.3(F13A1):c.-19+12=","F13A1","","Factor XIII, A subunit, deficiency of","Pathogenic(Last reviewed: Jul 1, 2011)","no assertion criteria provided","VCV000029695","6","6320808","6","6320575",29695,"38650","rs2815822","NC_000006.12:6320574:T:T"
"NM_000165.5(GJA1):c.427G>A (p.Gly143Ser)","GJA1","G143S","Syndactyly type 3","Pathogenic(Last reviewed: Jan 1, 2004)","no assertion criteria provided","VCV000016987","6","121768420","6","121447274",16987,"32026","rs28931600","NC_000006.12:121447273:G:A"
"NM_000410.3(HFE):c.845G>A (p.Cys282Tyr)","HFE","C282Y, C176Y, C180Y, C190Y, C194Y, C259Y, C268Y, C102Y","Hereditary cancer-predisposing syndrome|Porphyria variegata, susceptibility to|Hemochromatosis, juvenile, digenic|Alzheimer disease, susceptibility to|Transferrin serum level quantitative trait locus 2|Microvascular complications of diabetes 7|Alzheimer disease|Porphyrinuria|Cutaneous photosensitivity|not provided|Hemochromatosis type 2|Hemochromatosis type 1|Porphyria cutanea tarda, susceptibility to|Abdominal pain|Pain|Peripheral neuropathy|Abnormality of the male genitalia|Abnormal peripheral nervous system morphology|Abnormality of the nervous system|Behavioral abnormality|Bronze diabetes|Hereditary hemochromatosis","Conflicting interpretations of pathogenicity, other, risk factor(Last reviewed: May 1, 2021)","criteria provided, conflicting interpretations","VCV000000009","6","26093141","6","26092913",9,"15048","rs1800562","NC_000006.12:26092912:G:A"
"NM_139007.3(HFE):c.77-236T>C","HFE","I105T, I82T","Hemochromatosis type 1|Hereditary hemochromatosis","Uncertain significance(Last reviewed: Oct 20, 2020)","criteria provided, single submitter","VCV000000012","6","26091306","6","26091078",12,"15051","rs28934596","NC_000006.12:26091077:T:C"
"NM_139007.3(HFE):c.77-273G>C","HFE","G93R, G70R","Hemochromatosis type 1","Pathogenic(Last reviewed: Jun 1, 1999)","no assertion criteria provided","VCV000000013","6","26091269","6","26091041",13,"15052","rs28934597","NC_000006.12:26091040:G:C"
"NM_000500.9(CYP21A2):c.40G>T (p.Ala14Ser)","CYP21A2|LOC106780800","A14S","Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","Uncertain significance","no assertion criteria provided","VCV000998097","6","32006239","6","32038462",998097,"985825","rs6445","NC_000006.12:32038461:G:T"
"NM_000129.3(F13A1):c.-19+12A>C","F13A1","","Factor XIII, A subunit, deficiency of|not specified","Benign(Last reviewed: Jan 12, 2018)","criteria provided, single submitter","VCV000357680","6","6320808","6","6320575",357680,"300863","rs2815822","NC_000006.12:6320574:T:G"
"NM_000168.6(GLI3):c.2800G>C (p.Ala934Pro)","GLI3","A934P","Greig cephalopolysyndactyly syndrome, severe","Pathogenic(Last reviewed: Jun 1, 2006)","no assertion criteria provided","VCV000013825","7","42005871","7","41966273",13825,"28864","rs28933372","NC_000007.14:41966272:C:G"
"NM_172056.2(KCNH2):c.1778T>G (p.Ile593Arg)","KCNH2","I593R, I253R","Congenital long QT syndrome|not provided|Long QT syndrome 2","Pathogenic(Last reviewed: May 24, 2019)","criteria provided, single submitter","VCV000014423","7","150648703","7","150951615",14423,"29462","rs28928904","NC_000007.14:150951614:A:C"
"NM_172056.2(KCNH2):c.1714G>C (p.Gly572Arg)","KCNH2","G572R, G232R","Long QT syndrome 2|Congenital long QT syndrome","Pathogenic(Last reviewed: Feb 1, 2000)","no assertion criteria provided","VCV000014429","7","150648767","7","150951679",14429,"29468","rs9333649","NC_000007.14:150951678:C:G"
"NM_172056.2(KCNH2):c.1468G>A (p.Ala490Thr)","KCNH2","A490T, A150T","not provided|Long QT syndrome|Long QT syndrome, bradycardia-induced|Long QT syndrome 2|Congenital long QT syndrome","Pathogenic(Last reviewed: Sep 21, 2019)","criteria provided, multiple submitters, no conflicts","VCV000014430","7","150649602","7","150952514",14430,"29469","rs28928905","NC_000007.14:150952513:C:T"
"NM_000420.3(KEL):c.1790T>C (p.Leu597Pro)","KEL","L597P","not provided|Kel6 antigen","Benign(Last reviewed: May 4, 2017)","criteria provided, single submitter","VCV000031082","7","142640113","7","142943026",31082,"40039","rs8176038","NC_000007.14:142943025:A:G"
"NM_005228.5(EGFR):c.2155G>C (p.Gly719Arg)","EGFR","G719R, G666R, G452R, G674R","Non-small cell lung cancer|Squamous cell carcinoma of the head and neck","Likely pathogenic, drug response(Last reviewed: Aug 10, 2009)","no assertion criteria provided","VCV000045224","7","55241707","7","55174014",45224,"54391","rs28929495","NC_000007.14:55174013:G:C"
"NM_005228.5(EGFR):c.2155G>T (p.Gly719Cys)","EGFR","G719C, G452C, G674C, G666C","Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, somatic|Glioblastoma|Non-small cell lung cancer|Lung adenocarcinoma","Pathogenic/Likely pathogenic, drug response(Last reviewed: May 31, 2016)","no assertion criteria provided","VCV000016611","7","55241707","7","55174014",16611,"31650","rs28929495","NC_000007.14:55174013:G:T"
"NM_005228.5(EGFR):c.2155G>A (p.Gly719Ser)","EGFR","G719S, G452S, G674S, G666S","Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, somatic|Tyrosine kinase inhibitor response|Neoplasm of the large intestine|Non-small cell lung cancer","drug response(Last reviewed: Apr 20, 2012)","criteria provided, single submitter","VCV000016612","7","55241707","7","55174014",16612,"31651","rs28929495","NC_000007.14:55174013:G:A"
"NM_000941.3(POR):c.1475T>A (p.Val492Glu)","POR","V492E","Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis","Pathogenic(Last reviewed: Mar 1, 2004)","no assertion criteria provided","VCV000016901","7","75614973","7","75985655",16901,"31940","rs28931606","NC_000007.14:75985654:T:A"
"NM_000492.4(CFTR):c.3808G>A (p.Asp1270Asn)","CFTR","D1270N","CFTR-related disorders|Cystic fibrosis|ivacaftor response - Efficacy|Inborn genetic diseases|Congenital bilateral aplasia of vas deferens from CFTR mutation|not provided|Hereditary pancreatitis|not specified","drug response(Last reviewed: Mar 23, 2018)","reviewed by expert panel","VCV000007164","7","117282582","7","117642528",7164,"22203","rs11971167","NC_000007.14:117642527:G:A"
"NM_000290.4(PGAM2):c.233G>A (p.Trp78Ter)","PGAM2|DBNL","W78*","not provided|Glycogen storage disease type X","Pathogenic(Last reviewed: Feb 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000000418","7","44104896","7","44065297",418,"15457","rs10250779","NC_000007.14:44065296:C:T"
"NM_001098629.3(IRF5):c.-12+198=","IRF5","","Systemic lupus erythematosus 10|Rheumatoid arthritis","Pathogenic, risk factor(Last reviewed: Mar 15, 2008)","no assertion criteria provided","VCV000003396","7","128578301","7","128938247",3396,"18435","rs2004640","NC_000007.14:128938246:T:T"
"NM_000492.3(CFTR):c.1519A>T (p.Ile507Phe)","CFTR|CFTR-AS1","I507F","Cystic fibrosis","Likely pathogenic(Last reviewed: Dec 14, 2017)","criteria provided, single submitter","VCV000526022","7","117199644","7","117559590",526022,"522783","rs1801178","NC_000007.14:117559589:A:T"
"NM_172056.2(KCNH2):c.1468G>C (p.Ala490Pro)","KCNH2","A150P, A490P","Congenital long QT syndrome","not provided","no assertion provided","VCV000067202","7","150649602","7","150952514",67202,"78098","rs28928905","NC_000007.14:150952513:C:G"
"NM_172056.2(KCNH2):c.1714G>A (p.Gly572Ser)","KCNH2","G232S, G572S","not provided|Cardiovascular phenotype|Long QT syndrome 2|Long QT syndrome|Congenital long QT syndrome","Pathogenic(Last reviewed: Nov 8, 2019)","criteria provided, multiple submitters, no conflicts","VCV000067248","7","150648767","7","150951679",67248,"78144","rs9333649","NC_000007.14:150951678:C:T"
"NM_172056.2(KCNH2):c.1714G>T (p.Gly572Cys)","KCNH2","G232C, G572C","Congenital long QT syndrome","not provided","no assertion provided","VCV000067249","7","150648767","7","150951679",67249,"78145","rs9333649","NC_000007.14:150951678:C:A"
"NM_172056.2(KCNH2):c.1778T>A (p.Ile593Lys)","KCNH2","I253K, I593K","Long QT syndrome|Congenital long QT syndrome","Pathogenic(Last reviewed: Jul 25, 2017)","criteria provided, single submitter","VCV000067269","7","150648703","7","150951615",67269,"78165","rs28928904","NC_000007.14:150951614:A:T"
"NM_172056.2(KCNH2):c.1778T>C (p.Ile593Thr)","KCNH2","I253T, I593T","Congenital long QT syndrome|not provided","Pathogenic(Last reviewed: Feb 2, 2014)","criteria provided, single submitter","VCV000067270","7","150648703","7","150951615",67270,"78166","rs28928904","NC_000007.14:150951614:A:G"
"NM_000492.3(CFTR):c.741C>G (p.Tyr247Ter)","CFTR","Y247*","Cystic fibrosis","not provided","no assertion provided","VCV000054050","7","117175463","7","117535409",54050,"68717","rs1800082","NC_000007.14:117535408:C:G"
"NM_005045.4(RELN):c.5200C>G (p.Leu1734Val)","RELN","L1734V","not specified|Norman-Roberts syndrome|Epilepsy, familial temporal lobe, 7|Lissencephaly|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Nov 23, 2020)","criteria provided, conflicting interpretations","VCV000196901","7","103205735","7","103565288",196901,"194062","rs362800","NC_000007.14:103565287:G:C"
"NM_000492.3(CFTR):c.1519A>G (p.Ile507Val)","CFTR-AS1|CFTR","I507V","Cystic fibrosis|not provided","Benign/Likely benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000188863","7","117199644","7","117559590",188863,"186746","rs1801178","NC_000007.14:117559589:A:G"
"NM_003235.5(TG):c.6725G>A (p.Arg2242His)","TG","R2242H","not provided|Iodotyrosyl coupling defect|Autoimmune thyroid disease 3","Pathogenic(Last reviewed: Oct 11, 2019)","criteria provided, multiple submitters, no conflicts","VCV000012700","8","134030185","8","133017940",12700,"27739","rs2069566","NC_000008.11:133017939:G:A"
"NM_006096.3(NDRG1):c.538-1G>A","NDRG1","","Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4D","Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2003)","no assertion criteria provided","VCV000005121","8","134266839","8","133254596",5121,"20160","rs11575976","NC_000008.11:133254595:C:T"
"NM_000067.3(CA2):c.754A>G (p.Asn252Asp)","CA2","N252D, N151D","not provided|CARBONIC ANHYDRASE II VARIANT|Osteopetrosis with renal tubular acidosis","Benign/Likely benign(Last reviewed: Dec 31, 2019)","criteria provided, multiple submitters, no conflicts","VCV000000913","8","86392989","8","85480760",913,"15952","rs2228063","NC_000008.11:85480759:A:G"
"NM_000127.2(EXT1):c.1065C>A (p.Cys355Ter)","EXT1","C355*","Multiple congenital exostosis","Pathogenic(Last reviewed: Apr 24, 2018)","criteria provided, single submitter","VCV000570990","8","118847782","8","117835543",570990,"564600","rs11546829","NC_000008.11:117835542:G:T"
"NM_000127.2(EXT1):c.1065C>T (p.Cys355=)","EXT1","","Multiple exostoses type 1|Multiple congenital exostosis|not specified","Benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000196215","8","118847782","8","117835543",196215,"193376","rs11546829","NC_000008.11:117835542:G:A"
"NM_003995.3(NPR2):c.343T>G (p.Trp115Gly)","NPR2","W115G","Acromesomelic dysplasia, Maroteaux type","Pathogenic(Last reviewed: Jul 1, 2004)","no assertion criteria provided","VCV000017785","9","35792748","9","35792751",17785,"32824","rs28931582","NC_000009.12:35792750:T:G"
"NM_003995.3(NPR2):c.528T>A (p.Asp176Glu)","NPR2","D176E","Acromesomelic dysplasia, Maroteaux type","Pathogenic(Last reviewed: Jul 1, 2004)","no assertion criteria provided","VCV000017786","9","35792933","9","35792936",17786,"32825","rs28929479","NC_000009.12:35792935:T:A"
"NM_001701.4(BAAT):c.226A>G (p.Met76Val)","BAAT","M76V","Bile acid conjugation defect 1","Pathogenic(Last reviewed: May 1, 2003)","no assertion criteria provided","VCV000006720","9","104133461","9","101371179",6720,"21759","rs28937579","NC_000009.12:101371178:T:C"
"NM_005476.7(GNE):c.2135T>C (p.Met712Thr)","GNE","M712T, M743T, M602T, M638T, M653T, M661T","not provided|GNE myopathy|Sialuria|GNE myopathy","Pathogenic(Last reviewed: Oct 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000006025","9","36217396","9","36217399",6025,"21064","rs28937594","NC_000009.12:36217398:A:G"
"NM_000155.4(GALT):c.940A>G (p.Asn314Asp)","GALT","N314D, N205D","not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|GALT POLYMORPHISM (DUARTE, D2)|Galactosemia|not specified","Conflicting interpretations of pathogenicity, other(Last reviewed: Jun 10, 2021)","criteria provided, conflicting interpretations","VCV000003613","9","34649442","9","34649445",3613,"18652","rs2070074","NC_000009.12:34649444:A:G"
"NM_005502.4(ABCA1):c.3295G>T (p.Asp1099Tyr)","ABCA1","D1099Y","Familial hypoalphalipoproteinemia","Pathogenic(Last reviewed: May 21, 2002)","no assertion criteria provided","VCV000009501","9","107581111","9","104818830",9501,"24540","rs28933692","NC_000009.12:104818829:C:A"
"NM_005502.4(ABCA1):c.2804A>G (p.Asn935Ser)","ABCA1","N935S","Tangier disease","Pathogenic(Last reviewed: Aug 1, 1999)","no assertion criteria provided","VCV000009488","9","107584801","9","104822520",9488,"24527","rs28937313","NC_000009.12:104822519:T:C"
"NM_005502.4(ABCA1):c.2803A>C (p.Asn935His)","ABCA1","N935H","Tangier disease","Pathogenic(Last reviewed: Jan 1, 2002)","no assertion criteria provided","VCV000009498","9","107584802","9","104822521",9498,"24537","rs28937314","NC_000009.12:104822520:T:G"
"NM_000077.4(CDKN2A):c.242C>G (p.Pro81Arg)","CDKN2A","P81R, P30R","Hereditary melanoma|Hereditary cancer-predisposing syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Jan 26, 2019)","criteria provided, conflicting interpretations","VCV000463492","9","21971116","9","21971117",463492,"459469","rs11552823","NC_000009.12:21971116:G:C"
"NM_000077.4(CDKN2A):c.250G>T (p.Asp84Tyr)","CDKN2A","D84Y, R98L, D33Y","Neoplasm|Hereditary cancer-predisposing syndrome|Hereditary melanoma","Conflicting interpretations of pathogenicity(Last reviewed: Sep 19, 2020)","criteria provided, conflicting interpretations","VCV000376306","9","21971108","9","21971109",376306,"363185","rs11552822","NC_000009.12:21971108:C:A"
"NM_032888.4(COL27A1):c.3075del (p.Lys1026fs)","COL27A1","K1026fs","Steel syndrome","Pathogenic(Last reviewed: Jan 16, 2020)","no assertion criteria provided","VCV000807557","9","117014912","9","114252632",807557,"798607","rs5900078","NC_000009.12:114252631:CCC:CC"
"NM_005502.4(ABCA1):c.2803A>G (p.Asn935Asp)","ABCA1","N935D","Tangier disease","Likely pathogenic(Last reviewed: May 1, 2016)","no assertion criteria provided","VCV000374312","9","107584802","9","104822521",374312,"361192","rs28937314","NC_000009.12:104822520:T:C"
"NM_000077.4(CDKN2A):c.250G>A (p.Asp84Asn)","CDKN2A","D84N, R98Q, D33N","Hereditary melanoma|Hereditary cancer-predisposing syndrome|Melanoma-pancreatic cancer syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Sep 24, 2019)","criteria provided, conflicting interpretations","VCV000229806","9","21971108","9","21971109",229806,"233753","rs11552822","NC_000009.12:21971108:C:T"
"NM_001110792.2(MECP2):c.334C>G (p.Leu112Val)","MECP2","L100V, L112V, L7V","not provided|Rett syndrome","Pathogenic(Last reviewed: Oct 23, 2020)","criteria provided, multiple submitters, no conflicts","VCV000011835","X","153297737","X","154032286",11835,"26874","rs28935168","NC_000023.11:154032285:G:C"
"NM_012084.4(GLUD2):c.1492T>G (p.Ser498Ala)","GLUD2","S445A, S498A","Parkinson disease, late-onset","Pathogenic(Last reviewed: Mar 1, 2010)","no assertion criteria provided","VCV000029936","X","120183030","X","121049176",29936,"38891","rs9697983","NC_000023.11:121049175:T:G"
"NM_000402.4(G6PD):c.292G>A (p.Val98Met)","G6PD","V68M, V98M","Glucose 6 phosphate dehydrogenase deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD ASAHI|Inborn genetic diseases|not specified|chlorproguanil and dapsone response - Toxicity/ADR|not provided|Parkinsonism with spasticity, X-linked|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Glucose 6 phosphate dehydrogenase deficiency","drug response(Last reviewed: Oct 14, 2015)","reviewed by expert panel","VCV000037123","X","153764217","X","154536002",37123,"25400","rs1050828","NC_000023.11:154536001:C:T"
"NM_000402.4(G6PD):c.1093G>A (p.Ala365Thr)","G6PD","A335T, A365T","Susceptibility to malaria|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not specified|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD CHATHAM|not provided|Inborn genetic diseases","Pathogenic(Last reviewed: Nov 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000010363","X","153761205","X","154532990",10363,"25402","rs5030869","NC_000023.11:154532989:C:T"
"NM_000132.3(F8):c.5533A>C (p.Thr1845Pro)","F8","T1845P","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Jul 1, 1992)","no assertion criteria provided","VCV000010282","X","154133139","X","154904864",10282,"25321","rs28933676","NC_000023.11:154904863:T:G"
"NM_000169.3(GLA):c.644A>G (p.Asn215Ser)","GLA|RPL36A-HNRNPH2","N215S","not provided|Fabry disease|Fabry disease|Hypertrophic cardiomyopathy|Cardiovascular phenotype","Pathogenic(Last reviewed: Oct 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000010730","X","100653930","X","101398942",10730,"25769","rs28935197","NC_000023.11:101398941:T:C"
"NM_001278116.2(L1CAM):c.630C>A (p.His210Gln)","L1CAM","H210Q, H205Q","MASA syndrome","Pathogenic(Last reviewed: Jul 1, 1994)","no assertion criteria provided","VCV000009988","X","153136309","X","153870854",9988,"25027","rs28933683","NC_000023.11:153870853:G:T"
"NM_000132.3(F8):c.1172G>A (p.Arg391His)","F8","R391H","Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|FACTOR VIII (OKAYAMA)","Pathogenic(Last reviewed: Apr 16, 2019)","criteria provided, multiple submitters, no conflicts","VCV000010111","X","154194800","X","154966525",10111,"25150","rs28935499","NC_000023.11:154966524:C:T"
"NM_000132.3(F8):c.5336G>A (p.Gly1779Glu)","F8","G1779E","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Dec 1, 1993)","no assertion criteria provided","VCV000010273","X","154134732","X","154906457",10273,"25312","rs28937289","NC_000023.11:154906456:C:T"
"NM_000047.2(ARSL):c.1732C>T (p.Pro578Ser)","ARSL","P578S, P524S, P603S, P587S","X-linked chondrodysplasia punctata 1","Pathogenic(Last reviewed: Nov 3, 2011)","no assertion criteria provided","VCV000011528","X","2852911","X","2934870",11528,"26567","rs28935474","NC_000023.11:2934869:G:A"
"NM_001110556.2(FLNA):c.620C>T (p.Pro207Leu)","FLNA","P207L","not specified|Oto-palato-digital syndrome, type I|Cleft palate|Conductive hearing impairment|Short stature","Pathogenic(Last reviewed: Nov 20, 2018)","criteria provided, multiple submitters, no conflicts","VCV000011755","X","153596212","X","154367844",11755,"26794","rs28935469","NC_000023.11:154367843:G:A"
"NM_001110792.2(MECP2):c.433C>T (p.Arg145Cys)","MECP2","R133C, R145C, R40C","Inborn genetic diseases|not specified|not provided|Severe neonatal-onset encephalopathy with microcephaly|Intellectual disability|Rett syndrome|Mental retardation, X-linked, syndromic 13|Angelman syndrome|Rett syndrome, zappella variant|History of neurodevelopmental disorder","Conflicting interpretations of pathogenicity(Last reviewed: Feb 12, 2021)","criteria provided, conflicting interpretations","VCV000011809","X","153296882","X","154031431",11809,"26848","rs28934904","NC_000023.11:154031430:G:A"
"NM_000054.6(AVPR2):c.337C>T (p.Arg113Trp)","AVPR2","R113W","Nephrogenic diabetes insipidus, X-linked","Pathogenic(Last reviewed: May 27, 1993)","no assertion criteria provided","VCV000010840","X","153171297","X","153905843",10840,"25879","rs28935496","NC_000023.11:153905842:C:T"
"NM_000169.2(GLA):c.797A>T (p.Asp266Val)","GLA|RPL36A-HNRNPH2","D266V","not provided|Fabry disease","Pathogenic(Last reviewed: Jan 12, 2021)","criteria provided, multiple submitters, no conflicts","VCV000010735","X","100653777","X","101398789",10735,"25774","rs28935487","NC_000023.11:101398788:T:A"
"NM_001011551.3(C1GALT1C1):c.393T>A (p.Asp131Glu)","C1GALT1C1","D131E","Polyagglutinable erythrocyte syndrome","Benign(Last reviewed: Dec 3, 2020)","criteria provided, single submitter","VCV000010792","X","119760629","X","120626774",10792,"25831","rs17261572","NC_000023.11:120626773:A:T"
"NM_000381.4(MID1):c.1877T>C (p.Leu626Pro)","MID1","L626P, L588P","Opitz GBBB syndrome, type I","Pathogenic(Last reviewed: Oct 12, 2000)","no assertion criteria provided","VCV000010808","X","10417535","X","10449495",10808,"25847","rs28934611","NC_000023.11:10449494:A:G"
"NM_004463.3(FGD1):c.1829G>A (p.Arg610Gln)","FGD1","R610Q","not provided|Aarskog syndrome","Pathogenic(Last reviewed: Mar 30, 2016)","criteria provided, single submitter","VCV000010825","X","54482666","X","54456233",10825,"25864","rs28935497","NC_000023.11:54456232:C:T"
"NM_004463.3(FGD1):c.935C>T (p.Pro312Leu)","FGD1","P312L","not provided|Aarskog syndrome|Syndromic X-linked mental retardation 16|Intellectual disability|History of neurodevelopmental disorder","Conflicting interpretations of pathogenicity(Last reviewed: May 1, 2018)","criteria provided, conflicting interpretations","VCV000010828","X","54496615","X","54470182",10828,"25867","rs28935498","NC_000023.11:54470181:G:A"
"NM_139058.3(ARX):c.98T>C (p.Leu33Pro)","ARX","L33P","Mental retardation, with or without seizures, ARX-related, X-linked","Pathogenic(Last reviewed: Apr 15, 2002)","no assertion criteria provided","VCV000011198","X","25033757","X","25015640",11198,"26237","rs28936077","NC_000023.11:25015639:A:G"
"NM_139058.3(ARX):c.856G>A (p.Gly286Ser)","ARX","G286S","Mental retardation, with or without seizures, ARX-related, X-linked|Epileptic encephalopathy, early infantile, 1|Mental retardation, with or without seizures, ARX-related, X-linked|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Oct 8, 2020)","criteria provided, conflicting interpretations","VCV000011199","X","25031256","X","25013139",11199,"26238","rs28935479","NC_000023.11:25013138:C:T"
"NM_021083.4(XK):c.880T>C (p.Cys294Arg)","XK","C294R","McLeod neuroacanthocytosis syndrome","Pathogenic(Last reviewed: Dec 1, 2001)","no assertion criteria provided","VCV000009768","X","37587260","X","37728007",9768,"24807","rs28933690","NC_000023.11:37728006:T:C"
"NM_000354.5(SERPINA7):c.631G>A (p.Ala211Thr)","SERPINA7","A191T, A211T","not provided|Thyroxine-binding globulin deficiency|Thyroxine-binding globulin, variant A","Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)","criteria provided, conflicting interpretations","VCV000009784","X","105279368","X","106035377",9784,"24823","rs2234036","NC_000023.11:106035376:C:T"
"NM_001110792.2(MECP2):c.433C>A (p.Arg145Ser)","MECP2","R133S, R145S, R40S","not provided|Inborn genetic diseases","Likely pathogenic(Last reviewed: Apr 17, 2018)","criteria provided, multiple submitters, no conflicts","VCV000547103","X","153296882","X","154031431",547103,"537592","rs28934904","NC_000023.11:154031430:G:T"
"NM_000531.6(OTC):c.809A>G (p.Gln270Arg)","OTC","Q270R","Ornithine carbamoyltransferase deficiency|not specified|History of neurodevelopmental disorder","Benign/Likely benign(Last reviewed: May 18, 2021)","criteria provided, multiple submitters, no conflicts","VCV000129867","X","38268220","X","38408967",129867,"135313","rs1800328","NC_000023.11:38408966:A:G"
"NM_001110792.2(MECP2):c.433C>G (p.Arg145Gly)","MECP2","R133G, R145G, R40G","Rett syndrome","Uncertain significance(Last reviewed: Jan 21, 2008)","no assertion criteria provided","VCV000143558","X","153296882","X","154031431",143558,"153290","rs28934904","NC_000023.11:154031430:G:C"
"NM_000531.6(OTC):c.809A>C (p.Gln270Pro)","OTC","Q270P","not provided","Pathogenic","no assertion criteria provided","VCV000097336","X","38268220","X","38408967",97336,"103228","rs1800328","NC_000023.11:38408966:A:C"
"NM_000402.4(G6PD):c.466A>G (p.Asn156Asp)","G6PD","N126D, N156D","Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD A+|Glucose 6 phosphate dehydrogenase deficiency|Inborn genetic diseases|not provided|Bone mineral density quantitative trait locus 18|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Glucose 6 phosphate dehydrogenase deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Susceptibility to malaria|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Apr 8, 2021)","criteria provided, conflicting interpretations","VCV000100055","X","153763492","X","154535277",100055,"25399","rs1050829","NC_000023.11:154535276:T:C"
"NM_000402.4(G6PD):c.653C>T (p.Ser218Phe)","G6PD","S188F, S218F","none provided|Hemolytic anemia, G6PD deficient (favism)|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD SASSARI|G6PD CAGLIARI|Glucose 6 phosphate dehydrogenase deficiency|G6PD MEDITERRANEAN|Inborn genetic diseases|not provided|G6PD deficient hemolytic anemia|Angioedema induced by ACE inhibitors, susceptibility to|Susceptibility to malaria|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Susceptibility to malaria","Conflicting interpretations of pathogenicity(Last reviewed: Feb 1, 2021)","criteria provided, conflicting interpretations","VCV000100057","X","153762634","X","154534419",100057,"25407","rs5030868","NC_000023.11:154534418:G:A"
"NM_001278116.2(L1CAM):c.630C>T (p.His210=)","L1CAM","","not provided","Uncertain significance(Last reviewed: Jun 6, 2013)","criteria provided, single submitter","VCV000092933","X","153136309","X","153870854",92933,"98840","rs28933683","NC_000023.11:153870853:G:A"
"NM_000169.3(GLA):c.797A>C (p.Asp266Ala)","GLA|RPL36A-HNRNPH2","D266A","not specified","Uncertain significance(Last reviewed: Mar 11, 2015)","criteria provided, single submitter","VCV000228701","X","100653777","X","101398789",228701,"231408","rs28935487","NC_000023.11:101398788:T:G"
